Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Global health leaders discuss strategic medical innovation. From the left: Isabelle Kumar (moderator), Monique Vledder (World Bank), Penny Heaton (Johnson & Johnson), Florika Fink-Hooijer (EU HERA), and Michael Lobritz (Roche). Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of the luxurious Intercontinental Hotel, during a flagship event hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on Tuesday, large screens broadcast a simple promise of continuous innovation so that “the next generation of medicines and vaccines can deliver a healthier, stronger future”. “Pharmaceutical innovation has accounted for more than 70% of the increase in life expectancy across G20 and developing countries,” said moderator Isabelle Kumar in her opening remarks. But at the same time, G20 economies are losing an estimated one trillion dollars every year to preventable health conditions, she added. Exploring solutions at scale, the panel keynotes and discussions bridged public, private, and geopolitical sectors. The high-level speakers included Canadian Minister of Health Marjorie Michel and AstraZeneca chair Michel Demaré. They were followed by a panel discussion with Monique Vledder, World Bank Group global director, Florika Fink-Hooijer, Director-General of the EU’s Health Emergency Preparedness and Response Authority (HERA), Penny Heaton of Johnson & Johnson, and Michael Lobritz of Roche. The experts acknowledged that global health architecture currently faces immense strain from escalating vulnerabilities, including ageing populations, antimicrobial resistance, and rising rates of non-communicable diseases. Consequently, leaders urged a major mindset shift, positioning sustained investments in medical innovation as vital catalysts for economic growth. Health investments’ economic potential Despite their differing mandates, the panellists reached a firm consensus: governments must abandon short-term budgeting and invest in medical innovation to secure long-term national resilience and productivity. This demands a profound departure from reactive spending toward proactive strategic investments. IFPMA Director General David Reddy. Echoing this shared conviction during his concluding remarks, IFPMA Director General David Reddy emphasised the overarching economic value of the sector. “Investing in health innovation is not a tradeoff, it’s a multiplier,” said Reddy. To explain the broader economic stakes, the World Bank’s Vledder noted that an unhealthy workforce fundamentally stalls local economies, while funds flowing into the health sector offer tremendous potential for job creation. Industry pushes for tripling of prevention budgets AstraZeneca Chair Demaré reinforced this point, stating that a healthy population experiences fewer sick days and drives higher productivity. He highlighted that establishing a healthy global population could boost the GDP by 7% by 2050 – an economic gain equivalent to the combined economies of Germany and Japan. “So we need a mindset change here to look at medicine and especially innovative medicines as an investment for the future,” said Demaré. Early diagnosis and preventative treatments could drastically reduce long-term hospital costs and boost this overall economic productivity. Currently, OECD countries allocate an average of only 3% of their healthcare budgets to prevention, a figure Demaré argued should double or triple to have a real impact. He emphasised that this shift should rely heavily on functional public-private partnerships, pointing to specific collaborative efforts, such as the Partnership for Health System Sustainability and Resilience, which assesses health systems across more than 30 countries to identify localised governance gaps and propose targeted technological solutions. Canada announces strategic investment Canadian Health Minister Marjorie Michel announced a $131 million public investment into the Pan-Canadian Pharmaceutical Alliance. In the spirit of the industries’ demands, Canada positioned itself as a pragmatic, reliable partner in the global supply chain, navigating amidst geopolitical instability and contrasting its approach with nations relying heavily on threats and tariffs – an indirect reference to the United States under President Trump. “Tariffs are not the Canadian way. Our values are anchored in respect yet viability, predictability and collaboration and the fundamental belief in talent and research,” said Michel. Breaking news on the IFPMA stage, she announced a fresh $131 million injection into the Pan-Canadian Pharmaceutical Alliance. The public investment aims to unify Canada’s fragmented healthcare system into a single market, thereby accelerating drug price negotiations and reducing administrative burdens. The government had also previously announced $1.7 billion to attract world-leading researchers, transforming the nation into a clinical trial powerhouse. By modernising clinical trial frameworks and aligning with international regulators, Canada aims to reduce the time between drug submission and approval by up to 50%. “We need a regulatory system that is timely, predictable, and grounded in science. One that fiercely protects Canadians while giving companies a clear reason to invest in Canada,” said Michel. AstraZeneca Chair Michel Demaré calls for tripling prevention budgets during an IFPMA panel discussion. Europe pivots to security amidst new threats Across the Atlantic, the EU is also heavily investing in its pharmaceutical sector to secure long-term strategic autonomy. Recent legislative moves, such as the Critical Medicines Act, aim to prevent medicine shortages, boost domestic manufacturing, and position the bloc as a global leader by fostering a competitive innovation ecosystem. However, these proactive health initiatives face a formidable obstacle: severe budget constraints compounded by escalating geopolitical conflicts. As financial resources shrink across Europe, medical innovation is increasingly losing critical funding to traditional military priorities against the backdrop of Russia’s ongoing war in Ukraine and increased geopolitical tension. “We had quite a stable budget, and then the political levels decided… we have security as a major risk. So we lost €1 billion… because indeed health got the lower priority,” said Fink-Hooijer. HERA Director-General Florika Fink-Hooijer. To maintain regional production capacity and true preparedness, Fink-Hooijer argued that European officials can no longer view medical innovation merely as an ad hoc healthcare cost. Instead, they must treat it as a foundational pillar of geopolitical defence through structured investments. Reflecting this shift in mindset, HERA actively bridges the gap between health and traditional security by establishing a dedicated unit to monitor advanced biowarfare risks. “We do have now also a civil-military unit in order to really look at that type of threat scenario… because we know that it could also be with AI abuse due to other types of artificial or intentionally produced pathogens,” Fink-Hooijer announced. Meanwhile, restricted public budgets inevitably force regulatory bodies into making high-stakes gambles on future threats. HERA recently directed its scarce resources toward developing a vaccine for the Ebola Sudan strain – a calculated strategic bet that became a bad choice in hindsight, Fink-Hooijer admitted, as it completely missed the current outbreak. Fragility, fragmentation and folly Roche’s Michael Lobritz outlined the industry’s structural vulnerabilities through what he termed the “three Fs”: fragility, fragmentation, and folly. While scientific capabilities accelerate at unprecedented rates and countries compete over production capacities, the global health architecture remains vulnerable to fragmented supply chains. Roche’s Lobritz outlined the industry’s structural weak points through what he termed the “three Fs”: fragility, fragmentation, and folly. He warned that innovation pipelines remain extremely fragile, lacking the investor capital necessary to mature early-stage compounds. Out of 14 viral families with pandemic potential, there are currently only 18 clinical compounds in development, mirroring similar capital shortages in the antimicrobial resistance market. Furthermore, fragmented ecosystems prevent diverse health sectors from coordinating effectively, leading to the dangerous folly of relying on reactive scaling during a sudden crisis without prior preparation. True resilience demands sustained, peacetime collaboration to ensure every therapeutic agent is ready before the crisis hits. Likening the pharmaceutical supply chain to a bustling restaurant kitchen handling a massive dinner rush, he emphasised the vast, unseen preparation required behind the scenes to successfully deliver the final product. “The creation of a novel medicine that changes the course of the life of an individual is not an eventuality or a certainty and needs to be supported,” concluded Lobritz. Addressing the global healthcare gap For this, governments must invest, also to ensure life-saving medical innovation actually reaches the populations that need it most, the participants argued. Outside the IFPMA ballroom, however, health equity advocates caution that framing high-cost pharmaceutical innovation and public-private partnerships as primary drivers of economic resilience can overshadow the need for fundamental strengthening of public health infrastructure, particularly in low- and middle-income countries where access to basic therapeutics remains a major obstacle. The challenge extends far beyond laboratory breakthroughs to the ultimate end-user. Outlining the World Bank’s current attempt to reach 1.5 billion people with essential health services, Vledder acknowledged that scientific innovation means little if delivery systems in fragile states remain broken. Global Health Needs More than Money – Philanthropy Can Amplify Impacts Image Credits: Felix Sassmannshausen/HPW. Russia Tries to Block Debate on Attacks on Health Facilities in Ukraine 20/05/2026 Disha Shetty Interior of a hospital room in Kherson heavily damaged during conflict, showing extensive structural destruction and debris. Neither Russia’s delegate banging her desk to interrupt Ukraine’s representative speaking at the World Health Assembly (WHA), nor her request to dismiss debate, stopped member states from condemning Russia’s attacks on Ukraine’s health system. A report by the World Health Organization’s (WHO) Director-General before delegates estimated that Russia’s aggression on Ukraine has caused 55,600 civilian casualties, including 14,999 deaths. Violence intensified in 2025 with civilian casualties going up by 31% compared to the previous year, and by 70% when compared to 2023. The WHO also documented 579 attacks on healthcare facilities that caused 19 deaths and 204 injuries among healthcare workers and patients in 2025. This was an 18% increase compared to 2024. “Since this report was published, WHO has recorded 190 new attacks on health care, with 86 injuries and 15 deaths between 1 January and 6 May, 2026,” said Dr Altaf Mossani, Director of Humanitarian Disaster Management, WHO Emergency Preparedness and Response program. “On May 14, a clearly marked United Nations vehicle was severely damaged by drone strikes in Kherson City. This is the second incident that week,” he added. Russia targeting healthcare infrastructure The 79th World Health Assembly in session. Countries raised alarm at the WHA that 202 of Ukraine’s 11,887 health facilities have been severely damaged, and 1,013 units are partially damaged. “We strongly condemn Russia’s ongoing war of aggression against Ukraine and the deliberate escalation of attacks targeting civilians and civilian infrastructure, including health care facilities, and we are deeply alarmed by the sharp increase in attacks on the health infrastructure since the last World Health Assembly,” Moldova’s representative told the WHA. Civilian attacks also drew sharp criticism, leaving Russia isolated during the discussion. “Russia’s attacks on energy infrastructure and other civilian targets, such as hospitals, elderly homes, or kindergartens, became increasingly vicious and brutal,” said Germany’s delegate. “On average, it has been said already, there have been more than 3,000 Russian attacks directly affecting health care institutions, two each day.” Ghana empathised with countries that are receiving a large number of refugees from Ukraine as a result of the conflict, resulting in an additional burden on their health systems. High drama by the Russian representative Russia’s representative to the WHA banged the desk to interrupt Ukraine’s speaker and called the WHO’s report on the health situation in Ukraine “disinformation.” Russia’s representative first moved to dismiss the debate on the report on Ukraine entirely. That request was put to a vote and defeated. Following extensive discussion on the report, Russia again moved to stop the WHA from noting the report. Russia was reminded that noting the report was merely procedural, but it requested a vote again. Once again, countries voted in favour of noting the report. At one point, the Russian representative banged the desk several times to interrupt the Ukrainian speaker, and was reminded to raise the country’s flag if she wanted to make a statement. Russia then accused the WHO of spreading misinformation. “WHO is talking only about attacks on Ukraine, ignoring the information that has been submitted to WHO on attacks on Russian facilities. So, we would ask WHO to stop misleading the world and to stop disseminating misinformation when it comes to voting on this report,” the representative accused. WHO’s report noted that there were 21 attacks on healthcare facilities in Russia, causing 17 injuries. Russia did not agree with this number. However, the Russian representative said, “more than 250 Russian facilities were attacked by Ukraine, and only 35 of them have been officially reported by WHO. And indeed, in the report, even that figure has deliberately been lowered”. Russia opposed the noting of the report by the WHA. The report was noted nevertheless, following a vote. Polio needs attention Polio remains endemic in the WHO’s Eastern Mediterranean Region (EMRO) region. WHA also discussed polio that remains an issue in several countries like Pakistan and Afghanistan. Conflicts and funding cuts have in recent years interrupted polio vaccination campaigns. In Gaza, polio made a resurgence as conflict raged. Most of these areas fall under the WHO’s Eastern Mediterranean Region (EMRO) region. “We are actually the last part of the world where that virus remains endemic, but we are doing our utmost to tackle this issue. We have seen, however, that in Afghanistan and Pakistan there have been declines in transmission trends, and we think that is a cause for optimism about wild polio virus transmission,” Libya said, making a statement on behalf of the EMRO region. Other countries reminded the WHA that polio is still a relevant issue that needs attention. “We wish to recall that polio is still a global health challenge because new cases of wild polio have been recorded in certain countries, and there are new coast cases in conflict areas. Then, hence, the need for further international effort to ensure that we have national and regional preparedness,” Oman’s representative told the WHA. Also read: Polio Eradication Imperiled by $2.3 Billion Funding Gap Image Credits: WHO Ukraine, X/WHO, WHO. WHO: Ebola Outbreak Is a Deadly Regional Threat But Not a Global Pandemic Risk 20/05/2026 Stefan Anderson The WHO has determined that the Ebola outbreak raising alarm worldwide does not pose a pandemic threat. GENEVA — The Ebola outbreak unfolding in the Democratic Republic of Congo (DRC) and Uganda poses a “low” risk globally, according to an expert committee of the World Health Organization (WHO). However, the national and regional risk is “high”, according to the International Health Regulations (IHR) Emergency Committee. Last Sunday, WHO Director-General Dr Tedros Adhanom Ghebreyesus had already declared the outbreak a public health emergency of international concern (PHEIC), the WHO’s second-highest level of alert, before convening the emergency committee. This is the first time in WHO’s history that this has occurred. Tedros was motivated by the scale and speed of the spread of the Bundibugyo virus, a rare and particularly deadly strain of Ebola, which has killed at least 131 people and infected over 500 others. The emergency meeting, convened on Tuesday to assess the threat of the current outbreak, concurred that the situation is a PHEIC but “not a pandemic emergency,” Tedros told a media briefing on Wednesday. The committee, chaired by Professor Lucille Blumberg, agreed with the Director-General’s assessment and is finalising its recommendations in the coming days. “Our prime aim was to support the decision and decide whether this is a public health emergency of international concern, and to consider whether there’s a pandemic emergency. The former was agreed to,” Blumberg said. Investigations into the outbreak’s origin Anaïs Legand speaking at the emergency press conference on the Ebola crisis. “Investigations are ongoing to ascertain when and where exactly this outbreak started,” said Anaïs Legand, a technical officer for high-threat pathogens at WHO’s health emergencies programme. “Given the scale, we are thinking that it has started probably a couple of months ago, but investigations are ongoing, and our priority is really to cut the transmission chain by implementing contact tracing, isolating and caring for all suspect and confirmed cases.” The Bundibugyo species was last seen in 2007, and there is currently no vaccine or treatment licensed for it. Investigators say the true scale of the epidemic in DRC is much larger than current case counts suggest. War, and a very long drive Dr Mohamed Yakub Janabi, WHO’s regional director for Africa. WHO officials laid out several reasons the outbreak escaped detection. The province of Ituri, where it emerged, is engulfed in war. Fighting between the DRC army and the M23 armed group has intensified in recent months, displacing more than 100,000 people. Beyond the conflict, eastern DRC is among the most challenging places in the world to mount a public health response. Health facilities are sparse, roads are limited, and much of the terrain is forested and mountainous. A previous Ebola outbreak in the same region in 2018-19 took close to two years to bring under control, even with a licensed vaccine available. Dr Mohamed Yakub Janabi, WHO’s regional director for Africa, said the combination of factors made early detection enormously difficult. “Detecting outbreaks such as Ebola in a complex setting like Ituri province in the DRC is inherently challenging,” he said. “Surveillance systems rely on a combination of community reporting, local health facilities, lab confirmation, and partner coordination.” Samples from the outbreak zone must travel 1,700 kilometres to reach the Institut National de Recherche Biomédicale in Kinshasa, the only facility in the country with the capacity to test for Bundibugyo. The distance to the capital is comparable to London to Warsaw – a roughly a 24-hour drive on smooth European roads, a far cry from the remote jungle tracks and dirt roads of Ituri. “In remote or insecure areas, it can take time for cases to be recognised and samples transported,” Janabi said. Symptoms mistaken for endemic diseases Nearly 7 tonnes of emergency medical supplies and equipment along with a team of 35 experts from WHO and the DRC’s health ministry, arrived today in Bunia from Kinshasa to support frontline #Ebola response in Ituri Province. The Bundibugyo strain’s early symptoms also overlap with diseases endemic to eastern DRC, leading health workers to mistake initial cases for more common illnesses. “Nonspecific early symptoms, for instance, if you take malaria and typhoid, the early symptoms are the same,” Tedros said. “The region is very endemic to those diseases, so the health workers will associate the early signs with malaria or typhoid, and they can’t diagnose based on the symptoms. They may start treating that.” Dr Abdi Mahamud, WHO’s director for health emergency alert and response operations, said the diagnostic challenge would have tripped up better-resourced systems. “This outbreak is happening in a highly endemic [setting for] other diseases that present similar symptoms – malaria, dysentery, and others,” he said. “If you don’t have that high index of suspicion, if you don’t have the right facility to test, even in high-income countries, you will have that delay in the start of an outbreak.” Diagnostic tests routinely used across the region added another layer of delay. The Bundibugyo strain belongs to a different genus, Orthoebolavirus, than the more common Zaire strain that most existing tests are optimised to detect. “There was a problem linked to the traditional test we use,” Tedros said. “The traditional test is optimised with Zaire, and the same sample was taken and tested, but since the test kit is optimised with Zaire, [Bundibugyo] could not be detected.” No vaccine, but a pipeline Vasee Moorthy, WHO’s research and development lead on the current outbreak, laid out the state of the vaccine pipeline for the Bundibugyo strain. The Bundibugyo strain has no licensed vaccine or therapeutic. WHO’s research and development lead, Vasee Moorthy, said a pipeline of candidates is being accelerated but remains months away. Moorthy said the most promising candidate is an rVSV Bundibugyo vaccine, the equivalent for this strain of Ervebo, the licensed Merck vaccine used against the more common Zaire Ebola strain since 2019. “There are no doses of this which are currently available for clinical trial, so this needs to be prioritised,” Moorthy said. “The information that we have is that this is likely to take six to nine months.” A second candidate, built on the ChAdOx1 platform used in the AstraZeneca COVID-19 vaccine, is being developed by Oxford and the Serum Institute of India. “They are manufacturing that as we speak, but there is no animal data to support [its efficacy],” Moorthy said. “It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty about that.” Even in the most optimistic scenario, neither candidate is likely to be available to materially shape the trajectory of the current outbreak. In the meantime, the response is being built around the basics: safe treatment centres, patient referral pathways, contact tracing, and the protection of health workers, among whom the first confirmed case in the outbreak was identified. “The protection of healthcare workers and families is absolutely paramount,” Blumberg said. “The people in the area and those who respond need to be kept safe and allowed to be able to do what they need to do in a critical time such as this.” Tedros: Rubio suffers ‘lack of understanding’ US Secretary of State Marco Rubio. The WHO chief used the press conference to push back at US Secretary of State Marco Rubio, who said this week the agency had been “a little late to identify this thing.” The US has banned citizens of the DRC, Uganda and Sudan from entry, closed its only dedicated Ebola lab, withdrawn from the WHO, and defunded the agency. “On what the Secretary said, it could be from a lack of understanding of how IHR works, and the responsibilities of WHO and other entities,” Tedros said. “We don’t replace the country’s work, we only support them, so that’s why there could be some lack of understanding.” Tedros suggested conflict in the affected region was a more fundamental factor in the delay than anything WHO could have done differently. “Health facilities cannot work optimally when there is conflict and when the health workers are also fleeing as part of the community which is displaced,” he said. “It affects the whole surveillance system, and not only that, but it also affects access.” “I think that’s what we should understand, the secretary or others.” Asked repeatedly whether US funding cuts to DRC surveillance programmes had contributed to the outbreak going undetected, Tedros declined to draw a direct line. “We don’t need to jump to conclusions before we understand the whole complexity. It would be very difficult to associate it with funding alone,” he said, noting that the diagnostic gap was a question of the wrong tests being administered rather than supply. Legand echoed the point, noting the issue stems from test type, not supply: “For the time being, it’s not a supply issue. We need to ensure that the right platform with the right data arrives at the right place. This is the work that is being done as we speak.” The outbreak, meanwhile, continues to spread through a war zone with no vaccine, no cure, and a diagnostic system still catching up to the strain it now faces. Image Credits: @WHO African Region, Gage Skidmore. Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ 18/05/2026 Kerry Cullinan WHA president Dr Víctor Atallah (Dominican Republic), Spanish Prime Minister Pedros Sánchez, and WHO Director General Dr Tedros Adhanom Ghebreyesus. “From conflicts to economic crises to climate change and aid cuts, we live in difficult, dangerous and divisive times,” World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyesus told the opening plenary of the World Health Assembly (WHA) on Monday. While geopolitical disagreements have delayed Tedros’s official WHA address until Tuesday morning, the Director General acknowledged in a brief welcome that the WHO “has been through a difficult period as a result of sudden and steep cuts to our funding”. The organisation’s budget is 90% funded, although some of the funds are pledged rather than in the bank. Spain’s Prime Minister Pedro Sánchez, a WHA special guest speaker, appealed for solidarity and multilateral support for global health to combat “the pandemic of egotism and selfishness”. Sánchez said that Spain had increased its official development aid (ODA) by 30%, explaining: “No country can save itself. Protecting others is the best way to protect ourselves.” Without naming the United States, he added: “The greatest risk for global health is no longer the lack of science, but rather the lack of conscience. In just a few months, the same country that cut $18 billion from global public health and ODA has spent more than $29 billion on war, the humanitarian and geopolitical consequences of which will also be devastating.” Sánchez, who received a standing ovation, also appealed for countries in the Global South to “have the role that they deserve in decision-making”, and that the reform of global health needed to be focused on strengthening national health centres. Reforming global health The WHA is considering how to reform the “global health architecture”. Ghanaian President John Dramani Mahama, also a special guest speaker at the plenary, appealed for a more inclusive system of multilateralism. “I’m concerned about whispers I have heard that the draft resolution [on global health reform] seeks to protect existing organisational mandates and prohibit the recommendation of mergers or consolidations,” said Mahama, who is championing Africa’s health sovereignty through the Accra Reset Initiative. “If we launch a process of reform that is prohibited from recommending actual reform, we are merely performing a ritual. We cannot prioritise institutional comfort over human survival. The WHO’s legitimacy is not served by protecting silos. It is served by a fearless analysis of what works,” Mahama warned. Barbados’ Prime Minister Mia Mottley also appealed for a more responsive global health system: “Small states are not asking for pity. We’re asking for a system that recognises reality. Vulnerability is not measured by income alone. Fiscal space must be judged alongside climate risk, debt burden, disease burden, and yes, the cost of survival.” Motley also stressed that emergency funds must move with the speed of an emergency. “The WHO must not be asked to protect eight billion people on Planet Earth on the basis of uncertain contributions and political mood swings,” she said – a reference to the withdrawal from the WHO by the US. Syrian President Ahmed Hussein al-Sharaa addressing the WHA via a video link. Syrian President Ahmed Hussein al-Sharaa, who until December of last year was on both the UN and the US list of global terrorists facing sanctions, also addressed the plenary via video. Shortly after the opening, the business of the WHA was delayed by several hours by geopolitical disagreements, with some issues going to a vote. Member states decided against including Taiwan as an observer, but voted overwhelmingly in favour of a request by the Gulf Cooperation Council to discuss the impact of Iran’s recent attacks later in the week. Israel’s objection to the tabling of two separate reports on health conditions in the occupied Palestinian territory (OPT) – including one on the immense toll of the recent Gaza war and increasing Israeli military and settler violence affecting West Bank Palestinian communities – also delayed proceedings. The WHA has a massive agenda, including approving a new tuberculosis strategy and a plan on combating strokes; a global action plan on antimicrobial resistance (AMR) – still outstanding since the AMR UN high-level meeting two years ago; and how to improve emergency care. Zero for 52: WHO Warns World Set to Miss Every Global Health Target by 2030 18/05/2026 Stefan Anderson Annual report finds progress slowing, stalling or reversing across every global health set out in the SDG agenda. The world is on course to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the World Health Organization has warned, as ministers from its 194 member states gather in Geneva for an assembly tasked with reversing that trajectory. With malaria cases rising, maternal deaths still occurring at nearly three times the targeted rate and childhood vaccination coverage plateauing or falling in some regions, progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 edition of the WHO’s World Health Statistics report. “Progress is too slow, too uneven, and increasingly fragile,” Yukiko Nakatani, WHO assistant director-general for health systems, access and data, told a press briefing on Wednesday. “The report is an urgent reminder for member states and all health partners together: we must refocus efforts, safeguard hard-won gains and renew progress.” WHO Director-General Dr Tedros Adhanom Ghebreyesus said progress toward the health goals was “insufficient, uneven across regions and populations, and increasingly vulnerable to systemic shocks”, with a disproportionate burden falling on low- and middle-income countries, especially those in fragile and conflict-affected settings. “Progress has stalled on universal health coverage, maternal and child health and reduction in premature mortality due to noncommunicable diseases — which remain the leading causes of mortality globally,” Tedros said. “These data tell a story of both progress and persistent inequality,” the WHO chief added, “with many people – especially women, children and those in underserved communities – still denied the basic conditions for a healthy life.” Once achievable health targets out of reach The UN estimates that around 17% of SDG targets are on track globally. The SDG health targets are part of a wider agenda adopted by all UN member states in 2015, setting goals on poverty, hunger, education, gender equality, climate and health by 2030. The third goal — “ensure healthy lives and promote well-being for all at all ages” — sets the dozens of indicators tracked by the annual WHO report, ranging from maternal mortality and HIV incidence to tobacco use and air pollution deaths. These were once seen as among the most achievable of the SDGs, given significant progress made under the agenda’s predecessor, the Millennium Development Goals. That hope has not materialised — and the wider SDG agenda is faring no better, with the latest UN figures finding only about a sixth of all targets on course for the 2030 deadline. “Of the 52 health-related SDG indicators reviewed in this report, more than half have numeric SDG or other global targets,” WHO found. “And none is on track to meet the target at the global level.” Malaria reversing, TB barely moving Tuberculosis incidence rates, globally and by WHO region, 2015, 2024 and the 2030 target. The reversal of progress in eradicating malaria is perhaps the starkest failure on the SDG health agenda. While the world set a target to reduce cases by 90% by 2030, global incidence has instead risen by 8.5%. The African Region carries nearly the entire global burden, recording an estimated 282 million cases in 2024. Only the South-East Asia Region is on track to meet the 2025 milestone of a 75% reduction. Tuberculosis is another major failure: of the 80% reduction target set in the WHO End TB Strategy, just 12% has been achieved since 2015. The European Region cut its TB rate by 39% over the period, while the Region of the Americas went backwards, recording a 13% increase. The African Region, despite still bearing the highest burden, achieved a 28% reduction, more than double the global average. The HIV picture is brighter, with new infections falling 40% since 2010 to 1.3 million worldwide in 2024. The African Region has cut new infections by 70% — a major achievement — but still accounts for 65% of the 40.8 million people living with HIV worldwide. Yet HIV incidence cuts remain well short of the 90% SDG target. Hope circulated before 2015 that ending the AIDS epidemic by 2030 was within reach, has faded away. Maternal and child deaths: progress stalling Maternal mortality ratio, by WHO region, 2000–2023. The global maternal mortality ratio has fallen 40% since 2000, but at 197 deaths per 100,000 live births in 2023 it remains nearly three times the 2030 target of fewer than 70 deaths per 100,000 live births. The annual rate of reduction has slowed to 1.6% since 2015. The world needs that figure to climb to nearly 15% to hit the SDG, a pace more than nine times faster than the world has managed over the past quarter century. Doing so would mean preventing nearly 700,000 maternal deaths by 2030. Each day, 712 women still die from maternal causes — one every two minutes. A staggering 80% of those deaths occur in sub-Saharan Africa, where girls face a one-in-40 chance of dying of pregnancy-related complications by age 15. Central and Southern Asia come a distant second, accounting for 17% of the global death toll. Globally, nearly 95% of all maternal deaths occur in low- and lower middle-income countries. Meanwhile, 73 countries, mostly in Europe, Latin America and the Caribbean, recorded fewer than 20 maternal deaths in 2020. Vaccination coverage flatlines Global immunization rates against diphtheria, tetanus and pertussis, measles, pneumococcal infections, and human papillomavirus, 2000–2024. Routine childhood immunisation has largely flatlined, with global coverage stuck below the levels needed to prevent the outbreaks of vaccine-preventable diseases now resurging in several regions. Coverage with the third dose of the diphtheria-tetanus-pertussis vaccine has plateaued at around 85%, while second-dose measles vaccination sits at 76% — far below the roughly 95% the WHO says is needed to prevent outbreaks. The Region of the Americas, once a global leader on routine immunisation, now reports lower coverage for three of four core vaccines than in 2015. The WHO has linked persistent immunity gaps to the rising measles transmission reported across several regions over the past year, including major outbreaks in the United States, Europe and parts of the Eastern Mediterranean. Coverage of the human papillomavirus vaccine, which protects against cervical cancer, has grown faster than any other core vaccine since 2021 — but from a very low base, reaching just 28% of the target group of 9-14-year-old girls globally in 2024. A pandemic toll three times larger than officially recorded Excess death rates (crude and age-standardized), by World Bank income group, 2020–2023. A key finding buried deep in the report is a new estimate for excess deaths related to the COVID-19 pandemic. The WHO now estimates 22.1 million deaths above expectation occurred between 2020 and 2023, roughly three times the 7 million COVID-19 deaths officially reported worldwide. Excess mortality peaked at 10.4 million in 2021, with men experiencing age-standardised excess death rates around 50% higher than women, and people aged 85 and over recording rates ten times those of younger adults, the report found. The ratio of excess deaths to officially reported COVID-19 deaths rose from roughly 1:1 in 2020 to about 9:1 by 2023, which the WHO attributes increasingly to underreporting as many countries wound down testing and attempted to move past the crisis. The pandemic erased nearly a decade of gains in life expectancy and healthy life expectancy, the WHO chief said, with only female life expectancy returning to pre-pandemic levels globally by 2023. “The COVID-19 pandemic inflicted a setback of historic proportions,” Tedros said. “Recovery since 2022 has been uneven, with persistent disparities according to region, age and sex.” Where there has been progress Age-standardized prevalence of current tobacco use in people 15 years and older, by sex, globally and by WHO region, 2010 and 2024. Some indicators are moving in the right direction. Tobacco use has fallen 27% since 2010 — narrowly missing the 30% reduction target — and alcohol consumption is down 13%. Between 2015 and 2024, 961 million more people gained access to safely managed drinking water, 1.2 billion to safe sanitation, 1.6 billion to basic hygiene services, and 1.4 billion to clean cooking fuels. The number of people requiring interventions for neglected tropical diseases has fallen 36% since 2010. “These trends reflect too many deaths that could have been avoided,” Nakatani said. “With rising environmental risks, health emergencies, and a worsening health financing crisis, we must act urgently — strengthening primary health care, investing in prevention, and securing sustainable financing to build resilient health systems and get back on track.” A ‘global health financing emergency’ Density of health professionals, globally and by WHO region. The WHO warned that the limited gains were now under serious threat from a “global health financing emergency”, as billions of dollars cut by the United States and other wealthy donors, much of it destined to fund progress towards the SDGs, are now gone. “Official development assistance for health was estimated to be 30-40% less in 2025 than in 2023,” Tedros said. “Many countries face long-standing structural constraints including high debt burdens and insufficient domestic public financing. Sudden aid reductions risk significant disruption of essential health services, reduced access to life-saving essential medicines and vaccines.” A WHO rapid assessment of 108 low- and lower-middle-income countries earlier this year found that 63% reported job losses, salary suspensions or reductions among health and care workers as a result of the aid cuts. Nearly 70% anticipated future recruitment problems in the health sector. Alain Labrique, director of WHO’s Department of Data, Digital Health, Analytics and Artificial Intelligence, noted that because the report’s data run only through 2024, the full effect of recent cuts to US foreign aid and other donor retrenchment is not yet visible. “Should these trends continue, and we don’t see reinvigorated investment in global health, this will have an effect on global health indicators,” he said. “It may continue to cause a reversal in the patterns that we worked so hard to gain.” Missing data paints a darker picture Timeliness of WHO Member States in reporting cause-of-death data, 2025. Compounding the picture is the fact that the WHO’s own data is incomplete — and likely understates the scale of the problem. Of an estimated 61 million deaths globally in 2023, only around 21 million were reported to the agency with cause-of-death information. Just 12 million had meaningful coding under the International Classification of Diseases, the global standard used to record what people die from and the foundation of comparable mortality statistics worldwide. Only 18% of countries reported mortality data within a year. Nearly a third have never submitted cause-of-death data at all. The shortfalls are concentrated in low- and lower-middle-income countries, where civil registration systems are weakest and where the disease burden is heaviest. Funding cuts have also disrupted disease surveillance, Nakatani said. “Erosion of data, planning, and surveillance systems undermines reliable measurement, which is essential for progress,” Tedros said. “Too few deaths are recorded with timely, accurate, and meaningful cause-of-death information, limiting the accuracy and relevance of mortality statistics for policy and planning.” “Data gaps severely limit the ability to monitor real-time health trends, compare outcomes across countries, and design effective public health responses,” Labrique said. Image Credits: John Cameron, Priscila Oliveira. WHO Declares DRC Ebola Outbreak a Public Health Emergency: ‘May Be ‘Much Larger’ Than Reported 17/05/2026 Kerry Cullinan The outbreak of Ebola in the Democratic Republic of Congo (DRC) may be “a much larger outbreak than what is currently being detected and reported, with significant local and regional risk of spread”, the World Health Organization (WHO) warned on Sunday. The WHO declared the outbreak a public health emergency of international concern (PHEIC) on Sunday, confirming that it involves the Ebola species, Bundibugyo virus disease (BVD). There is no vaccine or treatment for BVD, and a high case fatality rate of 30-50%. By Saturday, there were 336 suspected cases and 87 deaths, 13 of which had been confirmed as BVD, according to the Africa Centres for Disease Control and Prevention. Very high risk of spread in DRC Africa CDC warned that the risk of spread within the DRC was “very high” as a “four-week detection delay” had enabled “extensive uncontrolled community transmission”. It also said the risk for East Africa is “high”. The outbreak is likely to have originated in the Mongbwalu health zone of DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Two laboratory-confirmed cases (including one death) with no apparent link to each other were reported in Kampala in Uganda, late last week, involving two people travelling from the DRC. Meanwhile, insecurity and conflict in the DRC are “restricting surveillance and rapid response operations”, Africa CDC noted. While there are no approved vaccines or therapeutics, Africa CDC said its research team is studying the candidate vaccine, Ervebo, and potential treatments including “DP134, Remdesivir, Opaldesivir (oral form), and monoclonal antibodies”. It also warned that while national and regional stocks of personal protective equipment (PPE) are “sufficient to cover existing demand patterns”, if transmission increases, countries will need to import new PPE and the lead time for this is six to eight weeks. Why ‘public health emergency’? “Response measures include deployment of rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, the set-up of safe treatment centres, and community engagement,” the WHO said in a statement issued on Sunday. WHO Director-General Dr Tedros Adhanom Ghebreyesus said that the outbreak meets the criteria of the definition of PHEIC in terms of the International Health Regulations as it is “extraordinary”, constitutes a public health risk to other countries and “requires international coordination and cooperation to understand the extent of the outbreak, to coordinate surveillance, prevention and response efforts, to scale up and strengthen operations and ensure ability to implement control measures.” The “extraordinary” nature of the outbreak includes “unusual clusters of community deaths with symptoms compatible BVD”, and the high positivity rate of the initial samples collected (eight positive out of 13 samples). The WHO is in the process of convening an emergency committee under the provisions of the IHR, “as soon as possible” to advise affected countries on how to respond to the outbreak. WHO Member States Should Treat Fossil Fuels like Tobacco – as a Public Health Threat 15/05/2026 Jeni Miller Protests against fossil fuel lobbyists at COP30 in Bélem, Brazil, likening them to having the tobacco industry at a health conference. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. In the coming days, the annual World Health Assembly will convene in Geneva. Following the recent Santa Marta Conference on Transitioning Away from Fossil Fuels, national health ministers and global health leaders have both an opportunity and responsibility to address the root cause of the climate-induced health crisis: fossil fuels. The Santa Marta conference addressed the need to transition away from fossil fuels, the root cause of climate change. Fifty-seven countries, representing one-third of the global economy, committed to developing roadmaps to end fossil fuel use, marking an important step toward protecting public health and the climate. Santa Marta demonstrated growing momentum beyond traditional climate negotiations. While the UN climate COP process remains essential, countries increasingly recognize that progress has been too slow given the escalating impacts of climate change and health. The next Santa Marta conference, hosted by Tuvalu and Ireland in 2027, will provide a key opportunity to strengthen international cooperation on phasing out fossil fuels. Fossil fuel combustion constitutes the biggest public health emergency of our time Heavy-Duty trucks and buses spew out soot, including climate-changing black carbon and health harmful PM2.5 on a highway. Climate change is not only an environmental issue; it is a public health emergency. Fossil fuels are not just an energy source; they are harmful to health. Despite this, health was largely overlooked – the final Santa Marta conference text had no mention of health. The health community must raise a clamour to ensure that future climate negotiations take our health into consideration. Fossil fuels harm human health throughout their lifecycle, from extraction and refining to transport, combustion, and petrochemical production. They pollute air, water, and soil; drive extreme heat and food insecurity; worsen respiratory and cardiovascular diseases; and contribute to millions of premature deaths each year. Frontline communities near extraction sites, refineries, highways, ports, and petrochemical facilities face disproportionate risks of toxic exposure, cancer, displacement, and economic disruption. The world is already experiencing the consequences of the fossil-fuel-driven climate crisis. Last month, temperatures in parts of South and Southeast Asia reached 45 to 46°C, making outdoor work unsafe and pushing the limits of human survivability. Floods, wildfires, storms, crop failures, and infectious disease outbreaks are increasingly overwhelming health systems worldwide. Subsidizing the sale of products that harm human health Ending fossil fuel subsidies would be one of the most effective global public health interventions ever, also averting 1.2 deaths a year from air pollution. Yet governments continue to subsidize the very products causing this harm. In 2024 alone, fossil fuels received an estimated US$725 billion in public subsidies, even as air pollution, much of it from fossil fuels, costs the global economy about US$8.1 trillion annually in healthcare expenses, lost productivity, and premature deaths. From a public health perspective, this contradiction is stark: governments are using public funds to subsidize disease, death, climate disruption, and increased pressure on already overburdened health systems. The true cost of fossil fuels remains obscured because health harms are treated as “externalities.” But asthma, strokes, heat deaths, cancers, pregnancy complications, and polluted drinking water are not externalities; they are direct and devastating impacts. When these costs are fully accounted for, fossil fuels are no longer economically rational. They are a dangerous and outdated relic. Following the example of Tobacco Six out of ten smokers, or 750 million people globally want to quit tobacco use. For decades already, the health community has carried the weight of responding to the symptoms of the climate-induced health crisis while often avoiding its primary cause. This must change. And yet, the health community has both the moral authority and institutional capacity to speak to the impacts of fossil fuels directly. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. There is already a clear precedent: the World Health Organization Framework Convention on Tobacco Control (FCTC), the first global treaty negotiated under WHO leadership. The FCTC recognized that protecting health requires more than treating disease; it requires regulating the industry responsible for the harm. We can apply this same approach to fossil fuels. Tobacco control showed that effective public health action requires conflict-of-interest protections, restrictions on advertising and sponsorship, public education, fiscal measures, warning labels, litigation support, and international cooperation to reduce demand for harmful products. Fossil fuels require a similarly comprehensive response. Health ministries and the WHO have a critical role in advancing this agenda. The 78th session of the World Health Assembly in May 2025 – member states passed a Global Action Plan for climate and health. Ending fossil fuel subsidies would put teeth into that decision. The World Health Assembly is the world’s highest decision-making forum on health. Resolutions passed in Geneva shape national health priorities, influence financing, guide public health norms, and determine how governments respond to emerging threats. WHA can guide the WHO Secretariat in advocating for stronger conflict-of-interest protections to limit the influence of the fossil fuel industry in health policymaking and other multilateral processes. They can document the full lifecycle health harms of fossil fuels, plan protective health measures, promote health impact assessments for fossil fuel projects and infrastructure, and support air pollution standards based on current science. They can also champion subsidy reform as a public health intervention and help redirect public finance toward clean energy, resilient health systems, and social protection. The health community can also help revoke the social license of the fossil fuel industry by clearly communicating that these products are fundamentally incompatible with health protection. This is especially urgent as fossil fuel companies continue to use disinformation, greenwashing, and political influence to delay action, tactics long recognized by the public health community from efforts against other health-harming industries. At WHA78 last year, countries made progress through the WHO Global Action Plan on Climate Change and Health and commitments to reduce air pollution deaths. However, these efforts will remain incomplete unless governments address the primary driver of both climate change and air pollution: fossil fuels. WHA member states must recognise that fossil fuels are health-harming products, and their phase-out is a public health imperative. The science is clear, the health evidence is overwhelming, and solutions exist. The question now is whether the global health community is prepared to address the cause of the crisis, not just its consequences. On May 19th, the Global Climate and Health Alliance and the Office of the United Nations High Commissioner for Human Rights (OHCHR) will co-host Fossil Fuels, Health, and Human Rights – Centering Health and Human Rights in the Global Transition Away from Fossil Fuels where the issue will be discussed. It would be open to attend in person in Geneva and via Zoom. Dr Jeni Miller is Executive Director of the Global Climate and Health Alliance, a consortium of more than 250 health professional and health civil society organisations and networks from around the world addressing climate change. Image Credits: Mike Muzurakis IISD/ENB , UNEP, Galen Crout , Sarah Johnson. Posts navigation Older postsNewer posts
Russia Tries to Block Debate on Attacks on Health Facilities in Ukraine 20/05/2026 Disha Shetty Interior of a hospital room in Kherson heavily damaged during conflict, showing extensive structural destruction and debris. Neither Russia’s delegate banging her desk to interrupt Ukraine’s representative speaking at the World Health Assembly (WHA), nor her request to dismiss debate, stopped member states from condemning Russia’s attacks on Ukraine’s health system. A report by the World Health Organization’s (WHO) Director-General before delegates estimated that Russia’s aggression on Ukraine has caused 55,600 civilian casualties, including 14,999 deaths. Violence intensified in 2025 with civilian casualties going up by 31% compared to the previous year, and by 70% when compared to 2023. The WHO also documented 579 attacks on healthcare facilities that caused 19 deaths and 204 injuries among healthcare workers and patients in 2025. This was an 18% increase compared to 2024. “Since this report was published, WHO has recorded 190 new attacks on health care, with 86 injuries and 15 deaths between 1 January and 6 May, 2026,” said Dr Altaf Mossani, Director of Humanitarian Disaster Management, WHO Emergency Preparedness and Response program. “On May 14, a clearly marked United Nations vehicle was severely damaged by drone strikes in Kherson City. This is the second incident that week,” he added. Russia targeting healthcare infrastructure The 79th World Health Assembly in session. Countries raised alarm at the WHA that 202 of Ukraine’s 11,887 health facilities have been severely damaged, and 1,013 units are partially damaged. “We strongly condemn Russia’s ongoing war of aggression against Ukraine and the deliberate escalation of attacks targeting civilians and civilian infrastructure, including health care facilities, and we are deeply alarmed by the sharp increase in attacks on the health infrastructure since the last World Health Assembly,” Moldova’s representative told the WHA. Civilian attacks also drew sharp criticism, leaving Russia isolated during the discussion. “Russia’s attacks on energy infrastructure and other civilian targets, such as hospitals, elderly homes, or kindergartens, became increasingly vicious and brutal,” said Germany’s delegate. “On average, it has been said already, there have been more than 3,000 Russian attacks directly affecting health care institutions, two each day.” Ghana empathised with countries that are receiving a large number of refugees from Ukraine as a result of the conflict, resulting in an additional burden on their health systems. High drama by the Russian representative Russia’s representative to the WHA banged the desk to interrupt Ukraine’s speaker and called the WHO’s report on the health situation in Ukraine “disinformation.” Russia’s representative first moved to dismiss the debate on the report on Ukraine entirely. That request was put to a vote and defeated. Following extensive discussion on the report, Russia again moved to stop the WHA from noting the report. Russia was reminded that noting the report was merely procedural, but it requested a vote again. Once again, countries voted in favour of noting the report. At one point, the Russian representative banged the desk several times to interrupt the Ukrainian speaker, and was reminded to raise the country’s flag if she wanted to make a statement. Russia then accused the WHO of spreading misinformation. “WHO is talking only about attacks on Ukraine, ignoring the information that has been submitted to WHO on attacks on Russian facilities. So, we would ask WHO to stop misleading the world and to stop disseminating misinformation when it comes to voting on this report,” the representative accused. WHO’s report noted that there were 21 attacks on healthcare facilities in Russia, causing 17 injuries. Russia did not agree with this number. However, the Russian representative said, “more than 250 Russian facilities were attacked by Ukraine, and only 35 of them have been officially reported by WHO. And indeed, in the report, even that figure has deliberately been lowered”. Russia opposed the noting of the report by the WHA. The report was noted nevertheless, following a vote. Polio needs attention Polio remains endemic in the WHO’s Eastern Mediterranean Region (EMRO) region. WHA also discussed polio that remains an issue in several countries like Pakistan and Afghanistan. Conflicts and funding cuts have in recent years interrupted polio vaccination campaigns. In Gaza, polio made a resurgence as conflict raged. Most of these areas fall under the WHO’s Eastern Mediterranean Region (EMRO) region. “We are actually the last part of the world where that virus remains endemic, but we are doing our utmost to tackle this issue. We have seen, however, that in Afghanistan and Pakistan there have been declines in transmission trends, and we think that is a cause for optimism about wild polio virus transmission,” Libya said, making a statement on behalf of the EMRO region. Other countries reminded the WHA that polio is still a relevant issue that needs attention. “We wish to recall that polio is still a global health challenge because new cases of wild polio have been recorded in certain countries, and there are new coast cases in conflict areas. Then, hence, the need for further international effort to ensure that we have national and regional preparedness,” Oman’s representative told the WHA. Also read: Polio Eradication Imperiled by $2.3 Billion Funding Gap Image Credits: WHO Ukraine, X/WHO, WHO. WHO: Ebola Outbreak Is a Deadly Regional Threat But Not a Global Pandemic Risk 20/05/2026 Stefan Anderson The WHO has determined that the Ebola outbreak raising alarm worldwide does not pose a pandemic threat. GENEVA — The Ebola outbreak unfolding in the Democratic Republic of Congo (DRC) and Uganda poses a “low” risk globally, according to an expert committee of the World Health Organization (WHO). However, the national and regional risk is “high”, according to the International Health Regulations (IHR) Emergency Committee. Last Sunday, WHO Director-General Dr Tedros Adhanom Ghebreyesus had already declared the outbreak a public health emergency of international concern (PHEIC), the WHO’s second-highest level of alert, before convening the emergency committee. This is the first time in WHO’s history that this has occurred. Tedros was motivated by the scale and speed of the spread of the Bundibugyo virus, a rare and particularly deadly strain of Ebola, which has killed at least 131 people and infected over 500 others. The emergency meeting, convened on Tuesday to assess the threat of the current outbreak, concurred that the situation is a PHEIC but “not a pandemic emergency,” Tedros told a media briefing on Wednesday. The committee, chaired by Professor Lucille Blumberg, agreed with the Director-General’s assessment and is finalising its recommendations in the coming days. “Our prime aim was to support the decision and decide whether this is a public health emergency of international concern, and to consider whether there’s a pandemic emergency. The former was agreed to,” Blumberg said. Investigations into the outbreak’s origin Anaïs Legand speaking at the emergency press conference on the Ebola crisis. “Investigations are ongoing to ascertain when and where exactly this outbreak started,” said Anaïs Legand, a technical officer for high-threat pathogens at WHO’s health emergencies programme. “Given the scale, we are thinking that it has started probably a couple of months ago, but investigations are ongoing, and our priority is really to cut the transmission chain by implementing contact tracing, isolating and caring for all suspect and confirmed cases.” The Bundibugyo species was last seen in 2007, and there is currently no vaccine or treatment licensed for it. Investigators say the true scale of the epidemic in DRC is much larger than current case counts suggest. War, and a very long drive Dr Mohamed Yakub Janabi, WHO’s regional director for Africa. WHO officials laid out several reasons the outbreak escaped detection. The province of Ituri, where it emerged, is engulfed in war. Fighting between the DRC army and the M23 armed group has intensified in recent months, displacing more than 100,000 people. Beyond the conflict, eastern DRC is among the most challenging places in the world to mount a public health response. Health facilities are sparse, roads are limited, and much of the terrain is forested and mountainous. A previous Ebola outbreak in the same region in 2018-19 took close to two years to bring under control, even with a licensed vaccine available. Dr Mohamed Yakub Janabi, WHO’s regional director for Africa, said the combination of factors made early detection enormously difficult. “Detecting outbreaks such as Ebola in a complex setting like Ituri province in the DRC is inherently challenging,” he said. “Surveillance systems rely on a combination of community reporting, local health facilities, lab confirmation, and partner coordination.” Samples from the outbreak zone must travel 1,700 kilometres to reach the Institut National de Recherche Biomédicale in Kinshasa, the only facility in the country with the capacity to test for Bundibugyo. The distance to the capital is comparable to London to Warsaw – a roughly a 24-hour drive on smooth European roads, a far cry from the remote jungle tracks and dirt roads of Ituri. “In remote or insecure areas, it can take time for cases to be recognised and samples transported,” Janabi said. Symptoms mistaken for endemic diseases Nearly 7 tonnes of emergency medical supplies and equipment along with a team of 35 experts from WHO and the DRC’s health ministry, arrived today in Bunia from Kinshasa to support frontline #Ebola response in Ituri Province. The Bundibugyo strain’s early symptoms also overlap with diseases endemic to eastern DRC, leading health workers to mistake initial cases for more common illnesses. “Nonspecific early symptoms, for instance, if you take malaria and typhoid, the early symptoms are the same,” Tedros said. “The region is very endemic to those diseases, so the health workers will associate the early signs with malaria or typhoid, and they can’t diagnose based on the symptoms. They may start treating that.” Dr Abdi Mahamud, WHO’s director for health emergency alert and response operations, said the diagnostic challenge would have tripped up better-resourced systems. “This outbreak is happening in a highly endemic [setting for] other diseases that present similar symptoms – malaria, dysentery, and others,” he said. “If you don’t have that high index of suspicion, if you don’t have the right facility to test, even in high-income countries, you will have that delay in the start of an outbreak.” Diagnostic tests routinely used across the region added another layer of delay. The Bundibugyo strain belongs to a different genus, Orthoebolavirus, than the more common Zaire strain that most existing tests are optimised to detect. “There was a problem linked to the traditional test we use,” Tedros said. “The traditional test is optimised with Zaire, and the same sample was taken and tested, but since the test kit is optimised with Zaire, [Bundibugyo] could not be detected.” No vaccine, but a pipeline Vasee Moorthy, WHO’s research and development lead on the current outbreak, laid out the state of the vaccine pipeline for the Bundibugyo strain. The Bundibugyo strain has no licensed vaccine or therapeutic. WHO’s research and development lead, Vasee Moorthy, said a pipeline of candidates is being accelerated but remains months away. Moorthy said the most promising candidate is an rVSV Bundibugyo vaccine, the equivalent for this strain of Ervebo, the licensed Merck vaccine used against the more common Zaire Ebola strain since 2019. “There are no doses of this which are currently available for clinical trial, so this needs to be prioritised,” Moorthy said. “The information that we have is that this is likely to take six to nine months.” A second candidate, built on the ChAdOx1 platform used in the AstraZeneca COVID-19 vaccine, is being developed by Oxford and the Serum Institute of India. “They are manufacturing that as we speak, but there is no animal data to support [its efficacy],” Moorthy said. “It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty about that.” Even in the most optimistic scenario, neither candidate is likely to be available to materially shape the trajectory of the current outbreak. In the meantime, the response is being built around the basics: safe treatment centres, patient referral pathways, contact tracing, and the protection of health workers, among whom the first confirmed case in the outbreak was identified. “The protection of healthcare workers and families is absolutely paramount,” Blumberg said. “The people in the area and those who respond need to be kept safe and allowed to be able to do what they need to do in a critical time such as this.” Tedros: Rubio suffers ‘lack of understanding’ US Secretary of State Marco Rubio. The WHO chief used the press conference to push back at US Secretary of State Marco Rubio, who said this week the agency had been “a little late to identify this thing.” The US has banned citizens of the DRC, Uganda and Sudan from entry, closed its only dedicated Ebola lab, withdrawn from the WHO, and defunded the agency. “On what the Secretary said, it could be from a lack of understanding of how IHR works, and the responsibilities of WHO and other entities,” Tedros said. “We don’t replace the country’s work, we only support them, so that’s why there could be some lack of understanding.” Tedros suggested conflict in the affected region was a more fundamental factor in the delay than anything WHO could have done differently. “Health facilities cannot work optimally when there is conflict and when the health workers are also fleeing as part of the community which is displaced,” he said. “It affects the whole surveillance system, and not only that, but it also affects access.” “I think that’s what we should understand, the secretary or others.” Asked repeatedly whether US funding cuts to DRC surveillance programmes had contributed to the outbreak going undetected, Tedros declined to draw a direct line. “We don’t need to jump to conclusions before we understand the whole complexity. It would be very difficult to associate it with funding alone,” he said, noting that the diagnostic gap was a question of the wrong tests being administered rather than supply. Legand echoed the point, noting the issue stems from test type, not supply: “For the time being, it’s not a supply issue. We need to ensure that the right platform with the right data arrives at the right place. This is the work that is being done as we speak.” The outbreak, meanwhile, continues to spread through a war zone with no vaccine, no cure, and a diagnostic system still catching up to the strain it now faces. Image Credits: @WHO African Region, Gage Skidmore. Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ 18/05/2026 Kerry Cullinan WHA president Dr Víctor Atallah (Dominican Republic), Spanish Prime Minister Pedros Sánchez, and WHO Director General Dr Tedros Adhanom Ghebreyesus. “From conflicts to economic crises to climate change and aid cuts, we live in difficult, dangerous and divisive times,” World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyesus told the opening plenary of the World Health Assembly (WHA) on Monday. While geopolitical disagreements have delayed Tedros’s official WHA address until Tuesday morning, the Director General acknowledged in a brief welcome that the WHO “has been through a difficult period as a result of sudden and steep cuts to our funding”. The organisation’s budget is 90% funded, although some of the funds are pledged rather than in the bank. Spain’s Prime Minister Pedro Sánchez, a WHA special guest speaker, appealed for solidarity and multilateral support for global health to combat “the pandemic of egotism and selfishness”. Sánchez said that Spain had increased its official development aid (ODA) by 30%, explaining: “No country can save itself. Protecting others is the best way to protect ourselves.” Without naming the United States, he added: “The greatest risk for global health is no longer the lack of science, but rather the lack of conscience. In just a few months, the same country that cut $18 billion from global public health and ODA has spent more than $29 billion on war, the humanitarian and geopolitical consequences of which will also be devastating.” Sánchez, who received a standing ovation, also appealed for countries in the Global South to “have the role that they deserve in decision-making”, and that the reform of global health needed to be focused on strengthening national health centres. Reforming global health The WHA is considering how to reform the “global health architecture”. Ghanaian President John Dramani Mahama, also a special guest speaker at the plenary, appealed for a more inclusive system of multilateralism. “I’m concerned about whispers I have heard that the draft resolution [on global health reform] seeks to protect existing organisational mandates and prohibit the recommendation of mergers or consolidations,” said Mahama, who is championing Africa’s health sovereignty through the Accra Reset Initiative. “If we launch a process of reform that is prohibited from recommending actual reform, we are merely performing a ritual. We cannot prioritise institutional comfort over human survival. The WHO’s legitimacy is not served by protecting silos. It is served by a fearless analysis of what works,” Mahama warned. Barbados’ Prime Minister Mia Mottley also appealed for a more responsive global health system: “Small states are not asking for pity. We’re asking for a system that recognises reality. Vulnerability is not measured by income alone. Fiscal space must be judged alongside climate risk, debt burden, disease burden, and yes, the cost of survival.” Motley also stressed that emergency funds must move with the speed of an emergency. “The WHO must not be asked to protect eight billion people on Planet Earth on the basis of uncertain contributions and political mood swings,” she said – a reference to the withdrawal from the WHO by the US. Syrian President Ahmed Hussein al-Sharaa addressing the WHA via a video link. Syrian President Ahmed Hussein al-Sharaa, who until December of last year was on both the UN and the US list of global terrorists facing sanctions, also addressed the plenary via video. Shortly after the opening, the business of the WHA was delayed by several hours by geopolitical disagreements, with some issues going to a vote. Member states decided against including Taiwan as an observer, but voted overwhelmingly in favour of a request by the Gulf Cooperation Council to discuss the impact of Iran’s recent attacks later in the week. Israel’s objection to the tabling of two separate reports on health conditions in the occupied Palestinian territory (OPT) – including one on the immense toll of the recent Gaza war and increasing Israeli military and settler violence affecting West Bank Palestinian communities – also delayed proceedings. The WHA has a massive agenda, including approving a new tuberculosis strategy and a plan on combating strokes; a global action plan on antimicrobial resistance (AMR) – still outstanding since the AMR UN high-level meeting two years ago; and how to improve emergency care. Zero for 52: WHO Warns World Set to Miss Every Global Health Target by 2030 18/05/2026 Stefan Anderson Annual report finds progress slowing, stalling or reversing across every global health set out in the SDG agenda. The world is on course to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the World Health Organization has warned, as ministers from its 194 member states gather in Geneva for an assembly tasked with reversing that trajectory. With malaria cases rising, maternal deaths still occurring at nearly three times the targeted rate and childhood vaccination coverage plateauing or falling in some regions, progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 edition of the WHO’s World Health Statistics report. “Progress is too slow, too uneven, and increasingly fragile,” Yukiko Nakatani, WHO assistant director-general for health systems, access and data, told a press briefing on Wednesday. “The report is an urgent reminder for member states and all health partners together: we must refocus efforts, safeguard hard-won gains and renew progress.” WHO Director-General Dr Tedros Adhanom Ghebreyesus said progress toward the health goals was “insufficient, uneven across regions and populations, and increasingly vulnerable to systemic shocks”, with a disproportionate burden falling on low- and middle-income countries, especially those in fragile and conflict-affected settings. “Progress has stalled on universal health coverage, maternal and child health and reduction in premature mortality due to noncommunicable diseases — which remain the leading causes of mortality globally,” Tedros said. “These data tell a story of both progress and persistent inequality,” the WHO chief added, “with many people – especially women, children and those in underserved communities – still denied the basic conditions for a healthy life.” Once achievable health targets out of reach The UN estimates that around 17% of SDG targets are on track globally. The SDG health targets are part of a wider agenda adopted by all UN member states in 2015, setting goals on poverty, hunger, education, gender equality, climate and health by 2030. The third goal — “ensure healthy lives and promote well-being for all at all ages” — sets the dozens of indicators tracked by the annual WHO report, ranging from maternal mortality and HIV incidence to tobacco use and air pollution deaths. These were once seen as among the most achievable of the SDGs, given significant progress made under the agenda’s predecessor, the Millennium Development Goals. That hope has not materialised — and the wider SDG agenda is faring no better, with the latest UN figures finding only about a sixth of all targets on course for the 2030 deadline. “Of the 52 health-related SDG indicators reviewed in this report, more than half have numeric SDG or other global targets,” WHO found. “And none is on track to meet the target at the global level.” Malaria reversing, TB barely moving Tuberculosis incidence rates, globally and by WHO region, 2015, 2024 and the 2030 target. The reversal of progress in eradicating malaria is perhaps the starkest failure on the SDG health agenda. While the world set a target to reduce cases by 90% by 2030, global incidence has instead risen by 8.5%. The African Region carries nearly the entire global burden, recording an estimated 282 million cases in 2024. Only the South-East Asia Region is on track to meet the 2025 milestone of a 75% reduction. Tuberculosis is another major failure: of the 80% reduction target set in the WHO End TB Strategy, just 12% has been achieved since 2015. The European Region cut its TB rate by 39% over the period, while the Region of the Americas went backwards, recording a 13% increase. The African Region, despite still bearing the highest burden, achieved a 28% reduction, more than double the global average. The HIV picture is brighter, with new infections falling 40% since 2010 to 1.3 million worldwide in 2024. The African Region has cut new infections by 70% — a major achievement — but still accounts for 65% of the 40.8 million people living with HIV worldwide. Yet HIV incidence cuts remain well short of the 90% SDG target. Hope circulated before 2015 that ending the AIDS epidemic by 2030 was within reach, has faded away. Maternal and child deaths: progress stalling Maternal mortality ratio, by WHO region, 2000–2023. The global maternal mortality ratio has fallen 40% since 2000, but at 197 deaths per 100,000 live births in 2023 it remains nearly three times the 2030 target of fewer than 70 deaths per 100,000 live births. The annual rate of reduction has slowed to 1.6% since 2015. The world needs that figure to climb to nearly 15% to hit the SDG, a pace more than nine times faster than the world has managed over the past quarter century. Doing so would mean preventing nearly 700,000 maternal deaths by 2030. Each day, 712 women still die from maternal causes — one every two minutes. A staggering 80% of those deaths occur in sub-Saharan Africa, where girls face a one-in-40 chance of dying of pregnancy-related complications by age 15. Central and Southern Asia come a distant second, accounting for 17% of the global death toll. Globally, nearly 95% of all maternal deaths occur in low- and lower middle-income countries. Meanwhile, 73 countries, mostly in Europe, Latin America and the Caribbean, recorded fewer than 20 maternal deaths in 2020. Vaccination coverage flatlines Global immunization rates against diphtheria, tetanus and pertussis, measles, pneumococcal infections, and human papillomavirus, 2000–2024. Routine childhood immunisation has largely flatlined, with global coverage stuck below the levels needed to prevent the outbreaks of vaccine-preventable diseases now resurging in several regions. Coverage with the third dose of the diphtheria-tetanus-pertussis vaccine has plateaued at around 85%, while second-dose measles vaccination sits at 76% — far below the roughly 95% the WHO says is needed to prevent outbreaks. The Region of the Americas, once a global leader on routine immunisation, now reports lower coverage for three of four core vaccines than in 2015. The WHO has linked persistent immunity gaps to the rising measles transmission reported across several regions over the past year, including major outbreaks in the United States, Europe and parts of the Eastern Mediterranean. Coverage of the human papillomavirus vaccine, which protects against cervical cancer, has grown faster than any other core vaccine since 2021 — but from a very low base, reaching just 28% of the target group of 9-14-year-old girls globally in 2024. A pandemic toll three times larger than officially recorded Excess death rates (crude and age-standardized), by World Bank income group, 2020–2023. A key finding buried deep in the report is a new estimate for excess deaths related to the COVID-19 pandemic. The WHO now estimates 22.1 million deaths above expectation occurred between 2020 and 2023, roughly three times the 7 million COVID-19 deaths officially reported worldwide. Excess mortality peaked at 10.4 million in 2021, with men experiencing age-standardised excess death rates around 50% higher than women, and people aged 85 and over recording rates ten times those of younger adults, the report found. The ratio of excess deaths to officially reported COVID-19 deaths rose from roughly 1:1 in 2020 to about 9:1 by 2023, which the WHO attributes increasingly to underreporting as many countries wound down testing and attempted to move past the crisis. The pandemic erased nearly a decade of gains in life expectancy and healthy life expectancy, the WHO chief said, with only female life expectancy returning to pre-pandemic levels globally by 2023. “The COVID-19 pandemic inflicted a setback of historic proportions,” Tedros said. “Recovery since 2022 has been uneven, with persistent disparities according to region, age and sex.” Where there has been progress Age-standardized prevalence of current tobacco use in people 15 years and older, by sex, globally and by WHO region, 2010 and 2024. Some indicators are moving in the right direction. Tobacco use has fallen 27% since 2010 — narrowly missing the 30% reduction target — and alcohol consumption is down 13%. Between 2015 and 2024, 961 million more people gained access to safely managed drinking water, 1.2 billion to safe sanitation, 1.6 billion to basic hygiene services, and 1.4 billion to clean cooking fuels. The number of people requiring interventions for neglected tropical diseases has fallen 36% since 2010. “These trends reflect too many deaths that could have been avoided,” Nakatani said. “With rising environmental risks, health emergencies, and a worsening health financing crisis, we must act urgently — strengthening primary health care, investing in prevention, and securing sustainable financing to build resilient health systems and get back on track.” A ‘global health financing emergency’ Density of health professionals, globally and by WHO region. The WHO warned that the limited gains were now under serious threat from a “global health financing emergency”, as billions of dollars cut by the United States and other wealthy donors, much of it destined to fund progress towards the SDGs, are now gone. “Official development assistance for health was estimated to be 30-40% less in 2025 than in 2023,” Tedros said. “Many countries face long-standing structural constraints including high debt burdens and insufficient domestic public financing. Sudden aid reductions risk significant disruption of essential health services, reduced access to life-saving essential medicines and vaccines.” A WHO rapid assessment of 108 low- and lower-middle-income countries earlier this year found that 63% reported job losses, salary suspensions or reductions among health and care workers as a result of the aid cuts. Nearly 70% anticipated future recruitment problems in the health sector. Alain Labrique, director of WHO’s Department of Data, Digital Health, Analytics and Artificial Intelligence, noted that because the report’s data run only through 2024, the full effect of recent cuts to US foreign aid and other donor retrenchment is not yet visible. “Should these trends continue, and we don’t see reinvigorated investment in global health, this will have an effect on global health indicators,” he said. “It may continue to cause a reversal in the patterns that we worked so hard to gain.” Missing data paints a darker picture Timeliness of WHO Member States in reporting cause-of-death data, 2025. Compounding the picture is the fact that the WHO’s own data is incomplete — and likely understates the scale of the problem. Of an estimated 61 million deaths globally in 2023, only around 21 million were reported to the agency with cause-of-death information. Just 12 million had meaningful coding under the International Classification of Diseases, the global standard used to record what people die from and the foundation of comparable mortality statistics worldwide. Only 18% of countries reported mortality data within a year. Nearly a third have never submitted cause-of-death data at all. The shortfalls are concentrated in low- and lower-middle-income countries, where civil registration systems are weakest and where the disease burden is heaviest. Funding cuts have also disrupted disease surveillance, Nakatani said. “Erosion of data, planning, and surveillance systems undermines reliable measurement, which is essential for progress,” Tedros said. “Too few deaths are recorded with timely, accurate, and meaningful cause-of-death information, limiting the accuracy and relevance of mortality statistics for policy and planning.” “Data gaps severely limit the ability to monitor real-time health trends, compare outcomes across countries, and design effective public health responses,” Labrique said. Image Credits: John Cameron, Priscila Oliveira. WHO Declares DRC Ebola Outbreak a Public Health Emergency: ‘May Be ‘Much Larger’ Than Reported 17/05/2026 Kerry Cullinan The outbreak of Ebola in the Democratic Republic of Congo (DRC) may be “a much larger outbreak than what is currently being detected and reported, with significant local and regional risk of spread”, the World Health Organization (WHO) warned on Sunday. The WHO declared the outbreak a public health emergency of international concern (PHEIC) on Sunday, confirming that it involves the Ebola species, Bundibugyo virus disease (BVD). There is no vaccine or treatment for BVD, and a high case fatality rate of 30-50%. By Saturday, there were 336 suspected cases and 87 deaths, 13 of which had been confirmed as BVD, according to the Africa Centres for Disease Control and Prevention. Very high risk of spread in DRC Africa CDC warned that the risk of spread within the DRC was “very high” as a “four-week detection delay” had enabled “extensive uncontrolled community transmission”. It also said the risk for East Africa is “high”. The outbreak is likely to have originated in the Mongbwalu health zone of DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Two laboratory-confirmed cases (including one death) with no apparent link to each other were reported in Kampala in Uganda, late last week, involving two people travelling from the DRC. Meanwhile, insecurity and conflict in the DRC are “restricting surveillance and rapid response operations”, Africa CDC noted. While there are no approved vaccines or therapeutics, Africa CDC said its research team is studying the candidate vaccine, Ervebo, and potential treatments including “DP134, Remdesivir, Opaldesivir (oral form), and monoclonal antibodies”. It also warned that while national and regional stocks of personal protective equipment (PPE) are “sufficient to cover existing demand patterns”, if transmission increases, countries will need to import new PPE and the lead time for this is six to eight weeks. Why ‘public health emergency’? “Response measures include deployment of rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, the set-up of safe treatment centres, and community engagement,” the WHO said in a statement issued on Sunday. WHO Director-General Dr Tedros Adhanom Ghebreyesus said that the outbreak meets the criteria of the definition of PHEIC in terms of the International Health Regulations as it is “extraordinary”, constitutes a public health risk to other countries and “requires international coordination and cooperation to understand the extent of the outbreak, to coordinate surveillance, prevention and response efforts, to scale up and strengthen operations and ensure ability to implement control measures.” The “extraordinary” nature of the outbreak includes “unusual clusters of community deaths with symptoms compatible BVD”, and the high positivity rate of the initial samples collected (eight positive out of 13 samples). The WHO is in the process of convening an emergency committee under the provisions of the IHR, “as soon as possible” to advise affected countries on how to respond to the outbreak. WHO Member States Should Treat Fossil Fuels like Tobacco – as a Public Health Threat 15/05/2026 Jeni Miller Protests against fossil fuel lobbyists at COP30 in Bélem, Brazil, likening them to having the tobacco industry at a health conference. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. In the coming days, the annual World Health Assembly will convene in Geneva. Following the recent Santa Marta Conference on Transitioning Away from Fossil Fuels, national health ministers and global health leaders have both an opportunity and responsibility to address the root cause of the climate-induced health crisis: fossil fuels. The Santa Marta conference addressed the need to transition away from fossil fuels, the root cause of climate change. Fifty-seven countries, representing one-third of the global economy, committed to developing roadmaps to end fossil fuel use, marking an important step toward protecting public health and the climate. Santa Marta demonstrated growing momentum beyond traditional climate negotiations. While the UN climate COP process remains essential, countries increasingly recognize that progress has been too slow given the escalating impacts of climate change and health. The next Santa Marta conference, hosted by Tuvalu and Ireland in 2027, will provide a key opportunity to strengthen international cooperation on phasing out fossil fuels. Fossil fuel combustion constitutes the biggest public health emergency of our time Heavy-Duty trucks and buses spew out soot, including climate-changing black carbon and health harmful PM2.5 on a highway. Climate change is not only an environmental issue; it is a public health emergency. Fossil fuels are not just an energy source; they are harmful to health. Despite this, health was largely overlooked – the final Santa Marta conference text had no mention of health. The health community must raise a clamour to ensure that future climate negotiations take our health into consideration. Fossil fuels harm human health throughout their lifecycle, from extraction and refining to transport, combustion, and petrochemical production. They pollute air, water, and soil; drive extreme heat and food insecurity; worsen respiratory and cardiovascular diseases; and contribute to millions of premature deaths each year. Frontline communities near extraction sites, refineries, highways, ports, and petrochemical facilities face disproportionate risks of toxic exposure, cancer, displacement, and economic disruption. The world is already experiencing the consequences of the fossil-fuel-driven climate crisis. Last month, temperatures in parts of South and Southeast Asia reached 45 to 46°C, making outdoor work unsafe and pushing the limits of human survivability. Floods, wildfires, storms, crop failures, and infectious disease outbreaks are increasingly overwhelming health systems worldwide. Subsidizing the sale of products that harm human health Ending fossil fuel subsidies would be one of the most effective global public health interventions ever, also averting 1.2 deaths a year from air pollution. Yet governments continue to subsidize the very products causing this harm. In 2024 alone, fossil fuels received an estimated US$725 billion in public subsidies, even as air pollution, much of it from fossil fuels, costs the global economy about US$8.1 trillion annually in healthcare expenses, lost productivity, and premature deaths. From a public health perspective, this contradiction is stark: governments are using public funds to subsidize disease, death, climate disruption, and increased pressure on already overburdened health systems. The true cost of fossil fuels remains obscured because health harms are treated as “externalities.” But asthma, strokes, heat deaths, cancers, pregnancy complications, and polluted drinking water are not externalities; they are direct and devastating impacts. When these costs are fully accounted for, fossil fuels are no longer economically rational. They are a dangerous and outdated relic. Following the example of Tobacco Six out of ten smokers, or 750 million people globally want to quit tobacco use. For decades already, the health community has carried the weight of responding to the symptoms of the climate-induced health crisis while often avoiding its primary cause. This must change. And yet, the health community has both the moral authority and institutional capacity to speak to the impacts of fossil fuels directly. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. There is already a clear precedent: the World Health Organization Framework Convention on Tobacco Control (FCTC), the first global treaty negotiated under WHO leadership. The FCTC recognized that protecting health requires more than treating disease; it requires regulating the industry responsible for the harm. We can apply this same approach to fossil fuels. Tobacco control showed that effective public health action requires conflict-of-interest protections, restrictions on advertising and sponsorship, public education, fiscal measures, warning labels, litigation support, and international cooperation to reduce demand for harmful products. Fossil fuels require a similarly comprehensive response. Health ministries and the WHO have a critical role in advancing this agenda. The 78th session of the World Health Assembly in May 2025 – member states passed a Global Action Plan for climate and health. Ending fossil fuel subsidies would put teeth into that decision. The World Health Assembly is the world’s highest decision-making forum on health. Resolutions passed in Geneva shape national health priorities, influence financing, guide public health norms, and determine how governments respond to emerging threats. WHA can guide the WHO Secretariat in advocating for stronger conflict-of-interest protections to limit the influence of the fossil fuel industry in health policymaking and other multilateral processes. They can document the full lifecycle health harms of fossil fuels, plan protective health measures, promote health impact assessments for fossil fuel projects and infrastructure, and support air pollution standards based on current science. They can also champion subsidy reform as a public health intervention and help redirect public finance toward clean energy, resilient health systems, and social protection. The health community can also help revoke the social license of the fossil fuel industry by clearly communicating that these products are fundamentally incompatible with health protection. This is especially urgent as fossil fuel companies continue to use disinformation, greenwashing, and political influence to delay action, tactics long recognized by the public health community from efforts against other health-harming industries. At WHA78 last year, countries made progress through the WHO Global Action Plan on Climate Change and Health and commitments to reduce air pollution deaths. However, these efforts will remain incomplete unless governments address the primary driver of both climate change and air pollution: fossil fuels. WHA member states must recognise that fossil fuels are health-harming products, and their phase-out is a public health imperative. The science is clear, the health evidence is overwhelming, and solutions exist. The question now is whether the global health community is prepared to address the cause of the crisis, not just its consequences. On May 19th, the Global Climate and Health Alliance and the Office of the United Nations High Commissioner for Human Rights (OHCHR) will co-host Fossil Fuels, Health, and Human Rights – Centering Health and Human Rights in the Global Transition Away from Fossil Fuels where the issue will be discussed. It would be open to attend in person in Geneva and via Zoom. Dr Jeni Miller is Executive Director of the Global Climate and Health Alliance, a consortium of more than 250 health professional and health civil society organisations and networks from around the world addressing climate change. Image Credits: Mike Muzurakis IISD/ENB , UNEP, Galen Crout , Sarah Johnson. Posts navigation Older postsNewer posts
WHO: Ebola Outbreak Is a Deadly Regional Threat But Not a Global Pandemic Risk 20/05/2026 Stefan Anderson The WHO has determined that the Ebola outbreak raising alarm worldwide does not pose a pandemic threat. GENEVA — The Ebola outbreak unfolding in the Democratic Republic of Congo (DRC) and Uganda poses a “low” risk globally, according to an expert committee of the World Health Organization (WHO). However, the national and regional risk is “high”, according to the International Health Regulations (IHR) Emergency Committee. Last Sunday, WHO Director-General Dr Tedros Adhanom Ghebreyesus had already declared the outbreak a public health emergency of international concern (PHEIC), the WHO’s second-highest level of alert, before convening the emergency committee. This is the first time in WHO’s history that this has occurred. Tedros was motivated by the scale and speed of the spread of the Bundibugyo virus, a rare and particularly deadly strain of Ebola, which has killed at least 131 people and infected over 500 others. The emergency meeting, convened on Tuesday to assess the threat of the current outbreak, concurred that the situation is a PHEIC but “not a pandemic emergency,” Tedros told a media briefing on Wednesday. The committee, chaired by Professor Lucille Blumberg, agreed with the Director-General’s assessment and is finalising its recommendations in the coming days. “Our prime aim was to support the decision and decide whether this is a public health emergency of international concern, and to consider whether there’s a pandemic emergency. The former was agreed to,” Blumberg said. Investigations into the outbreak’s origin Anaïs Legand speaking at the emergency press conference on the Ebola crisis. “Investigations are ongoing to ascertain when and where exactly this outbreak started,” said Anaïs Legand, a technical officer for high-threat pathogens at WHO’s health emergencies programme. “Given the scale, we are thinking that it has started probably a couple of months ago, but investigations are ongoing, and our priority is really to cut the transmission chain by implementing contact tracing, isolating and caring for all suspect and confirmed cases.” The Bundibugyo species was last seen in 2007, and there is currently no vaccine or treatment licensed for it. Investigators say the true scale of the epidemic in DRC is much larger than current case counts suggest. War, and a very long drive Dr Mohamed Yakub Janabi, WHO’s regional director for Africa. WHO officials laid out several reasons the outbreak escaped detection. The province of Ituri, where it emerged, is engulfed in war. Fighting between the DRC army and the M23 armed group has intensified in recent months, displacing more than 100,000 people. Beyond the conflict, eastern DRC is among the most challenging places in the world to mount a public health response. Health facilities are sparse, roads are limited, and much of the terrain is forested and mountainous. A previous Ebola outbreak in the same region in 2018-19 took close to two years to bring under control, even with a licensed vaccine available. Dr Mohamed Yakub Janabi, WHO’s regional director for Africa, said the combination of factors made early detection enormously difficult. “Detecting outbreaks such as Ebola in a complex setting like Ituri province in the DRC is inherently challenging,” he said. “Surveillance systems rely on a combination of community reporting, local health facilities, lab confirmation, and partner coordination.” Samples from the outbreak zone must travel 1,700 kilometres to reach the Institut National de Recherche Biomédicale in Kinshasa, the only facility in the country with the capacity to test for Bundibugyo. The distance to the capital is comparable to London to Warsaw – a roughly a 24-hour drive on smooth European roads, a far cry from the remote jungle tracks and dirt roads of Ituri. “In remote or insecure areas, it can take time for cases to be recognised and samples transported,” Janabi said. Symptoms mistaken for endemic diseases Nearly 7 tonnes of emergency medical supplies and equipment along with a team of 35 experts from WHO and the DRC’s health ministry, arrived today in Bunia from Kinshasa to support frontline #Ebola response in Ituri Province. The Bundibugyo strain’s early symptoms also overlap with diseases endemic to eastern DRC, leading health workers to mistake initial cases for more common illnesses. “Nonspecific early symptoms, for instance, if you take malaria and typhoid, the early symptoms are the same,” Tedros said. “The region is very endemic to those diseases, so the health workers will associate the early signs with malaria or typhoid, and they can’t diagnose based on the symptoms. They may start treating that.” Dr Abdi Mahamud, WHO’s director for health emergency alert and response operations, said the diagnostic challenge would have tripped up better-resourced systems. “This outbreak is happening in a highly endemic [setting for] other diseases that present similar symptoms – malaria, dysentery, and others,” he said. “If you don’t have that high index of suspicion, if you don’t have the right facility to test, even in high-income countries, you will have that delay in the start of an outbreak.” Diagnostic tests routinely used across the region added another layer of delay. The Bundibugyo strain belongs to a different genus, Orthoebolavirus, than the more common Zaire strain that most existing tests are optimised to detect. “There was a problem linked to the traditional test we use,” Tedros said. “The traditional test is optimised with Zaire, and the same sample was taken and tested, but since the test kit is optimised with Zaire, [Bundibugyo] could not be detected.” No vaccine, but a pipeline Vasee Moorthy, WHO’s research and development lead on the current outbreak, laid out the state of the vaccine pipeline for the Bundibugyo strain. The Bundibugyo strain has no licensed vaccine or therapeutic. WHO’s research and development lead, Vasee Moorthy, said a pipeline of candidates is being accelerated but remains months away. Moorthy said the most promising candidate is an rVSV Bundibugyo vaccine, the equivalent for this strain of Ervebo, the licensed Merck vaccine used against the more common Zaire Ebola strain since 2019. “There are no doses of this which are currently available for clinical trial, so this needs to be prioritised,” Moorthy said. “The information that we have is that this is likely to take six to nine months.” A second candidate, built on the ChAdOx1 platform used in the AstraZeneca COVID-19 vaccine, is being developed by Oxford and the Serum Institute of India. “They are manufacturing that as we speak, but there is no animal data to support [its efficacy],” Moorthy said. “It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty about that.” Even in the most optimistic scenario, neither candidate is likely to be available to materially shape the trajectory of the current outbreak. In the meantime, the response is being built around the basics: safe treatment centres, patient referral pathways, contact tracing, and the protection of health workers, among whom the first confirmed case in the outbreak was identified. “The protection of healthcare workers and families is absolutely paramount,” Blumberg said. “The people in the area and those who respond need to be kept safe and allowed to be able to do what they need to do in a critical time such as this.” Tedros: Rubio suffers ‘lack of understanding’ US Secretary of State Marco Rubio. The WHO chief used the press conference to push back at US Secretary of State Marco Rubio, who said this week the agency had been “a little late to identify this thing.” The US has banned citizens of the DRC, Uganda and Sudan from entry, closed its only dedicated Ebola lab, withdrawn from the WHO, and defunded the agency. “On what the Secretary said, it could be from a lack of understanding of how IHR works, and the responsibilities of WHO and other entities,” Tedros said. “We don’t replace the country’s work, we only support them, so that’s why there could be some lack of understanding.” Tedros suggested conflict in the affected region was a more fundamental factor in the delay than anything WHO could have done differently. “Health facilities cannot work optimally when there is conflict and when the health workers are also fleeing as part of the community which is displaced,” he said. “It affects the whole surveillance system, and not only that, but it also affects access.” “I think that’s what we should understand, the secretary or others.” Asked repeatedly whether US funding cuts to DRC surveillance programmes had contributed to the outbreak going undetected, Tedros declined to draw a direct line. “We don’t need to jump to conclusions before we understand the whole complexity. It would be very difficult to associate it with funding alone,” he said, noting that the diagnostic gap was a question of the wrong tests being administered rather than supply. Legand echoed the point, noting the issue stems from test type, not supply: “For the time being, it’s not a supply issue. We need to ensure that the right platform with the right data arrives at the right place. This is the work that is being done as we speak.” The outbreak, meanwhile, continues to spread through a war zone with no vaccine, no cure, and a diagnostic system still catching up to the strain it now faces. Image Credits: @WHO African Region, Gage Skidmore. Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ 18/05/2026 Kerry Cullinan WHA president Dr Víctor Atallah (Dominican Republic), Spanish Prime Minister Pedros Sánchez, and WHO Director General Dr Tedros Adhanom Ghebreyesus. “From conflicts to economic crises to climate change and aid cuts, we live in difficult, dangerous and divisive times,” World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyesus told the opening plenary of the World Health Assembly (WHA) on Monday. While geopolitical disagreements have delayed Tedros’s official WHA address until Tuesday morning, the Director General acknowledged in a brief welcome that the WHO “has been through a difficult period as a result of sudden and steep cuts to our funding”. The organisation’s budget is 90% funded, although some of the funds are pledged rather than in the bank. Spain’s Prime Minister Pedro Sánchez, a WHA special guest speaker, appealed for solidarity and multilateral support for global health to combat “the pandemic of egotism and selfishness”. Sánchez said that Spain had increased its official development aid (ODA) by 30%, explaining: “No country can save itself. Protecting others is the best way to protect ourselves.” Without naming the United States, he added: “The greatest risk for global health is no longer the lack of science, but rather the lack of conscience. In just a few months, the same country that cut $18 billion from global public health and ODA has spent more than $29 billion on war, the humanitarian and geopolitical consequences of which will also be devastating.” Sánchez, who received a standing ovation, also appealed for countries in the Global South to “have the role that they deserve in decision-making”, and that the reform of global health needed to be focused on strengthening national health centres. Reforming global health The WHA is considering how to reform the “global health architecture”. Ghanaian President John Dramani Mahama, also a special guest speaker at the plenary, appealed for a more inclusive system of multilateralism. “I’m concerned about whispers I have heard that the draft resolution [on global health reform] seeks to protect existing organisational mandates and prohibit the recommendation of mergers or consolidations,” said Mahama, who is championing Africa’s health sovereignty through the Accra Reset Initiative. “If we launch a process of reform that is prohibited from recommending actual reform, we are merely performing a ritual. We cannot prioritise institutional comfort over human survival. The WHO’s legitimacy is not served by protecting silos. It is served by a fearless analysis of what works,” Mahama warned. Barbados’ Prime Minister Mia Mottley also appealed for a more responsive global health system: “Small states are not asking for pity. We’re asking for a system that recognises reality. Vulnerability is not measured by income alone. Fiscal space must be judged alongside climate risk, debt burden, disease burden, and yes, the cost of survival.” Motley also stressed that emergency funds must move with the speed of an emergency. “The WHO must not be asked to protect eight billion people on Planet Earth on the basis of uncertain contributions and political mood swings,” she said – a reference to the withdrawal from the WHO by the US. Syrian President Ahmed Hussein al-Sharaa addressing the WHA via a video link. Syrian President Ahmed Hussein al-Sharaa, who until December of last year was on both the UN and the US list of global terrorists facing sanctions, also addressed the plenary via video. Shortly after the opening, the business of the WHA was delayed by several hours by geopolitical disagreements, with some issues going to a vote. Member states decided against including Taiwan as an observer, but voted overwhelmingly in favour of a request by the Gulf Cooperation Council to discuss the impact of Iran’s recent attacks later in the week. Israel’s objection to the tabling of two separate reports on health conditions in the occupied Palestinian territory (OPT) – including one on the immense toll of the recent Gaza war and increasing Israeli military and settler violence affecting West Bank Palestinian communities – also delayed proceedings. The WHA has a massive agenda, including approving a new tuberculosis strategy and a plan on combating strokes; a global action plan on antimicrobial resistance (AMR) – still outstanding since the AMR UN high-level meeting two years ago; and how to improve emergency care. Zero for 52: WHO Warns World Set to Miss Every Global Health Target by 2030 18/05/2026 Stefan Anderson Annual report finds progress slowing, stalling or reversing across every global health set out in the SDG agenda. The world is on course to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the World Health Organization has warned, as ministers from its 194 member states gather in Geneva for an assembly tasked with reversing that trajectory. With malaria cases rising, maternal deaths still occurring at nearly three times the targeted rate and childhood vaccination coverage plateauing or falling in some regions, progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 edition of the WHO’s World Health Statistics report. “Progress is too slow, too uneven, and increasingly fragile,” Yukiko Nakatani, WHO assistant director-general for health systems, access and data, told a press briefing on Wednesday. “The report is an urgent reminder for member states and all health partners together: we must refocus efforts, safeguard hard-won gains and renew progress.” WHO Director-General Dr Tedros Adhanom Ghebreyesus said progress toward the health goals was “insufficient, uneven across regions and populations, and increasingly vulnerable to systemic shocks”, with a disproportionate burden falling on low- and middle-income countries, especially those in fragile and conflict-affected settings. “Progress has stalled on universal health coverage, maternal and child health and reduction in premature mortality due to noncommunicable diseases — which remain the leading causes of mortality globally,” Tedros said. “These data tell a story of both progress and persistent inequality,” the WHO chief added, “with many people – especially women, children and those in underserved communities – still denied the basic conditions for a healthy life.” Once achievable health targets out of reach The UN estimates that around 17% of SDG targets are on track globally. The SDG health targets are part of a wider agenda adopted by all UN member states in 2015, setting goals on poverty, hunger, education, gender equality, climate and health by 2030. The third goal — “ensure healthy lives and promote well-being for all at all ages” — sets the dozens of indicators tracked by the annual WHO report, ranging from maternal mortality and HIV incidence to tobacco use and air pollution deaths. These were once seen as among the most achievable of the SDGs, given significant progress made under the agenda’s predecessor, the Millennium Development Goals. That hope has not materialised — and the wider SDG agenda is faring no better, with the latest UN figures finding only about a sixth of all targets on course for the 2030 deadline. “Of the 52 health-related SDG indicators reviewed in this report, more than half have numeric SDG or other global targets,” WHO found. “And none is on track to meet the target at the global level.” Malaria reversing, TB barely moving Tuberculosis incidence rates, globally and by WHO region, 2015, 2024 and the 2030 target. The reversal of progress in eradicating malaria is perhaps the starkest failure on the SDG health agenda. While the world set a target to reduce cases by 90% by 2030, global incidence has instead risen by 8.5%. The African Region carries nearly the entire global burden, recording an estimated 282 million cases in 2024. Only the South-East Asia Region is on track to meet the 2025 milestone of a 75% reduction. Tuberculosis is another major failure: of the 80% reduction target set in the WHO End TB Strategy, just 12% has been achieved since 2015. The European Region cut its TB rate by 39% over the period, while the Region of the Americas went backwards, recording a 13% increase. The African Region, despite still bearing the highest burden, achieved a 28% reduction, more than double the global average. The HIV picture is brighter, with new infections falling 40% since 2010 to 1.3 million worldwide in 2024. The African Region has cut new infections by 70% — a major achievement — but still accounts for 65% of the 40.8 million people living with HIV worldwide. Yet HIV incidence cuts remain well short of the 90% SDG target. Hope circulated before 2015 that ending the AIDS epidemic by 2030 was within reach, has faded away. Maternal and child deaths: progress stalling Maternal mortality ratio, by WHO region, 2000–2023. The global maternal mortality ratio has fallen 40% since 2000, but at 197 deaths per 100,000 live births in 2023 it remains nearly three times the 2030 target of fewer than 70 deaths per 100,000 live births. The annual rate of reduction has slowed to 1.6% since 2015. The world needs that figure to climb to nearly 15% to hit the SDG, a pace more than nine times faster than the world has managed over the past quarter century. Doing so would mean preventing nearly 700,000 maternal deaths by 2030. Each day, 712 women still die from maternal causes — one every two minutes. A staggering 80% of those deaths occur in sub-Saharan Africa, where girls face a one-in-40 chance of dying of pregnancy-related complications by age 15. Central and Southern Asia come a distant second, accounting for 17% of the global death toll. Globally, nearly 95% of all maternal deaths occur in low- and lower middle-income countries. Meanwhile, 73 countries, mostly in Europe, Latin America and the Caribbean, recorded fewer than 20 maternal deaths in 2020. Vaccination coverage flatlines Global immunization rates against diphtheria, tetanus and pertussis, measles, pneumococcal infections, and human papillomavirus, 2000–2024. Routine childhood immunisation has largely flatlined, with global coverage stuck below the levels needed to prevent the outbreaks of vaccine-preventable diseases now resurging in several regions. Coverage with the third dose of the diphtheria-tetanus-pertussis vaccine has plateaued at around 85%, while second-dose measles vaccination sits at 76% — far below the roughly 95% the WHO says is needed to prevent outbreaks. The Region of the Americas, once a global leader on routine immunisation, now reports lower coverage for three of four core vaccines than in 2015. The WHO has linked persistent immunity gaps to the rising measles transmission reported across several regions over the past year, including major outbreaks in the United States, Europe and parts of the Eastern Mediterranean. Coverage of the human papillomavirus vaccine, which protects against cervical cancer, has grown faster than any other core vaccine since 2021 — but from a very low base, reaching just 28% of the target group of 9-14-year-old girls globally in 2024. A pandemic toll three times larger than officially recorded Excess death rates (crude and age-standardized), by World Bank income group, 2020–2023. A key finding buried deep in the report is a new estimate for excess deaths related to the COVID-19 pandemic. The WHO now estimates 22.1 million deaths above expectation occurred between 2020 and 2023, roughly three times the 7 million COVID-19 deaths officially reported worldwide. Excess mortality peaked at 10.4 million in 2021, with men experiencing age-standardised excess death rates around 50% higher than women, and people aged 85 and over recording rates ten times those of younger adults, the report found. The ratio of excess deaths to officially reported COVID-19 deaths rose from roughly 1:1 in 2020 to about 9:1 by 2023, which the WHO attributes increasingly to underreporting as many countries wound down testing and attempted to move past the crisis. The pandemic erased nearly a decade of gains in life expectancy and healthy life expectancy, the WHO chief said, with only female life expectancy returning to pre-pandemic levels globally by 2023. “The COVID-19 pandemic inflicted a setback of historic proportions,” Tedros said. “Recovery since 2022 has been uneven, with persistent disparities according to region, age and sex.” Where there has been progress Age-standardized prevalence of current tobacco use in people 15 years and older, by sex, globally and by WHO region, 2010 and 2024. Some indicators are moving in the right direction. Tobacco use has fallen 27% since 2010 — narrowly missing the 30% reduction target — and alcohol consumption is down 13%. Between 2015 and 2024, 961 million more people gained access to safely managed drinking water, 1.2 billion to safe sanitation, 1.6 billion to basic hygiene services, and 1.4 billion to clean cooking fuels. The number of people requiring interventions for neglected tropical diseases has fallen 36% since 2010. “These trends reflect too many deaths that could have been avoided,” Nakatani said. “With rising environmental risks, health emergencies, and a worsening health financing crisis, we must act urgently — strengthening primary health care, investing in prevention, and securing sustainable financing to build resilient health systems and get back on track.” A ‘global health financing emergency’ Density of health professionals, globally and by WHO region. The WHO warned that the limited gains were now under serious threat from a “global health financing emergency”, as billions of dollars cut by the United States and other wealthy donors, much of it destined to fund progress towards the SDGs, are now gone. “Official development assistance for health was estimated to be 30-40% less in 2025 than in 2023,” Tedros said. “Many countries face long-standing structural constraints including high debt burdens and insufficient domestic public financing. Sudden aid reductions risk significant disruption of essential health services, reduced access to life-saving essential medicines and vaccines.” A WHO rapid assessment of 108 low- and lower-middle-income countries earlier this year found that 63% reported job losses, salary suspensions or reductions among health and care workers as a result of the aid cuts. Nearly 70% anticipated future recruitment problems in the health sector. Alain Labrique, director of WHO’s Department of Data, Digital Health, Analytics and Artificial Intelligence, noted that because the report’s data run only through 2024, the full effect of recent cuts to US foreign aid and other donor retrenchment is not yet visible. “Should these trends continue, and we don’t see reinvigorated investment in global health, this will have an effect on global health indicators,” he said. “It may continue to cause a reversal in the patterns that we worked so hard to gain.” Missing data paints a darker picture Timeliness of WHO Member States in reporting cause-of-death data, 2025. Compounding the picture is the fact that the WHO’s own data is incomplete — and likely understates the scale of the problem. Of an estimated 61 million deaths globally in 2023, only around 21 million were reported to the agency with cause-of-death information. Just 12 million had meaningful coding under the International Classification of Diseases, the global standard used to record what people die from and the foundation of comparable mortality statistics worldwide. Only 18% of countries reported mortality data within a year. Nearly a third have never submitted cause-of-death data at all. The shortfalls are concentrated in low- and lower-middle-income countries, where civil registration systems are weakest and where the disease burden is heaviest. Funding cuts have also disrupted disease surveillance, Nakatani said. “Erosion of data, planning, and surveillance systems undermines reliable measurement, which is essential for progress,” Tedros said. “Too few deaths are recorded with timely, accurate, and meaningful cause-of-death information, limiting the accuracy and relevance of mortality statistics for policy and planning.” “Data gaps severely limit the ability to monitor real-time health trends, compare outcomes across countries, and design effective public health responses,” Labrique said. Image Credits: John Cameron, Priscila Oliveira. WHO Declares DRC Ebola Outbreak a Public Health Emergency: ‘May Be ‘Much Larger’ Than Reported 17/05/2026 Kerry Cullinan The outbreak of Ebola in the Democratic Republic of Congo (DRC) may be “a much larger outbreak than what is currently being detected and reported, with significant local and regional risk of spread”, the World Health Organization (WHO) warned on Sunday. The WHO declared the outbreak a public health emergency of international concern (PHEIC) on Sunday, confirming that it involves the Ebola species, Bundibugyo virus disease (BVD). There is no vaccine or treatment for BVD, and a high case fatality rate of 30-50%. By Saturday, there were 336 suspected cases and 87 deaths, 13 of which had been confirmed as BVD, according to the Africa Centres for Disease Control and Prevention. Very high risk of spread in DRC Africa CDC warned that the risk of spread within the DRC was “very high” as a “four-week detection delay” had enabled “extensive uncontrolled community transmission”. It also said the risk for East Africa is “high”. The outbreak is likely to have originated in the Mongbwalu health zone of DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Two laboratory-confirmed cases (including one death) with no apparent link to each other were reported in Kampala in Uganda, late last week, involving two people travelling from the DRC. Meanwhile, insecurity and conflict in the DRC are “restricting surveillance and rapid response operations”, Africa CDC noted. While there are no approved vaccines or therapeutics, Africa CDC said its research team is studying the candidate vaccine, Ervebo, and potential treatments including “DP134, Remdesivir, Opaldesivir (oral form), and monoclonal antibodies”. It also warned that while national and regional stocks of personal protective equipment (PPE) are “sufficient to cover existing demand patterns”, if transmission increases, countries will need to import new PPE and the lead time for this is six to eight weeks. Why ‘public health emergency’? “Response measures include deployment of rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, the set-up of safe treatment centres, and community engagement,” the WHO said in a statement issued on Sunday. WHO Director-General Dr Tedros Adhanom Ghebreyesus said that the outbreak meets the criteria of the definition of PHEIC in terms of the International Health Regulations as it is “extraordinary”, constitutes a public health risk to other countries and “requires international coordination and cooperation to understand the extent of the outbreak, to coordinate surveillance, prevention and response efforts, to scale up and strengthen operations and ensure ability to implement control measures.” The “extraordinary” nature of the outbreak includes “unusual clusters of community deaths with symptoms compatible BVD”, and the high positivity rate of the initial samples collected (eight positive out of 13 samples). The WHO is in the process of convening an emergency committee under the provisions of the IHR, “as soon as possible” to advise affected countries on how to respond to the outbreak. WHO Member States Should Treat Fossil Fuels like Tobacco – as a Public Health Threat 15/05/2026 Jeni Miller Protests against fossil fuel lobbyists at COP30 in Bélem, Brazil, likening them to having the tobacco industry at a health conference. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. In the coming days, the annual World Health Assembly will convene in Geneva. Following the recent Santa Marta Conference on Transitioning Away from Fossil Fuels, national health ministers and global health leaders have both an opportunity and responsibility to address the root cause of the climate-induced health crisis: fossil fuels. The Santa Marta conference addressed the need to transition away from fossil fuels, the root cause of climate change. Fifty-seven countries, representing one-third of the global economy, committed to developing roadmaps to end fossil fuel use, marking an important step toward protecting public health and the climate. Santa Marta demonstrated growing momentum beyond traditional climate negotiations. While the UN climate COP process remains essential, countries increasingly recognize that progress has been too slow given the escalating impacts of climate change and health. The next Santa Marta conference, hosted by Tuvalu and Ireland in 2027, will provide a key opportunity to strengthen international cooperation on phasing out fossil fuels. Fossil fuel combustion constitutes the biggest public health emergency of our time Heavy-Duty trucks and buses spew out soot, including climate-changing black carbon and health harmful PM2.5 on a highway. Climate change is not only an environmental issue; it is a public health emergency. Fossil fuels are not just an energy source; they are harmful to health. Despite this, health was largely overlooked – the final Santa Marta conference text had no mention of health. The health community must raise a clamour to ensure that future climate negotiations take our health into consideration. Fossil fuels harm human health throughout their lifecycle, from extraction and refining to transport, combustion, and petrochemical production. They pollute air, water, and soil; drive extreme heat and food insecurity; worsen respiratory and cardiovascular diseases; and contribute to millions of premature deaths each year. Frontline communities near extraction sites, refineries, highways, ports, and petrochemical facilities face disproportionate risks of toxic exposure, cancer, displacement, and economic disruption. The world is already experiencing the consequences of the fossil-fuel-driven climate crisis. Last month, temperatures in parts of South and Southeast Asia reached 45 to 46°C, making outdoor work unsafe and pushing the limits of human survivability. Floods, wildfires, storms, crop failures, and infectious disease outbreaks are increasingly overwhelming health systems worldwide. Subsidizing the sale of products that harm human health Ending fossil fuel subsidies would be one of the most effective global public health interventions ever, also averting 1.2 deaths a year from air pollution. Yet governments continue to subsidize the very products causing this harm. In 2024 alone, fossil fuels received an estimated US$725 billion in public subsidies, even as air pollution, much of it from fossil fuels, costs the global economy about US$8.1 trillion annually in healthcare expenses, lost productivity, and premature deaths. From a public health perspective, this contradiction is stark: governments are using public funds to subsidize disease, death, climate disruption, and increased pressure on already overburdened health systems. The true cost of fossil fuels remains obscured because health harms are treated as “externalities.” But asthma, strokes, heat deaths, cancers, pregnancy complications, and polluted drinking water are not externalities; they are direct and devastating impacts. When these costs are fully accounted for, fossil fuels are no longer economically rational. They are a dangerous and outdated relic. Following the example of Tobacco Six out of ten smokers, or 750 million people globally want to quit tobacco use. For decades already, the health community has carried the weight of responding to the symptoms of the climate-induced health crisis while often avoiding its primary cause. This must change. And yet, the health community has both the moral authority and institutional capacity to speak to the impacts of fossil fuels directly. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. There is already a clear precedent: the World Health Organization Framework Convention on Tobacco Control (FCTC), the first global treaty negotiated under WHO leadership. The FCTC recognized that protecting health requires more than treating disease; it requires regulating the industry responsible for the harm. We can apply this same approach to fossil fuels. Tobacco control showed that effective public health action requires conflict-of-interest protections, restrictions on advertising and sponsorship, public education, fiscal measures, warning labels, litigation support, and international cooperation to reduce demand for harmful products. Fossil fuels require a similarly comprehensive response. Health ministries and the WHO have a critical role in advancing this agenda. The 78th session of the World Health Assembly in May 2025 – member states passed a Global Action Plan for climate and health. Ending fossil fuel subsidies would put teeth into that decision. The World Health Assembly is the world’s highest decision-making forum on health. Resolutions passed in Geneva shape national health priorities, influence financing, guide public health norms, and determine how governments respond to emerging threats. WHA can guide the WHO Secretariat in advocating for stronger conflict-of-interest protections to limit the influence of the fossil fuel industry in health policymaking and other multilateral processes. They can document the full lifecycle health harms of fossil fuels, plan protective health measures, promote health impact assessments for fossil fuel projects and infrastructure, and support air pollution standards based on current science. They can also champion subsidy reform as a public health intervention and help redirect public finance toward clean energy, resilient health systems, and social protection. The health community can also help revoke the social license of the fossil fuel industry by clearly communicating that these products are fundamentally incompatible with health protection. This is especially urgent as fossil fuel companies continue to use disinformation, greenwashing, and political influence to delay action, tactics long recognized by the public health community from efforts against other health-harming industries. At WHA78 last year, countries made progress through the WHO Global Action Plan on Climate Change and Health and commitments to reduce air pollution deaths. However, these efforts will remain incomplete unless governments address the primary driver of both climate change and air pollution: fossil fuels. WHA member states must recognise that fossil fuels are health-harming products, and their phase-out is a public health imperative. The science is clear, the health evidence is overwhelming, and solutions exist. The question now is whether the global health community is prepared to address the cause of the crisis, not just its consequences. On May 19th, the Global Climate and Health Alliance and the Office of the United Nations High Commissioner for Human Rights (OHCHR) will co-host Fossil Fuels, Health, and Human Rights – Centering Health and Human Rights in the Global Transition Away from Fossil Fuels where the issue will be discussed. It would be open to attend in person in Geneva and via Zoom. Dr Jeni Miller is Executive Director of the Global Climate and Health Alliance, a consortium of more than 250 health professional and health civil society organisations and networks from around the world addressing climate change. Image Credits: Mike Muzurakis IISD/ENB , UNEP, Galen Crout , Sarah Johnson. Posts navigation Older postsNewer posts
Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ 18/05/2026 Kerry Cullinan WHA president Dr Víctor Atallah (Dominican Republic), Spanish Prime Minister Pedros Sánchez, and WHO Director General Dr Tedros Adhanom Ghebreyesus. “From conflicts to economic crises to climate change and aid cuts, we live in difficult, dangerous and divisive times,” World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyesus told the opening plenary of the World Health Assembly (WHA) on Monday. While geopolitical disagreements have delayed Tedros’s official WHA address until Tuesday morning, the Director General acknowledged in a brief welcome that the WHO “has been through a difficult period as a result of sudden and steep cuts to our funding”. The organisation’s budget is 90% funded, although some of the funds are pledged rather than in the bank. Spain’s Prime Minister Pedro Sánchez, a WHA special guest speaker, appealed for solidarity and multilateral support for global health to combat “the pandemic of egotism and selfishness”. Sánchez said that Spain had increased its official development aid (ODA) by 30%, explaining: “No country can save itself. Protecting others is the best way to protect ourselves.” Without naming the United States, he added: “The greatest risk for global health is no longer the lack of science, but rather the lack of conscience. In just a few months, the same country that cut $18 billion from global public health and ODA has spent more than $29 billion on war, the humanitarian and geopolitical consequences of which will also be devastating.” Sánchez, who received a standing ovation, also appealed for countries in the Global South to “have the role that they deserve in decision-making”, and that the reform of global health needed to be focused on strengthening national health centres. Reforming global health The WHA is considering how to reform the “global health architecture”. Ghanaian President John Dramani Mahama, also a special guest speaker at the plenary, appealed for a more inclusive system of multilateralism. “I’m concerned about whispers I have heard that the draft resolution [on global health reform] seeks to protect existing organisational mandates and prohibit the recommendation of mergers or consolidations,” said Mahama, who is championing Africa’s health sovereignty through the Accra Reset Initiative. “If we launch a process of reform that is prohibited from recommending actual reform, we are merely performing a ritual. We cannot prioritise institutional comfort over human survival. The WHO’s legitimacy is not served by protecting silos. It is served by a fearless analysis of what works,” Mahama warned. Barbados’ Prime Minister Mia Mottley also appealed for a more responsive global health system: “Small states are not asking for pity. We’re asking for a system that recognises reality. Vulnerability is not measured by income alone. Fiscal space must be judged alongside climate risk, debt burden, disease burden, and yes, the cost of survival.” Motley also stressed that emergency funds must move with the speed of an emergency. “The WHO must not be asked to protect eight billion people on Planet Earth on the basis of uncertain contributions and political mood swings,” she said – a reference to the withdrawal from the WHO by the US. Syrian President Ahmed Hussein al-Sharaa addressing the WHA via a video link. Syrian President Ahmed Hussein al-Sharaa, who until December of last year was on both the UN and the US list of global terrorists facing sanctions, also addressed the plenary via video. Shortly after the opening, the business of the WHA was delayed by several hours by geopolitical disagreements, with some issues going to a vote. Member states decided against including Taiwan as an observer, but voted overwhelmingly in favour of a request by the Gulf Cooperation Council to discuss the impact of Iran’s recent attacks later in the week. Israel’s objection to the tabling of two separate reports on health conditions in the occupied Palestinian territory (OPT) – including one on the immense toll of the recent Gaza war and increasing Israeli military and settler violence affecting West Bank Palestinian communities – also delayed proceedings. The WHA has a massive agenda, including approving a new tuberculosis strategy and a plan on combating strokes; a global action plan on antimicrobial resistance (AMR) – still outstanding since the AMR UN high-level meeting two years ago; and how to improve emergency care. Zero for 52: WHO Warns World Set to Miss Every Global Health Target by 2030 18/05/2026 Stefan Anderson Annual report finds progress slowing, stalling or reversing across every global health set out in the SDG agenda. The world is on course to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the World Health Organization has warned, as ministers from its 194 member states gather in Geneva for an assembly tasked with reversing that trajectory. With malaria cases rising, maternal deaths still occurring at nearly three times the targeted rate and childhood vaccination coverage plateauing or falling in some regions, progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 edition of the WHO’s World Health Statistics report. “Progress is too slow, too uneven, and increasingly fragile,” Yukiko Nakatani, WHO assistant director-general for health systems, access and data, told a press briefing on Wednesday. “The report is an urgent reminder for member states and all health partners together: we must refocus efforts, safeguard hard-won gains and renew progress.” WHO Director-General Dr Tedros Adhanom Ghebreyesus said progress toward the health goals was “insufficient, uneven across regions and populations, and increasingly vulnerable to systemic shocks”, with a disproportionate burden falling on low- and middle-income countries, especially those in fragile and conflict-affected settings. “Progress has stalled on universal health coverage, maternal and child health and reduction in premature mortality due to noncommunicable diseases — which remain the leading causes of mortality globally,” Tedros said. “These data tell a story of both progress and persistent inequality,” the WHO chief added, “with many people – especially women, children and those in underserved communities – still denied the basic conditions for a healthy life.” Once achievable health targets out of reach The UN estimates that around 17% of SDG targets are on track globally. The SDG health targets are part of a wider agenda adopted by all UN member states in 2015, setting goals on poverty, hunger, education, gender equality, climate and health by 2030. The third goal — “ensure healthy lives and promote well-being for all at all ages” — sets the dozens of indicators tracked by the annual WHO report, ranging from maternal mortality and HIV incidence to tobacco use and air pollution deaths. These were once seen as among the most achievable of the SDGs, given significant progress made under the agenda’s predecessor, the Millennium Development Goals. That hope has not materialised — and the wider SDG agenda is faring no better, with the latest UN figures finding only about a sixth of all targets on course for the 2030 deadline. “Of the 52 health-related SDG indicators reviewed in this report, more than half have numeric SDG or other global targets,” WHO found. “And none is on track to meet the target at the global level.” Malaria reversing, TB barely moving Tuberculosis incidence rates, globally and by WHO region, 2015, 2024 and the 2030 target. The reversal of progress in eradicating malaria is perhaps the starkest failure on the SDG health agenda. While the world set a target to reduce cases by 90% by 2030, global incidence has instead risen by 8.5%. The African Region carries nearly the entire global burden, recording an estimated 282 million cases in 2024. Only the South-East Asia Region is on track to meet the 2025 milestone of a 75% reduction. Tuberculosis is another major failure: of the 80% reduction target set in the WHO End TB Strategy, just 12% has been achieved since 2015. The European Region cut its TB rate by 39% over the period, while the Region of the Americas went backwards, recording a 13% increase. The African Region, despite still bearing the highest burden, achieved a 28% reduction, more than double the global average. The HIV picture is brighter, with new infections falling 40% since 2010 to 1.3 million worldwide in 2024. The African Region has cut new infections by 70% — a major achievement — but still accounts for 65% of the 40.8 million people living with HIV worldwide. Yet HIV incidence cuts remain well short of the 90% SDG target. Hope circulated before 2015 that ending the AIDS epidemic by 2030 was within reach, has faded away. Maternal and child deaths: progress stalling Maternal mortality ratio, by WHO region, 2000–2023. The global maternal mortality ratio has fallen 40% since 2000, but at 197 deaths per 100,000 live births in 2023 it remains nearly three times the 2030 target of fewer than 70 deaths per 100,000 live births. The annual rate of reduction has slowed to 1.6% since 2015. The world needs that figure to climb to nearly 15% to hit the SDG, a pace more than nine times faster than the world has managed over the past quarter century. Doing so would mean preventing nearly 700,000 maternal deaths by 2030. Each day, 712 women still die from maternal causes — one every two minutes. A staggering 80% of those deaths occur in sub-Saharan Africa, where girls face a one-in-40 chance of dying of pregnancy-related complications by age 15. Central and Southern Asia come a distant second, accounting for 17% of the global death toll. Globally, nearly 95% of all maternal deaths occur in low- and lower middle-income countries. Meanwhile, 73 countries, mostly in Europe, Latin America and the Caribbean, recorded fewer than 20 maternal deaths in 2020. Vaccination coverage flatlines Global immunization rates against diphtheria, tetanus and pertussis, measles, pneumococcal infections, and human papillomavirus, 2000–2024. Routine childhood immunisation has largely flatlined, with global coverage stuck below the levels needed to prevent the outbreaks of vaccine-preventable diseases now resurging in several regions. Coverage with the third dose of the diphtheria-tetanus-pertussis vaccine has plateaued at around 85%, while second-dose measles vaccination sits at 76% — far below the roughly 95% the WHO says is needed to prevent outbreaks. The Region of the Americas, once a global leader on routine immunisation, now reports lower coverage for three of four core vaccines than in 2015. The WHO has linked persistent immunity gaps to the rising measles transmission reported across several regions over the past year, including major outbreaks in the United States, Europe and parts of the Eastern Mediterranean. Coverage of the human papillomavirus vaccine, which protects against cervical cancer, has grown faster than any other core vaccine since 2021 — but from a very low base, reaching just 28% of the target group of 9-14-year-old girls globally in 2024. A pandemic toll three times larger than officially recorded Excess death rates (crude and age-standardized), by World Bank income group, 2020–2023. A key finding buried deep in the report is a new estimate for excess deaths related to the COVID-19 pandemic. The WHO now estimates 22.1 million deaths above expectation occurred between 2020 and 2023, roughly three times the 7 million COVID-19 deaths officially reported worldwide. Excess mortality peaked at 10.4 million in 2021, with men experiencing age-standardised excess death rates around 50% higher than women, and people aged 85 and over recording rates ten times those of younger adults, the report found. The ratio of excess deaths to officially reported COVID-19 deaths rose from roughly 1:1 in 2020 to about 9:1 by 2023, which the WHO attributes increasingly to underreporting as many countries wound down testing and attempted to move past the crisis. The pandemic erased nearly a decade of gains in life expectancy and healthy life expectancy, the WHO chief said, with only female life expectancy returning to pre-pandemic levels globally by 2023. “The COVID-19 pandemic inflicted a setback of historic proportions,” Tedros said. “Recovery since 2022 has been uneven, with persistent disparities according to region, age and sex.” Where there has been progress Age-standardized prevalence of current tobacco use in people 15 years and older, by sex, globally and by WHO region, 2010 and 2024. Some indicators are moving in the right direction. Tobacco use has fallen 27% since 2010 — narrowly missing the 30% reduction target — and alcohol consumption is down 13%. Between 2015 and 2024, 961 million more people gained access to safely managed drinking water, 1.2 billion to safe sanitation, 1.6 billion to basic hygiene services, and 1.4 billion to clean cooking fuels. The number of people requiring interventions for neglected tropical diseases has fallen 36% since 2010. “These trends reflect too many deaths that could have been avoided,” Nakatani said. “With rising environmental risks, health emergencies, and a worsening health financing crisis, we must act urgently — strengthening primary health care, investing in prevention, and securing sustainable financing to build resilient health systems and get back on track.” A ‘global health financing emergency’ Density of health professionals, globally and by WHO region. The WHO warned that the limited gains were now under serious threat from a “global health financing emergency”, as billions of dollars cut by the United States and other wealthy donors, much of it destined to fund progress towards the SDGs, are now gone. “Official development assistance for health was estimated to be 30-40% less in 2025 than in 2023,” Tedros said. “Many countries face long-standing structural constraints including high debt burdens and insufficient domestic public financing. Sudden aid reductions risk significant disruption of essential health services, reduced access to life-saving essential medicines and vaccines.” A WHO rapid assessment of 108 low- and lower-middle-income countries earlier this year found that 63% reported job losses, salary suspensions or reductions among health and care workers as a result of the aid cuts. Nearly 70% anticipated future recruitment problems in the health sector. Alain Labrique, director of WHO’s Department of Data, Digital Health, Analytics and Artificial Intelligence, noted that because the report’s data run only through 2024, the full effect of recent cuts to US foreign aid and other donor retrenchment is not yet visible. “Should these trends continue, and we don’t see reinvigorated investment in global health, this will have an effect on global health indicators,” he said. “It may continue to cause a reversal in the patterns that we worked so hard to gain.” Missing data paints a darker picture Timeliness of WHO Member States in reporting cause-of-death data, 2025. Compounding the picture is the fact that the WHO’s own data is incomplete — and likely understates the scale of the problem. Of an estimated 61 million deaths globally in 2023, only around 21 million were reported to the agency with cause-of-death information. Just 12 million had meaningful coding under the International Classification of Diseases, the global standard used to record what people die from and the foundation of comparable mortality statistics worldwide. Only 18% of countries reported mortality data within a year. Nearly a third have never submitted cause-of-death data at all. The shortfalls are concentrated in low- and lower-middle-income countries, where civil registration systems are weakest and where the disease burden is heaviest. Funding cuts have also disrupted disease surveillance, Nakatani said. “Erosion of data, planning, and surveillance systems undermines reliable measurement, which is essential for progress,” Tedros said. “Too few deaths are recorded with timely, accurate, and meaningful cause-of-death information, limiting the accuracy and relevance of mortality statistics for policy and planning.” “Data gaps severely limit the ability to monitor real-time health trends, compare outcomes across countries, and design effective public health responses,” Labrique said. Image Credits: John Cameron, Priscila Oliveira. WHO Declares DRC Ebola Outbreak a Public Health Emergency: ‘May Be ‘Much Larger’ Than Reported 17/05/2026 Kerry Cullinan The outbreak of Ebola in the Democratic Republic of Congo (DRC) may be “a much larger outbreak than what is currently being detected and reported, with significant local and regional risk of spread”, the World Health Organization (WHO) warned on Sunday. The WHO declared the outbreak a public health emergency of international concern (PHEIC) on Sunday, confirming that it involves the Ebola species, Bundibugyo virus disease (BVD). There is no vaccine or treatment for BVD, and a high case fatality rate of 30-50%. By Saturday, there were 336 suspected cases and 87 deaths, 13 of which had been confirmed as BVD, according to the Africa Centres for Disease Control and Prevention. Very high risk of spread in DRC Africa CDC warned that the risk of spread within the DRC was “very high” as a “four-week detection delay” had enabled “extensive uncontrolled community transmission”. It also said the risk for East Africa is “high”. The outbreak is likely to have originated in the Mongbwalu health zone of DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Two laboratory-confirmed cases (including one death) with no apparent link to each other were reported in Kampala in Uganda, late last week, involving two people travelling from the DRC. Meanwhile, insecurity and conflict in the DRC are “restricting surveillance and rapid response operations”, Africa CDC noted. While there are no approved vaccines or therapeutics, Africa CDC said its research team is studying the candidate vaccine, Ervebo, and potential treatments including “DP134, Remdesivir, Opaldesivir (oral form), and monoclonal antibodies”. It also warned that while national and regional stocks of personal protective equipment (PPE) are “sufficient to cover existing demand patterns”, if transmission increases, countries will need to import new PPE and the lead time for this is six to eight weeks. Why ‘public health emergency’? “Response measures include deployment of rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, the set-up of safe treatment centres, and community engagement,” the WHO said in a statement issued on Sunday. WHO Director-General Dr Tedros Adhanom Ghebreyesus said that the outbreak meets the criteria of the definition of PHEIC in terms of the International Health Regulations as it is “extraordinary”, constitutes a public health risk to other countries and “requires international coordination and cooperation to understand the extent of the outbreak, to coordinate surveillance, prevention and response efforts, to scale up and strengthen operations and ensure ability to implement control measures.” The “extraordinary” nature of the outbreak includes “unusual clusters of community deaths with symptoms compatible BVD”, and the high positivity rate of the initial samples collected (eight positive out of 13 samples). The WHO is in the process of convening an emergency committee under the provisions of the IHR, “as soon as possible” to advise affected countries on how to respond to the outbreak. WHO Member States Should Treat Fossil Fuels like Tobacco – as a Public Health Threat 15/05/2026 Jeni Miller Protests against fossil fuel lobbyists at COP30 in Bélem, Brazil, likening them to having the tobacco industry at a health conference. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. In the coming days, the annual World Health Assembly will convene in Geneva. Following the recent Santa Marta Conference on Transitioning Away from Fossil Fuels, national health ministers and global health leaders have both an opportunity and responsibility to address the root cause of the climate-induced health crisis: fossil fuels. The Santa Marta conference addressed the need to transition away from fossil fuels, the root cause of climate change. Fifty-seven countries, representing one-third of the global economy, committed to developing roadmaps to end fossil fuel use, marking an important step toward protecting public health and the climate. Santa Marta demonstrated growing momentum beyond traditional climate negotiations. While the UN climate COP process remains essential, countries increasingly recognize that progress has been too slow given the escalating impacts of climate change and health. The next Santa Marta conference, hosted by Tuvalu and Ireland in 2027, will provide a key opportunity to strengthen international cooperation on phasing out fossil fuels. Fossil fuel combustion constitutes the biggest public health emergency of our time Heavy-Duty trucks and buses spew out soot, including climate-changing black carbon and health harmful PM2.5 on a highway. Climate change is not only an environmental issue; it is a public health emergency. Fossil fuels are not just an energy source; they are harmful to health. Despite this, health was largely overlooked – the final Santa Marta conference text had no mention of health. The health community must raise a clamour to ensure that future climate negotiations take our health into consideration. Fossil fuels harm human health throughout their lifecycle, from extraction and refining to transport, combustion, and petrochemical production. They pollute air, water, and soil; drive extreme heat and food insecurity; worsen respiratory and cardiovascular diseases; and contribute to millions of premature deaths each year. Frontline communities near extraction sites, refineries, highways, ports, and petrochemical facilities face disproportionate risks of toxic exposure, cancer, displacement, and economic disruption. The world is already experiencing the consequences of the fossil-fuel-driven climate crisis. Last month, temperatures in parts of South and Southeast Asia reached 45 to 46°C, making outdoor work unsafe and pushing the limits of human survivability. Floods, wildfires, storms, crop failures, and infectious disease outbreaks are increasingly overwhelming health systems worldwide. Subsidizing the sale of products that harm human health Ending fossil fuel subsidies would be one of the most effective global public health interventions ever, also averting 1.2 deaths a year from air pollution. Yet governments continue to subsidize the very products causing this harm. In 2024 alone, fossil fuels received an estimated US$725 billion in public subsidies, even as air pollution, much of it from fossil fuels, costs the global economy about US$8.1 trillion annually in healthcare expenses, lost productivity, and premature deaths. From a public health perspective, this contradiction is stark: governments are using public funds to subsidize disease, death, climate disruption, and increased pressure on already overburdened health systems. The true cost of fossil fuels remains obscured because health harms are treated as “externalities.” But asthma, strokes, heat deaths, cancers, pregnancy complications, and polluted drinking water are not externalities; they are direct and devastating impacts. When these costs are fully accounted for, fossil fuels are no longer economically rational. They are a dangerous and outdated relic. Following the example of Tobacco Six out of ten smokers, or 750 million people globally want to quit tobacco use. For decades already, the health community has carried the weight of responding to the symptoms of the climate-induced health crisis while often avoiding its primary cause. This must change. And yet, the health community has both the moral authority and institutional capacity to speak to the impacts of fossil fuels directly. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. There is already a clear precedent: the World Health Organization Framework Convention on Tobacco Control (FCTC), the first global treaty negotiated under WHO leadership. The FCTC recognized that protecting health requires more than treating disease; it requires regulating the industry responsible for the harm. We can apply this same approach to fossil fuels. Tobacco control showed that effective public health action requires conflict-of-interest protections, restrictions on advertising and sponsorship, public education, fiscal measures, warning labels, litigation support, and international cooperation to reduce demand for harmful products. Fossil fuels require a similarly comprehensive response. Health ministries and the WHO have a critical role in advancing this agenda. The 78th session of the World Health Assembly in May 2025 – member states passed a Global Action Plan for climate and health. Ending fossil fuel subsidies would put teeth into that decision. The World Health Assembly is the world’s highest decision-making forum on health. Resolutions passed in Geneva shape national health priorities, influence financing, guide public health norms, and determine how governments respond to emerging threats. WHA can guide the WHO Secretariat in advocating for stronger conflict-of-interest protections to limit the influence of the fossil fuel industry in health policymaking and other multilateral processes. They can document the full lifecycle health harms of fossil fuels, plan protective health measures, promote health impact assessments for fossil fuel projects and infrastructure, and support air pollution standards based on current science. They can also champion subsidy reform as a public health intervention and help redirect public finance toward clean energy, resilient health systems, and social protection. The health community can also help revoke the social license of the fossil fuel industry by clearly communicating that these products are fundamentally incompatible with health protection. This is especially urgent as fossil fuel companies continue to use disinformation, greenwashing, and political influence to delay action, tactics long recognized by the public health community from efforts against other health-harming industries. At WHA78 last year, countries made progress through the WHO Global Action Plan on Climate Change and Health and commitments to reduce air pollution deaths. However, these efforts will remain incomplete unless governments address the primary driver of both climate change and air pollution: fossil fuels. WHA member states must recognise that fossil fuels are health-harming products, and their phase-out is a public health imperative. The science is clear, the health evidence is overwhelming, and solutions exist. The question now is whether the global health community is prepared to address the cause of the crisis, not just its consequences. On May 19th, the Global Climate and Health Alliance and the Office of the United Nations High Commissioner for Human Rights (OHCHR) will co-host Fossil Fuels, Health, and Human Rights – Centering Health and Human Rights in the Global Transition Away from Fossil Fuels where the issue will be discussed. It would be open to attend in person in Geneva and via Zoom. Dr Jeni Miller is Executive Director of the Global Climate and Health Alliance, a consortium of more than 250 health professional and health civil society organisations and networks from around the world addressing climate change. Image Credits: Mike Muzurakis IISD/ENB , UNEP, Galen Crout , Sarah Johnson. Posts navigation Older postsNewer posts
WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ 18/05/2026 Kerry Cullinan WHA president Dr Víctor Atallah (Dominican Republic), Spanish Prime Minister Pedros Sánchez, and WHO Director General Dr Tedros Adhanom Ghebreyesus. “From conflicts to economic crises to climate change and aid cuts, we live in difficult, dangerous and divisive times,” World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyesus told the opening plenary of the World Health Assembly (WHA) on Monday. While geopolitical disagreements have delayed Tedros’s official WHA address until Tuesday morning, the Director General acknowledged in a brief welcome that the WHO “has been through a difficult period as a result of sudden and steep cuts to our funding”. The organisation’s budget is 90% funded, although some of the funds are pledged rather than in the bank. Spain’s Prime Minister Pedro Sánchez, a WHA special guest speaker, appealed for solidarity and multilateral support for global health to combat “the pandemic of egotism and selfishness”. Sánchez said that Spain had increased its official development aid (ODA) by 30%, explaining: “No country can save itself. Protecting others is the best way to protect ourselves.” Without naming the United States, he added: “The greatest risk for global health is no longer the lack of science, but rather the lack of conscience. In just a few months, the same country that cut $18 billion from global public health and ODA has spent more than $29 billion on war, the humanitarian and geopolitical consequences of which will also be devastating.” Sánchez, who received a standing ovation, also appealed for countries in the Global South to “have the role that they deserve in decision-making”, and that the reform of global health needed to be focused on strengthening national health centres. Reforming global health The WHA is considering how to reform the “global health architecture”. Ghanaian President John Dramani Mahama, also a special guest speaker at the plenary, appealed for a more inclusive system of multilateralism. “I’m concerned about whispers I have heard that the draft resolution [on global health reform] seeks to protect existing organisational mandates and prohibit the recommendation of mergers or consolidations,” said Mahama, who is championing Africa’s health sovereignty through the Accra Reset Initiative. “If we launch a process of reform that is prohibited from recommending actual reform, we are merely performing a ritual. We cannot prioritise institutional comfort over human survival. The WHO’s legitimacy is not served by protecting silos. It is served by a fearless analysis of what works,” Mahama warned. Barbados’ Prime Minister Mia Mottley also appealed for a more responsive global health system: “Small states are not asking for pity. We’re asking for a system that recognises reality. Vulnerability is not measured by income alone. Fiscal space must be judged alongside climate risk, debt burden, disease burden, and yes, the cost of survival.” Motley also stressed that emergency funds must move with the speed of an emergency. “The WHO must not be asked to protect eight billion people on Planet Earth on the basis of uncertain contributions and political mood swings,” she said – a reference to the withdrawal from the WHO by the US. Syrian President Ahmed Hussein al-Sharaa addressing the WHA via a video link. Syrian President Ahmed Hussein al-Sharaa, who until December of last year was on both the UN and the US list of global terrorists facing sanctions, also addressed the plenary via video. Shortly after the opening, the business of the WHA was delayed by several hours by geopolitical disagreements, with some issues going to a vote. Member states decided against including Taiwan as an observer, but voted overwhelmingly in favour of a request by the Gulf Cooperation Council to discuss the impact of Iran’s recent attacks later in the week. Israel’s objection to the tabling of two separate reports on health conditions in the occupied Palestinian territory (OPT) – including one on the immense toll of the recent Gaza war and increasing Israeli military and settler violence affecting West Bank Palestinian communities – also delayed proceedings. The WHA has a massive agenda, including approving a new tuberculosis strategy and a plan on combating strokes; a global action plan on antimicrobial resistance (AMR) – still outstanding since the AMR UN high-level meeting two years ago; and how to improve emergency care. Zero for 52: WHO Warns World Set to Miss Every Global Health Target by 2030 18/05/2026 Stefan Anderson Annual report finds progress slowing, stalling or reversing across every global health set out in the SDG agenda. The world is on course to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the World Health Organization has warned, as ministers from its 194 member states gather in Geneva for an assembly tasked with reversing that trajectory. With malaria cases rising, maternal deaths still occurring at nearly three times the targeted rate and childhood vaccination coverage plateauing or falling in some regions, progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 edition of the WHO’s World Health Statistics report. “Progress is too slow, too uneven, and increasingly fragile,” Yukiko Nakatani, WHO assistant director-general for health systems, access and data, told a press briefing on Wednesday. “The report is an urgent reminder for member states and all health partners together: we must refocus efforts, safeguard hard-won gains and renew progress.” WHO Director-General Dr Tedros Adhanom Ghebreyesus said progress toward the health goals was “insufficient, uneven across regions and populations, and increasingly vulnerable to systemic shocks”, with a disproportionate burden falling on low- and middle-income countries, especially those in fragile and conflict-affected settings. “Progress has stalled on universal health coverage, maternal and child health and reduction in premature mortality due to noncommunicable diseases — which remain the leading causes of mortality globally,” Tedros said. “These data tell a story of both progress and persistent inequality,” the WHO chief added, “with many people – especially women, children and those in underserved communities – still denied the basic conditions for a healthy life.” Once achievable health targets out of reach The UN estimates that around 17% of SDG targets are on track globally. The SDG health targets are part of a wider agenda adopted by all UN member states in 2015, setting goals on poverty, hunger, education, gender equality, climate and health by 2030. The third goal — “ensure healthy lives and promote well-being for all at all ages” — sets the dozens of indicators tracked by the annual WHO report, ranging from maternal mortality and HIV incidence to tobacco use and air pollution deaths. These were once seen as among the most achievable of the SDGs, given significant progress made under the agenda’s predecessor, the Millennium Development Goals. That hope has not materialised — and the wider SDG agenda is faring no better, with the latest UN figures finding only about a sixth of all targets on course for the 2030 deadline. “Of the 52 health-related SDG indicators reviewed in this report, more than half have numeric SDG or other global targets,” WHO found. “And none is on track to meet the target at the global level.” Malaria reversing, TB barely moving Tuberculosis incidence rates, globally and by WHO region, 2015, 2024 and the 2030 target. The reversal of progress in eradicating malaria is perhaps the starkest failure on the SDG health agenda. While the world set a target to reduce cases by 90% by 2030, global incidence has instead risen by 8.5%. The African Region carries nearly the entire global burden, recording an estimated 282 million cases in 2024. Only the South-East Asia Region is on track to meet the 2025 milestone of a 75% reduction. Tuberculosis is another major failure: of the 80% reduction target set in the WHO End TB Strategy, just 12% has been achieved since 2015. The European Region cut its TB rate by 39% over the period, while the Region of the Americas went backwards, recording a 13% increase. The African Region, despite still bearing the highest burden, achieved a 28% reduction, more than double the global average. The HIV picture is brighter, with new infections falling 40% since 2010 to 1.3 million worldwide in 2024. The African Region has cut new infections by 70% — a major achievement — but still accounts for 65% of the 40.8 million people living with HIV worldwide. Yet HIV incidence cuts remain well short of the 90% SDG target. Hope circulated before 2015 that ending the AIDS epidemic by 2030 was within reach, has faded away. Maternal and child deaths: progress stalling Maternal mortality ratio, by WHO region, 2000–2023. The global maternal mortality ratio has fallen 40% since 2000, but at 197 deaths per 100,000 live births in 2023 it remains nearly three times the 2030 target of fewer than 70 deaths per 100,000 live births. The annual rate of reduction has slowed to 1.6% since 2015. The world needs that figure to climb to nearly 15% to hit the SDG, a pace more than nine times faster than the world has managed over the past quarter century. Doing so would mean preventing nearly 700,000 maternal deaths by 2030. Each day, 712 women still die from maternal causes — one every two minutes. A staggering 80% of those deaths occur in sub-Saharan Africa, where girls face a one-in-40 chance of dying of pregnancy-related complications by age 15. Central and Southern Asia come a distant second, accounting for 17% of the global death toll. Globally, nearly 95% of all maternal deaths occur in low- and lower middle-income countries. Meanwhile, 73 countries, mostly in Europe, Latin America and the Caribbean, recorded fewer than 20 maternal deaths in 2020. Vaccination coverage flatlines Global immunization rates against diphtheria, tetanus and pertussis, measles, pneumococcal infections, and human papillomavirus, 2000–2024. Routine childhood immunisation has largely flatlined, with global coverage stuck below the levels needed to prevent the outbreaks of vaccine-preventable diseases now resurging in several regions. Coverage with the third dose of the diphtheria-tetanus-pertussis vaccine has plateaued at around 85%, while second-dose measles vaccination sits at 76% — far below the roughly 95% the WHO says is needed to prevent outbreaks. The Region of the Americas, once a global leader on routine immunisation, now reports lower coverage for three of four core vaccines than in 2015. The WHO has linked persistent immunity gaps to the rising measles transmission reported across several regions over the past year, including major outbreaks in the United States, Europe and parts of the Eastern Mediterranean. Coverage of the human papillomavirus vaccine, which protects against cervical cancer, has grown faster than any other core vaccine since 2021 — but from a very low base, reaching just 28% of the target group of 9-14-year-old girls globally in 2024. A pandemic toll three times larger than officially recorded Excess death rates (crude and age-standardized), by World Bank income group, 2020–2023. A key finding buried deep in the report is a new estimate for excess deaths related to the COVID-19 pandemic. The WHO now estimates 22.1 million deaths above expectation occurred between 2020 and 2023, roughly three times the 7 million COVID-19 deaths officially reported worldwide. Excess mortality peaked at 10.4 million in 2021, with men experiencing age-standardised excess death rates around 50% higher than women, and people aged 85 and over recording rates ten times those of younger adults, the report found. The ratio of excess deaths to officially reported COVID-19 deaths rose from roughly 1:1 in 2020 to about 9:1 by 2023, which the WHO attributes increasingly to underreporting as many countries wound down testing and attempted to move past the crisis. The pandemic erased nearly a decade of gains in life expectancy and healthy life expectancy, the WHO chief said, with only female life expectancy returning to pre-pandemic levels globally by 2023. “The COVID-19 pandemic inflicted a setback of historic proportions,” Tedros said. “Recovery since 2022 has been uneven, with persistent disparities according to region, age and sex.” Where there has been progress Age-standardized prevalence of current tobacco use in people 15 years and older, by sex, globally and by WHO region, 2010 and 2024. Some indicators are moving in the right direction. Tobacco use has fallen 27% since 2010 — narrowly missing the 30% reduction target — and alcohol consumption is down 13%. Between 2015 and 2024, 961 million more people gained access to safely managed drinking water, 1.2 billion to safe sanitation, 1.6 billion to basic hygiene services, and 1.4 billion to clean cooking fuels. The number of people requiring interventions for neglected tropical diseases has fallen 36% since 2010. “These trends reflect too many deaths that could have been avoided,” Nakatani said. “With rising environmental risks, health emergencies, and a worsening health financing crisis, we must act urgently — strengthening primary health care, investing in prevention, and securing sustainable financing to build resilient health systems and get back on track.” A ‘global health financing emergency’ Density of health professionals, globally and by WHO region. The WHO warned that the limited gains were now under serious threat from a “global health financing emergency”, as billions of dollars cut by the United States and other wealthy donors, much of it destined to fund progress towards the SDGs, are now gone. “Official development assistance for health was estimated to be 30-40% less in 2025 than in 2023,” Tedros said. “Many countries face long-standing structural constraints including high debt burdens and insufficient domestic public financing. Sudden aid reductions risk significant disruption of essential health services, reduced access to life-saving essential medicines and vaccines.” A WHO rapid assessment of 108 low- and lower-middle-income countries earlier this year found that 63% reported job losses, salary suspensions or reductions among health and care workers as a result of the aid cuts. Nearly 70% anticipated future recruitment problems in the health sector. Alain Labrique, director of WHO’s Department of Data, Digital Health, Analytics and Artificial Intelligence, noted that because the report’s data run only through 2024, the full effect of recent cuts to US foreign aid and other donor retrenchment is not yet visible. “Should these trends continue, and we don’t see reinvigorated investment in global health, this will have an effect on global health indicators,” he said. “It may continue to cause a reversal in the patterns that we worked so hard to gain.” Missing data paints a darker picture Timeliness of WHO Member States in reporting cause-of-death data, 2025. Compounding the picture is the fact that the WHO’s own data is incomplete — and likely understates the scale of the problem. Of an estimated 61 million deaths globally in 2023, only around 21 million were reported to the agency with cause-of-death information. Just 12 million had meaningful coding under the International Classification of Diseases, the global standard used to record what people die from and the foundation of comparable mortality statistics worldwide. Only 18% of countries reported mortality data within a year. Nearly a third have never submitted cause-of-death data at all. The shortfalls are concentrated in low- and lower-middle-income countries, where civil registration systems are weakest and where the disease burden is heaviest. Funding cuts have also disrupted disease surveillance, Nakatani said. “Erosion of data, planning, and surveillance systems undermines reliable measurement, which is essential for progress,” Tedros said. “Too few deaths are recorded with timely, accurate, and meaningful cause-of-death information, limiting the accuracy and relevance of mortality statistics for policy and planning.” “Data gaps severely limit the ability to monitor real-time health trends, compare outcomes across countries, and design effective public health responses,” Labrique said. Image Credits: John Cameron, Priscila Oliveira. WHO Declares DRC Ebola Outbreak a Public Health Emergency: ‘May Be ‘Much Larger’ Than Reported 17/05/2026 Kerry Cullinan The outbreak of Ebola in the Democratic Republic of Congo (DRC) may be “a much larger outbreak than what is currently being detected and reported, with significant local and regional risk of spread”, the World Health Organization (WHO) warned on Sunday. The WHO declared the outbreak a public health emergency of international concern (PHEIC) on Sunday, confirming that it involves the Ebola species, Bundibugyo virus disease (BVD). There is no vaccine or treatment for BVD, and a high case fatality rate of 30-50%. By Saturday, there were 336 suspected cases and 87 deaths, 13 of which had been confirmed as BVD, according to the Africa Centres for Disease Control and Prevention. Very high risk of spread in DRC Africa CDC warned that the risk of spread within the DRC was “very high” as a “four-week detection delay” had enabled “extensive uncontrolled community transmission”. It also said the risk for East Africa is “high”. The outbreak is likely to have originated in the Mongbwalu health zone of DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Two laboratory-confirmed cases (including one death) with no apparent link to each other were reported in Kampala in Uganda, late last week, involving two people travelling from the DRC. Meanwhile, insecurity and conflict in the DRC are “restricting surveillance and rapid response operations”, Africa CDC noted. While there are no approved vaccines or therapeutics, Africa CDC said its research team is studying the candidate vaccine, Ervebo, and potential treatments including “DP134, Remdesivir, Opaldesivir (oral form), and monoclonal antibodies”. It also warned that while national and regional stocks of personal protective equipment (PPE) are “sufficient to cover existing demand patterns”, if transmission increases, countries will need to import new PPE and the lead time for this is six to eight weeks. Why ‘public health emergency’? “Response measures include deployment of rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, the set-up of safe treatment centres, and community engagement,” the WHO said in a statement issued on Sunday. WHO Director-General Dr Tedros Adhanom Ghebreyesus said that the outbreak meets the criteria of the definition of PHEIC in terms of the International Health Regulations as it is “extraordinary”, constitutes a public health risk to other countries and “requires international coordination and cooperation to understand the extent of the outbreak, to coordinate surveillance, prevention and response efforts, to scale up and strengthen operations and ensure ability to implement control measures.” The “extraordinary” nature of the outbreak includes “unusual clusters of community deaths with symptoms compatible BVD”, and the high positivity rate of the initial samples collected (eight positive out of 13 samples). The WHO is in the process of convening an emergency committee under the provisions of the IHR, “as soon as possible” to advise affected countries on how to respond to the outbreak. WHO Member States Should Treat Fossil Fuels like Tobacco – as a Public Health Threat 15/05/2026 Jeni Miller Protests against fossil fuel lobbyists at COP30 in Bélem, Brazil, likening them to having the tobacco industry at a health conference. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. In the coming days, the annual World Health Assembly will convene in Geneva. Following the recent Santa Marta Conference on Transitioning Away from Fossil Fuels, national health ministers and global health leaders have both an opportunity and responsibility to address the root cause of the climate-induced health crisis: fossil fuels. The Santa Marta conference addressed the need to transition away from fossil fuels, the root cause of climate change. Fifty-seven countries, representing one-third of the global economy, committed to developing roadmaps to end fossil fuel use, marking an important step toward protecting public health and the climate. Santa Marta demonstrated growing momentum beyond traditional climate negotiations. While the UN climate COP process remains essential, countries increasingly recognize that progress has been too slow given the escalating impacts of climate change and health. The next Santa Marta conference, hosted by Tuvalu and Ireland in 2027, will provide a key opportunity to strengthen international cooperation on phasing out fossil fuels. Fossil fuel combustion constitutes the biggest public health emergency of our time Heavy-Duty trucks and buses spew out soot, including climate-changing black carbon and health harmful PM2.5 on a highway. Climate change is not only an environmental issue; it is a public health emergency. Fossil fuels are not just an energy source; they are harmful to health. Despite this, health was largely overlooked – the final Santa Marta conference text had no mention of health. The health community must raise a clamour to ensure that future climate negotiations take our health into consideration. Fossil fuels harm human health throughout their lifecycle, from extraction and refining to transport, combustion, and petrochemical production. They pollute air, water, and soil; drive extreme heat and food insecurity; worsen respiratory and cardiovascular diseases; and contribute to millions of premature deaths each year. Frontline communities near extraction sites, refineries, highways, ports, and petrochemical facilities face disproportionate risks of toxic exposure, cancer, displacement, and economic disruption. The world is already experiencing the consequences of the fossil-fuel-driven climate crisis. Last month, temperatures in parts of South and Southeast Asia reached 45 to 46°C, making outdoor work unsafe and pushing the limits of human survivability. Floods, wildfires, storms, crop failures, and infectious disease outbreaks are increasingly overwhelming health systems worldwide. Subsidizing the sale of products that harm human health Ending fossil fuel subsidies would be one of the most effective global public health interventions ever, also averting 1.2 deaths a year from air pollution. Yet governments continue to subsidize the very products causing this harm. In 2024 alone, fossil fuels received an estimated US$725 billion in public subsidies, even as air pollution, much of it from fossil fuels, costs the global economy about US$8.1 trillion annually in healthcare expenses, lost productivity, and premature deaths. From a public health perspective, this contradiction is stark: governments are using public funds to subsidize disease, death, climate disruption, and increased pressure on already overburdened health systems. The true cost of fossil fuels remains obscured because health harms are treated as “externalities.” But asthma, strokes, heat deaths, cancers, pregnancy complications, and polluted drinking water are not externalities; they are direct and devastating impacts. When these costs are fully accounted for, fossil fuels are no longer economically rational. They are a dangerous and outdated relic. Following the example of Tobacco Six out of ten smokers, or 750 million people globally want to quit tobacco use. For decades already, the health community has carried the weight of responding to the symptoms of the climate-induced health crisis while often avoiding its primary cause. This must change. And yet, the health community has both the moral authority and institutional capacity to speak to the impacts of fossil fuels directly. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. There is already a clear precedent: the World Health Organization Framework Convention on Tobacco Control (FCTC), the first global treaty negotiated under WHO leadership. The FCTC recognized that protecting health requires more than treating disease; it requires regulating the industry responsible for the harm. We can apply this same approach to fossil fuels. Tobacco control showed that effective public health action requires conflict-of-interest protections, restrictions on advertising and sponsorship, public education, fiscal measures, warning labels, litigation support, and international cooperation to reduce demand for harmful products. Fossil fuels require a similarly comprehensive response. Health ministries and the WHO have a critical role in advancing this agenda. The 78th session of the World Health Assembly in May 2025 – member states passed a Global Action Plan for climate and health. Ending fossil fuel subsidies would put teeth into that decision. The World Health Assembly is the world’s highest decision-making forum on health. Resolutions passed in Geneva shape national health priorities, influence financing, guide public health norms, and determine how governments respond to emerging threats. WHA can guide the WHO Secretariat in advocating for stronger conflict-of-interest protections to limit the influence of the fossil fuel industry in health policymaking and other multilateral processes. They can document the full lifecycle health harms of fossil fuels, plan protective health measures, promote health impact assessments for fossil fuel projects and infrastructure, and support air pollution standards based on current science. They can also champion subsidy reform as a public health intervention and help redirect public finance toward clean energy, resilient health systems, and social protection. The health community can also help revoke the social license of the fossil fuel industry by clearly communicating that these products are fundamentally incompatible with health protection. This is especially urgent as fossil fuel companies continue to use disinformation, greenwashing, and political influence to delay action, tactics long recognized by the public health community from efforts against other health-harming industries. At WHA78 last year, countries made progress through the WHO Global Action Plan on Climate Change and Health and commitments to reduce air pollution deaths. However, these efforts will remain incomplete unless governments address the primary driver of both climate change and air pollution: fossil fuels. WHA member states must recognise that fossil fuels are health-harming products, and their phase-out is a public health imperative. The science is clear, the health evidence is overwhelming, and solutions exist. The question now is whether the global health community is prepared to address the cause of the crisis, not just its consequences. On May 19th, the Global Climate and Health Alliance and the Office of the United Nations High Commissioner for Human Rights (OHCHR) will co-host Fossil Fuels, Health, and Human Rights – Centering Health and Human Rights in the Global Transition Away from Fossil Fuels where the issue will be discussed. It would be open to attend in person in Geneva and via Zoom. Dr Jeni Miller is Executive Director of the Global Climate and Health Alliance, a consortium of more than 250 health professional and health civil society organisations and networks from around the world addressing climate change. Image Credits: Mike Muzurakis IISD/ENB , UNEP, Galen Crout , Sarah Johnson. Posts navigation Older postsNewer posts
Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ 18/05/2026 Kerry Cullinan WHA president Dr Víctor Atallah (Dominican Republic), Spanish Prime Minister Pedros Sánchez, and WHO Director General Dr Tedros Adhanom Ghebreyesus. “From conflicts to economic crises to climate change and aid cuts, we live in difficult, dangerous and divisive times,” World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyesus told the opening plenary of the World Health Assembly (WHA) on Monday. While geopolitical disagreements have delayed Tedros’s official WHA address until Tuesday morning, the Director General acknowledged in a brief welcome that the WHO “has been through a difficult period as a result of sudden and steep cuts to our funding”. The organisation’s budget is 90% funded, although some of the funds are pledged rather than in the bank. Spain’s Prime Minister Pedro Sánchez, a WHA special guest speaker, appealed for solidarity and multilateral support for global health to combat “the pandemic of egotism and selfishness”. Sánchez said that Spain had increased its official development aid (ODA) by 30%, explaining: “No country can save itself. Protecting others is the best way to protect ourselves.” Without naming the United States, he added: “The greatest risk for global health is no longer the lack of science, but rather the lack of conscience. In just a few months, the same country that cut $18 billion from global public health and ODA has spent more than $29 billion on war, the humanitarian and geopolitical consequences of which will also be devastating.” Sánchez, who received a standing ovation, also appealed for countries in the Global South to “have the role that they deserve in decision-making”, and that the reform of global health needed to be focused on strengthening national health centres. Reforming global health The WHA is considering how to reform the “global health architecture”. Ghanaian President John Dramani Mahama, also a special guest speaker at the plenary, appealed for a more inclusive system of multilateralism. “I’m concerned about whispers I have heard that the draft resolution [on global health reform] seeks to protect existing organisational mandates and prohibit the recommendation of mergers or consolidations,” said Mahama, who is championing Africa’s health sovereignty through the Accra Reset Initiative. “If we launch a process of reform that is prohibited from recommending actual reform, we are merely performing a ritual. We cannot prioritise institutional comfort over human survival. The WHO’s legitimacy is not served by protecting silos. It is served by a fearless analysis of what works,” Mahama warned. Barbados’ Prime Minister Mia Mottley also appealed for a more responsive global health system: “Small states are not asking for pity. We’re asking for a system that recognises reality. Vulnerability is not measured by income alone. Fiscal space must be judged alongside climate risk, debt burden, disease burden, and yes, the cost of survival.” Motley also stressed that emergency funds must move with the speed of an emergency. “The WHO must not be asked to protect eight billion people on Planet Earth on the basis of uncertain contributions and political mood swings,” she said – a reference to the withdrawal from the WHO by the US. Syrian President Ahmed Hussein al-Sharaa addressing the WHA via a video link. Syrian President Ahmed Hussein al-Sharaa, who until December of last year was on both the UN and the US list of global terrorists facing sanctions, also addressed the plenary via video. Shortly after the opening, the business of the WHA was delayed by several hours by geopolitical disagreements, with some issues going to a vote. Member states decided against including Taiwan as an observer, but voted overwhelmingly in favour of a request by the Gulf Cooperation Council to discuss the impact of Iran’s recent attacks later in the week. Israel’s objection to the tabling of two separate reports on health conditions in the occupied Palestinian territory (OPT) – including one on the immense toll of the recent Gaza war and increasing Israeli military and settler violence affecting West Bank Palestinian communities – also delayed proceedings. The WHA has a massive agenda, including approving a new tuberculosis strategy and a plan on combating strokes; a global action plan on antimicrobial resistance (AMR) – still outstanding since the AMR UN high-level meeting two years ago; and how to improve emergency care. Zero for 52: WHO Warns World Set to Miss Every Global Health Target by 2030 18/05/2026 Stefan Anderson Annual report finds progress slowing, stalling or reversing across every global health set out in the SDG agenda. The world is on course to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the World Health Organization has warned, as ministers from its 194 member states gather in Geneva for an assembly tasked with reversing that trajectory. With malaria cases rising, maternal deaths still occurring at nearly three times the targeted rate and childhood vaccination coverage plateauing or falling in some regions, progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 edition of the WHO’s World Health Statistics report. “Progress is too slow, too uneven, and increasingly fragile,” Yukiko Nakatani, WHO assistant director-general for health systems, access and data, told a press briefing on Wednesday. “The report is an urgent reminder for member states and all health partners together: we must refocus efforts, safeguard hard-won gains and renew progress.” WHO Director-General Dr Tedros Adhanom Ghebreyesus said progress toward the health goals was “insufficient, uneven across regions and populations, and increasingly vulnerable to systemic shocks”, with a disproportionate burden falling on low- and middle-income countries, especially those in fragile and conflict-affected settings. “Progress has stalled on universal health coverage, maternal and child health and reduction in premature mortality due to noncommunicable diseases — which remain the leading causes of mortality globally,” Tedros said. “These data tell a story of both progress and persistent inequality,” the WHO chief added, “with many people – especially women, children and those in underserved communities – still denied the basic conditions for a healthy life.” Once achievable health targets out of reach The UN estimates that around 17% of SDG targets are on track globally. The SDG health targets are part of a wider agenda adopted by all UN member states in 2015, setting goals on poverty, hunger, education, gender equality, climate and health by 2030. The third goal — “ensure healthy lives and promote well-being for all at all ages” — sets the dozens of indicators tracked by the annual WHO report, ranging from maternal mortality and HIV incidence to tobacco use and air pollution deaths. These were once seen as among the most achievable of the SDGs, given significant progress made under the agenda’s predecessor, the Millennium Development Goals. That hope has not materialised — and the wider SDG agenda is faring no better, with the latest UN figures finding only about a sixth of all targets on course for the 2030 deadline. “Of the 52 health-related SDG indicators reviewed in this report, more than half have numeric SDG or other global targets,” WHO found. “And none is on track to meet the target at the global level.” Malaria reversing, TB barely moving Tuberculosis incidence rates, globally and by WHO region, 2015, 2024 and the 2030 target. The reversal of progress in eradicating malaria is perhaps the starkest failure on the SDG health agenda. While the world set a target to reduce cases by 90% by 2030, global incidence has instead risen by 8.5%. The African Region carries nearly the entire global burden, recording an estimated 282 million cases in 2024. Only the South-East Asia Region is on track to meet the 2025 milestone of a 75% reduction. Tuberculosis is another major failure: of the 80% reduction target set in the WHO End TB Strategy, just 12% has been achieved since 2015. The European Region cut its TB rate by 39% over the period, while the Region of the Americas went backwards, recording a 13% increase. The African Region, despite still bearing the highest burden, achieved a 28% reduction, more than double the global average. The HIV picture is brighter, with new infections falling 40% since 2010 to 1.3 million worldwide in 2024. The African Region has cut new infections by 70% — a major achievement — but still accounts for 65% of the 40.8 million people living with HIV worldwide. Yet HIV incidence cuts remain well short of the 90% SDG target. Hope circulated before 2015 that ending the AIDS epidemic by 2030 was within reach, has faded away. Maternal and child deaths: progress stalling Maternal mortality ratio, by WHO region, 2000–2023. The global maternal mortality ratio has fallen 40% since 2000, but at 197 deaths per 100,000 live births in 2023 it remains nearly three times the 2030 target of fewer than 70 deaths per 100,000 live births. The annual rate of reduction has slowed to 1.6% since 2015. The world needs that figure to climb to nearly 15% to hit the SDG, a pace more than nine times faster than the world has managed over the past quarter century. Doing so would mean preventing nearly 700,000 maternal deaths by 2030. Each day, 712 women still die from maternal causes — one every two minutes. A staggering 80% of those deaths occur in sub-Saharan Africa, where girls face a one-in-40 chance of dying of pregnancy-related complications by age 15. Central and Southern Asia come a distant second, accounting for 17% of the global death toll. Globally, nearly 95% of all maternal deaths occur in low- and lower middle-income countries. Meanwhile, 73 countries, mostly in Europe, Latin America and the Caribbean, recorded fewer than 20 maternal deaths in 2020. Vaccination coverage flatlines Global immunization rates against diphtheria, tetanus and pertussis, measles, pneumococcal infections, and human papillomavirus, 2000–2024. Routine childhood immunisation has largely flatlined, with global coverage stuck below the levels needed to prevent the outbreaks of vaccine-preventable diseases now resurging in several regions. Coverage with the third dose of the diphtheria-tetanus-pertussis vaccine has plateaued at around 85%, while second-dose measles vaccination sits at 76% — far below the roughly 95% the WHO says is needed to prevent outbreaks. The Region of the Americas, once a global leader on routine immunisation, now reports lower coverage for three of four core vaccines than in 2015. The WHO has linked persistent immunity gaps to the rising measles transmission reported across several regions over the past year, including major outbreaks in the United States, Europe and parts of the Eastern Mediterranean. Coverage of the human papillomavirus vaccine, which protects against cervical cancer, has grown faster than any other core vaccine since 2021 — but from a very low base, reaching just 28% of the target group of 9-14-year-old girls globally in 2024. A pandemic toll three times larger than officially recorded Excess death rates (crude and age-standardized), by World Bank income group, 2020–2023. A key finding buried deep in the report is a new estimate for excess deaths related to the COVID-19 pandemic. The WHO now estimates 22.1 million deaths above expectation occurred between 2020 and 2023, roughly three times the 7 million COVID-19 deaths officially reported worldwide. Excess mortality peaked at 10.4 million in 2021, with men experiencing age-standardised excess death rates around 50% higher than women, and people aged 85 and over recording rates ten times those of younger adults, the report found. The ratio of excess deaths to officially reported COVID-19 deaths rose from roughly 1:1 in 2020 to about 9:1 by 2023, which the WHO attributes increasingly to underreporting as many countries wound down testing and attempted to move past the crisis. The pandemic erased nearly a decade of gains in life expectancy and healthy life expectancy, the WHO chief said, with only female life expectancy returning to pre-pandemic levels globally by 2023. “The COVID-19 pandemic inflicted a setback of historic proportions,” Tedros said. “Recovery since 2022 has been uneven, with persistent disparities according to region, age and sex.” Where there has been progress Age-standardized prevalence of current tobacco use in people 15 years and older, by sex, globally and by WHO region, 2010 and 2024. Some indicators are moving in the right direction. Tobacco use has fallen 27% since 2010 — narrowly missing the 30% reduction target — and alcohol consumption is down 13%. Between 2015 and 2024, 961 million more people gained access to safely managed drinking water, 1.2 billion to safe sanitation, 1.6 billion to basic hygiene services, and 1.4 billion to clean cooking fuels. The number of people requiring interventions for neglected tropical diseases has fallen 36% since 2010. “These trends reflect too many deaths that could have been avoided,” Nakatani said. “With rising environmental risks, health emergencies, and a worsening health financing crisis, we must act urgently — strengthening primary health care, investing in prevention, and securing sustainable financing to build resilient health systems and get back on track.” A ‘global health financing emergency’ Density of health professionals, globally and by WHO region. The WHO warned that the limited gains were now under serious threat from a “global health financing emergency”, as billions of dollars cut by the United States and other wealthy donors, much of it destined to fund progress towards the SDGs, are now gone. “Official development assistance for health was estimated to be 30-40% less in 2025 than in 2023,” Tedros said. “Many countries face long-standing structural constraints including high debt burdens and insufficient domestic public financing. Sudden aid reductions risk significant disruption of essential health services, reduced access to life-saving essential medicines and vaccines.” A WHO rapid assessment of 108 low- and lower-middle-income countries earlier this year found that 63% reported job losses, salary suspensions or reductions among health and care workers as a result of the aid cuts. Nearly 70% anticipated future recruitment problems in the health sector. Alain Labrique, director of WHO’s Department of Data, Digital Health, Analytics and Artificial Intelligence, noted that because the report’s data run only through 2024, the full effect of recent cuts to US foreign aid and other donor retrenchment is not yet visible. “Should these trends continue, and we don’t see reinvigorated investment in global health, this will have an effect on global health indicators,” he said. “It may continue to cause a reversal in the patterns that we worked so hard to gain.” Missing data paints a darker picture Timeliness of WHO Member States in reporting cause-of-death data, 2025. Compounding the picture is the fact that the WHO’s own data is incomplete — and likely understates the scale of the problem. Of an estimated 61 million deaths globally in 2023, only around 21 million were reported to the agency with cause-of-death information. Just 12 million had meaningful coding under the International Classification of Diseases, the global standard used to record what people die from and the foundation of comparable mortality statistics worldwide. Only 18% of countries reported mortality data within a year. Nearly a third have never submitted cause-of-death data at all. The shortfalls are concentrated in low- and lower-middle-income countries, where civil registration systems are weakest and where the disease burden is heaviest. Funding cuts have also disrupted disease surveillance, Nakatani said. “Erosion of data, planning, and surveillance systems undermines reliable measurement, which is essential for progress,” Tedros said. “Too few deaths are recorded with timely, accurate, and meaningful cause-of-death information, limiting the accuracy and relevance of mortality statistics for policy and planning.” “Data gaps severely limit the ability to monitor real-time health trends, compare outcomes across countries, and design effective public health responses,” Labrique said. Image Credits: John Cameron, Priscila Oliveira. WHO Declares DRC Ebola Outbreak a Public Health Emergency: ‘May Be ‘Much Larger’ Than Reported 17/05/2026 Kerry Cullinan The outbreak of Ebola in the Democratic Republic of Congo (DRC) may be “a much larger outbreak than what is currently being detected and reported, with significant local and regional risk of spread”, the World Health Organization (WHO) warned on Sunday. The WHO declared the outbreak a public health emergency of international concern (PHEIC) on Sunday, confirming that it involves the Ebola species, Bundibugyo virus disease (BVD). There is no vaccine or treatment for BVD, and a high case fatality rate of 30-50%. By Saturday, there were 336 suspected cases and 87 deaths, 13 of which had been confirmed as BVD, according to the Africa Centres for Disease Control and Prevention. Very high risk of spread in DRC Africa CDC warned that the risk of spread within the DRC was “very high” as a “four-week detection delay” had enabled “extensive uncontrolled community transmission”. It also said the risk for East Africa is “high”. The outbreak is likely to have originated in the Mongbwalu health zone of DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Two laboratory-confirmed cases (including one death) with no apparent link to each other were reported in Kampala in Uganda, late last week, involving two people travelling from the DRC. Meanwhile, insecurity and conflict in the DRC are “restricting surveillance and rapid response operations”, Africa CDC noted. While there are no approved vaccines or therapeutics, Africa CDC said its research team is studying the candidate vaccine, Ervebo, and potential treatments including “DP134, Remdesivir, Opaldesivir (oral form), and monoclonal antibodies”. It also warned that while national and regional stocks of personal protective equipment (PPE) are “sufficient to cover existing demand patterns”, if transmission increases, countries will need to import new PPE and the lead time for this is six to eight weeks. Why ‘public health emergency’? “Response measures include deployment of rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, the set-up of safe treatment centres, and community engagement,” the WHO said in a statement issued on Sunday. WHO Director-General Dr Tedros Adhanom Ghebreyesus said that the outbreak meets the criteria of the definition of PHEIC in terms of the International Health Regulations as it is “extraordinary”, constitutes a public health risk to other countries and “requires international coordination and cooperation to understand the extent of the outbreak, to coordinate surveillance, prevention and response efforts, to scale up and strengthen operations and ensure ability to implement control measures.” The “extraordinary” nature of the outbreak includes “unusual clusters of community deaths with symptoms compatible BVD”, and the high positivity rate of the initial samples collected (eight positive out of 13 samples). The WHO is in the process of convening an emergency committee under the provisions of the IHR, “as soon as possible” to advise affected countries on how to respond to the outbreak. WHO Member States Should Treat Fossil Fuels like Tobacco – as a Public Health Threat 15/05/2026 Jeni Miller Protests against fossil fuel lobbyists at COP30 in Bélem, Brazil, likening them to having the tobacco industry at a health conference. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. In the coming days, the annual World Health Assembly will convene in Geneva. Following the recent Santa Marta Conference on Transitioning Away from Fossil Fuels, national health ministers and global health leaders have both an opportunity and responsibility to address the root cause of the climate-induced health crisis: fossil fuels. The Santa Marta conference addressed the need to transition away from fossil fuels, the root cause of climate change. Fifty-seven countries, representing one-third of the global economy, committed to developing roadmaps to end fossil fuel use, marking an important step toward protecting public health and the climate. Santa Marta demonstrated growing momentum beyond traditional climate negotiations. While the UN climate COP process remains essential, countries increasingly recognize that progress has been too slow given the escalating impacts of climate change and health. The next Santa Marta conference, hosted by Tuvalu and Ireland in 2027, will provide a key opportunity to strengthen international cooperation on phasing out fossil fuels. Fossil fuel combustion constitutes the biggest public health emergency of our time Heavy-Duty trucks and buses spew out soot, including climate-changing black carbon and health harmful PM2.5 on a highway. Climate change is not only an environmental issue; it is a public health emergency. Fossil fuels are not just an energy source; they are harmful to health. Despite this, health was largely overlooked – the final Santa Marta conference text had no mention of health. The health community must raise a clamour to ensure that future climate negotiations take our health into consideration. Fossil fuels harm human health throughout their lifecycle, from extraction and refining to transport, combustion, and petrochemical production. They pollute air, water, and soil; drive extreme heat and food insecurity; worsen respiratory and cardiovascular diseases; and contribute to millions of premature deaths each year. Frontline communities near extraction sites, refineries, highways, ports, and petrochemical facilities face disproportionate risks of toxic exposure, cancer, displacement, and economic disruption. The world is already experiencing the consequences of the fossil-fuel-driven climate crisis. Last month, temperatures in parts of South and Southeast Asia reached 45 to 46°C, making outdoor work unsafe and pushing the limits of human survivability. Floods, wildfires, storms, crop failures, and infectious disease outbreaks are increasingly overwhelming health systems worldwide. Subsidizing the sale of products that harm human health Ending fossil fuel subsidies would be one of the most effective global public health interventions ever, also averting 1.2 deaths a year from air pollution. Yet governments continue to subsidize the very products causing this harm. In 2024 alone, fossil fuels received an estimated US$725 billion in public subsidies, even as air pollution, much of it from fossil fuels, costs the global economy about US$8.1 trillion annually in healthcare expenses, lost productivity, and premature deaths. From a public health perspective, this contradiction is stark: governments are using public funds to subsidize disease, death, climate disruption, and increased pressure on already overburdened health systems. The true cost of fossil fuels remains obscured because health harms are treated as “externalities.” But asthma, strokes, heat deaths, cancers, pregnancy complications, and polluted drinking water are not externalities; they are direct and devastating impacts. When these costs are fully accounted for, fossil fuels are no longer economically rational. They are a dangerous and outdated relic. Following the example of Tobacco Six out of ten smokers, or 750 million people globally want to quit tobacco use. For decades already, the health community has carried the weight of responding to the symptoms of the climate-induced health crisis while often avoiding its primary cause. This must change. And yet, the health community has both the moral authority and institutional capacity to speak to the impacts of fossil fuels directly. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. There is already a clear precedent: the World Health Organization Framework Convention on Tobacco Control (FCTC), the first global treaty negotiated under WHO leadership. The FCTC recognized that protecting health requires more than treating disease; it requires regulating the industry responsible for the harm. We can apply this same approach to fossil fuels. Tobacco control showed that effective public health action requires conflict-of-interest protections, restrictions on advertising and sponsorship, public education, fiscal measures, warning labels, litigation support, and international cooperation to reduce demand for harmful products. Fossil fuels require a similarly comprehensive response. Health ministries and the WHO have a critical role in advancing this agenda. The 78th session of the World Health Assembly in May 2025 – member states passed a Global Action Plan for climate and health. Ending fossil fuel subsidies would put teeth into that decision. The World Health Assembly is the world’s highest decision-making forum on health. Resolutions passed in Geneva shape national health priorities, influence financing, guide public health norms, and determine how governments respond to emerging threats. WHA can guide the WHO Secretariat in advocating for stronger conflict-of-interest protections to limit the influence of the fossil fuel industry in health policymaking and other multilateral processes. They can document the full lifecycle health harms of fossil fuels, plan protective health measures, promote health impact assessments for fossil fuel projects and infrastructure, and support air pollution standards based on current science. They can also champion subsidy reform as a public health intervention and help redirect public finance toward clean energy, resilient health systems, and social protection. The health community can also help revoke the social license of the fossil fuel industry by clearly communicating that these products are fundamentally incompatible with health protection. This is especially urgent as fossil fuel companies continue to use disinformation, greenwashing, and political influence to delay action, tactics long recognized by the public health community from efforts against other health-harming industries. At WHA78 last year, countries made progress through the WHO Global Action Plan on Climate Change and Health and commitments to reduce air pollution deaths. However, these efforts will remain incomplete unless governments address the primary driver of both climate change and air pollution: fossil fuels. WHA member states must recognise that fossil fuels are health-harming products, and their phase-out is a public health imperative. The science is clear, the health evidence is overwhelming, and solutions exist. The question now is whether the global health community is prepared to address the cause of the crisis, not just its consequences. On May 19th, the Global Climate and Health Alliance and the Office of the United Nations High Commissioner for Human Rights (OHCHR) will co-host Fossil Fuels, Health, and Human Rights – Centering Health and Human Rights in the Global Transition Away from Fossil Fuels where the issue will be discussed. It would be open to attend in person in Geneva and via Zoom. Dr Jeni Miller is Executive Director of the Global Climate and Health Alliance, a consortium of more than 250 health professional and health civil society organisations and networks from around the world addressing climate change. Image Credits: Mike Muzurakis IISD/ENB , UNEP, Galen Crout , Sarah Johnson. Posts navigation Older postsNewer posts
Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ 18/05/2026 Kerry Cullinan WHA president Dr Víctor Atallah (Dominican Republic), Spanish Prime Minister Pedros Sánchez, and WHO Director General Dr Tedros Adhanom Ghebreyesus. “From conflicts to economic crises to climate change and aid cuts, we live in difficult, dangerous and divisive times,” World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyesus told the opening plenary of the World Health Assembly (WHA) on Monday. While geopolitical disagreements have delayed Tedros’s official WHA address until Tuesday morning, the Director General acknowledged in a brief welcome that the WHO “has been through a difficult period as a result of sudden and steep cuts to our funding”. The organisation’s budget is 90% funded, although some of the funds are pledged rather than in the bank. Spain’s Prime Minister Pedro Sánchez, a WHA special guest speaker, appealed for solidarity and multilateral support for global health to combat “the pandemic of egotism and selfishness”. Sánchez said that Spain had increased its official development aid (ODA) by 30%, explaining: “No country can save itself. Protecting others is the best way to protect ourselves.” Without naming the United States, he added: “The greatest risk for global health is no longer the lack of science, but rather the lack of conscience. In just a few months, the same country that cut $18 billion from global public health and ODA has spent more than $29 billion on war, the humanitarian and geopolitical consequences of which will also be devastating.” Sánchez, who received a standing ovation, also appealed for countries in the Global South to “have the role that they deserve in decision-making”, and that the reform of global health needed to be focused on strengthening national health centres. Reforming global health The WHA is considering how to reform the “global health architecture”. Ghanaian President John Dramani Mahama, also a special guest speaker at the plenary, appealed for a more inclusive system of multilateralism. “I’m concerned about whispers I have heard that the draft resolution [on global health reform] seeks to protect existing organisational mandates and prohibit the recommendation of mergers or consolidations,” said Mahama, who is championing Africa’s health sovereignty through the Accra Reset Initiative. “If we launch a process of reform that is prohibited from recommending actual reform, we are merely performing a ritual. We cannot prioritise institutional comfort over human survival. The WHO’s legitimacy is not served by protecting silos. It is served by a fearless analysis of what works,” Mahama warned. Barbados’ Prime Minister Mia Mottley also appealed for a more responsive global health system: “Small states are not asking for pity. We’re asking for a system that recognises reality. Vulnerability is not measured by income alone. Fiscal space must be judged alongside climate risk, debt burden, disease burden, and yes, the cost of survival.” Motley also stressed that emergency funds must move with the speed of an emergency. “The WHO must not be asked to protect eight billion people on Planet Earth on the basis of uncertain contributions and political mood swings,” she said – a reference to the withdrawal from the WHO by the US. Syrian President Ahmed Hussein al-Sharaa addressing the WHA via a video link. Syrian President Ahmed Hussein al-Sharaa, who until December of last year was on both the UN and the US list of global terrorists facing sanctions, also addressed the plenary via video. Shortly after the opening, the business of the WHA was delayed by several hours by geopolitical disagreements, with some issues going to a vote. Member states decided against including Taiwan as an observer, but voted overwhelmingly in favour of a request by the Gulf Cooperation Council to discuss the impact of Iran’s recent attacks later in the week. Israel’s objection to the tabling of two separate reports on health conditions in the occupied Palestinian territory (OPT) – including one on the immense toll of the recent Gaza war and increasing Israeli military and settler violence affecting West Bank Palestinian communities – also delayed proceedings. The WHA has a massive agenda, including approving a new tuberculosis strategy and a plan on combating strokes; a global action plan on antimicrobial resistance (AMR) – still outstanding since the AMR UN high-level meeting two years ago; and how to improve emergency care. Zero for 52: WHO Warns World Set to Miss Every Global Health Target by 2030 18/05/2026 Stefan Anderson Annual report finds progress slowing, stalling or reversing across every global health set out in the SDG agenda. The world is on course to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the World Health Organization has warned, as ministers from its 194 member states gather in Geneva for an assembly tasked with reversing that trajectory. With malaria cases rising, maternal deaths still occurring at nearly three times the targeted rate and childhood vaccination coverage plateauing or falling in some regions, progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 edition of the WHO’s World Health Statistics report. “Progress is too slow, too uneven, and increasingly fragile,” Yukiko Nakatani, WHO assistant director-general for health systems, access and data, told a press briefing on Wednesday. “The report is an urgent reminder for member states and all health partners together: we must refocus efforts, safeguard hard-won gains and renew progress.” WHO Director-General Dr Tedros Adhanom Ghebreyesus said progress toward the health goals was “insufficient, uneven across regions and populations, and increasingly vulnerable to systemic shocks”, with a disproportionate burden falling on low- and middle-income countries, especially those in fragile and conflict-affected settings. “Progress has stalled on universal health coverage, maternal and child health and reduction in premature mortality due to noncommunicable diseases — which remain the leading causes of mortality globally,” Tedros said. “These data tell a story of both progress and persistent inequality,” the WHO chief added, “with many people – especially women, children and those in underserved communities – still denied the basic conditions for a healthy life.” Once achievable health targets out of reach The UN estimates that around 17% of SDG targets are on track globally. The SDG health targets are part of a wider agenda adopted by all UN member states in 2015, setting goals on poverty, hunger, education, gender equality, climate and health by 2030. The third goal — “ensure healthy lives and promote well-being for all at all ages” — sets the dozens of indicators tracked by the annual WHO report, ranging from maternal mortality and HIV incidence to tobacco use and air pollution deaths. These were once seen as among the most achievable of the SDGs, given significant progress made under the agenda’s predecessor, the Millennium Development Goals. That hope has not materialised — and the wider SDG agenda is faring no better, with the latest UN figures finding only about a sixth of all targets on course for the 2030 deadline. “Of the 52 health-related SDG indicators reviewed in this report, more than half have numeric SDG or other global targets,” WHO found. “And none is on track to meet the target at the global level.” Malaria reversing, TB barely moving Tuberculosis incidence rates, globally and by WHO region, 2015, 2024 and the 2030 target. The reversal of progress in eradicating malaria is perhaps the starkest failure on the SDG health agenda. While the world set a target to reduce cases by 90% by 2030, global incidence has instead risen by 8.5%. The African Region carries nearly the entire global burden, recording an estimated 282 million cases in 2024. Only the South-East Asia Region is on track to meet the 2025 milestone of a 75% reduction. Tuberculosis is another major failure: of the 80% reduction target set in the WHO End TB Strategy, just 12% has been achieved since 2015. The European Region cut its TB rate by 39% over the period, while the Region of the Americas went backwards, recording a 13% increase. The African Region, despite still bearing the highest burden, achieved a 28% reduction, more than double the global average. The HIV picture is brighter, with new infections falling 40% since 2010 to 1.3 million worldwide in 2024. The African Region has cut new infections by 70% — a major achievement — but still accounts for 65% of the 40.8 million people living with HIV worldwide. Yet HIV incidence cuts remain well short of the 90% SDG target. Hope circulated before 2015 that ending the AIDS epidemic by 2030 was within reach, has faded away. Maternal and child deaths: progress stalling Maternal mortality ratio, by WHO region, 2000–2023. The global maternal mortality ratio has fallen 40% since 2000, but at 197 deaths per 100,000 live births in 2023 it remains nearly three times the 2030 target of fewer than 70 deaths per 100,000 live births. The annual rate of reduction has slowed to 1.6% since 2015. The world needs that figure to climb to nearly 15% to hit the SDG, a pace more than nine times faster than the world has managed over the past quarter century. Doing so would mean preventing nearly 700,000 maternal deaths by 2030. Each day, 712 women still die from maternal causes — one every two minutes. A staggering 80% of those deaths occur in sub-Saharan Africa, where girls face a one-in-40 chance of dying of pregnancy-related complications by age 15. Central and Southern Asia come a distant second, accounting for 17% of the global death toll. Globally, nearly 95% of all maternal deaths occur in low- and lower middle-income countries. Meanwhile, 73 countries, mostly in Europe, Latin America and the Caribbean, recorded fewer than 20 maternal deaths in 2020. Vaccination coverage flatlines Global immunization rates against diphtheria, tetanus and pertussis, measles, pneumococcal infections, and human papillomavirus, 2000–2024. Routine childhood immunisation has largely flatlined, with global coverage stuck below the levels needed to prevent the outbreaks of vaccine-preventable diseases now resurging in several regions. Coverage with the third dose of the diphtheria-tetanus-pertussis vaccine has plateaued at around 85%, while second-dose measles vaccination sits at 76% — far below the roughly 95% the WHO says is needed to prevent outbreaks. The Region of the Americas, once a global leader on routine immunisation, now reports lower coverage for three of four core vaccines than in 2015. The WHO has linked persistent immunity gaps to the rising measles transmission reported across several regions over the past year, including major outbreaks in the United States, Europe and parts of the Eastern Mediterranean. Coverage of the human papillomavirus vaccine, which protects against cervical cancer, has grown faster than any other core vaccine since 2021 — but from a very low base, reaching just 28% of the target group of 9-14-year-old girls globally in 2024. A pandemic toll three times larger than officially recorded Excess death rates (crude and age-standardized), by World Bank income group, 2020–2023. A key finding buried deep in the report is a new estimate for excess deaths related to the COVID-19 pandemic. The WHO now estimates 22.1 million deaths above expectation occurred between 2020 and 2023, roughly three times the 7 million COVID-19 deaths officially reported worldwide. Excess mortality peaked at 10.4 million in 2021, with men experiencing age-standardised excess death rates around 50% higher than women, and people aged 85 and over recording rates ten times those of younger adults, the report found. The ratio of excess deaths to officially reported COVID-19 deaths rose from roughly 1:1 in 2020 to about 9:1 by 2023, which the WHO attributes increasingly to underreporting as many countries wound down testing and attempted to move past the crisis. The pandemic erased nearly a decade of gains in life expectancy and healthy life expectancy, the WHO chief said, with only female life expectancy returning to pre-pandemic levels globally by 2023. “The COVID-19 pandemic inflicted a setback of historic proportions,” Tedros said. “Recovery since 2022 has been uneven, with persistent disparities according to region, age and sex.” Where there has been progress Age-standardized prevalence of current tobacco use in people 15 years and older, by sex, globally and by WHO region, 2010 and 2024. Some indicators are moving in the right direction. Tobacco use has fallen 27% since 2010 — narrowly missing the 30% reduction target — and alcohol consumption is down 13%. Between 2015 and 2024, 961 million more people gained access to safely managed drinking water, 1.2 billion to safe sanitation, 1.6 billion to basic hygiene services, and 1.4 billion to clean cooking fuels. The number of people requiring interventions for neglected tropical diseases has fallen 36% since 2010. “These trends reflect too many deaths that could have been avoided,” Nakatani said. “With rising environmental risks, health emergencies, and a worsening health financing crisis, we must act urgently — strengthening primary health care, investing in prevention, and securing sustainable financing to build resilient health systems and get back on track.” A ‘global health financing emergency’ Density of health professionals, globally and by WHO region. The WHO warned that the limited gains were now under serious threat from a “global health financing emergency”, as billions of dollars cut by the United States and other wealthy donors, much of it destined to fund progress towards the SDGs, are now gone. “Official development assistance for health was estimated to be 30-40% less in 2025 than in 2023,” Tedros said. “Many countries face long-standing structural constraints including high debt burdens and insufficient domestic public financing. Sudden aid reductions risk significant disruption of essential health services, reduced access to life-saving essential medicines and vaccines.” A WHO rapid assessment of 108 low- and lower-middle-income countries earlier this year found that 63% reported job losses, salary suspensions or reductions among health and care workers as a result of the aid cuts. Nearly 70% anticipated future recruitment problems in the health sector. Alain Labrique, director of WHO’s Department of Data, Digital Health, Analytics and Artificial Intelligence, noted that because the report’s data run only through 2024, the full effect of recent cuts to US foreign aid and other donor retrenchment is not yet visible. “Should these trends continue, and we don’t see reinvigorated investment in global health, this will have an effect on global health indicators,” he said. “It may continue to cause a reversal in the patterns that we worked so hard to gain.” Missing data paints a darker picture Timeliness of WHO Member States in reporting cause-of-death data, 2025. Compounding the picture is the fact that the WHO’s own data is incomplete — and likely understates the scale of the problem. Of an estimated 61 million deaths globally in 2023, only around 21 million were reported to the agency with cause-of-death information. Just 12 million had meaningful coding under the International Classification of Diseases, the global standard used to record what people die from and the foundation of comparable mortality statistics worldwide. Only 18% of countries reported mortality data within a year. Nearly a third have never submitted cause-of-death data at all. The shortfalls are concentrated in low- and lower-middle-income countries, where civil registration systems are weakest and where the disease burden is heaviest. Funding cuts have also disrupted disease surveillance, Nakatani said. “Erosion of data, planning, and surveillance systems undermines reliable measurement, which is essential for progress,” Tedros said. “Too few deaths are recorded with timely, accurate, and meaningful cause-of-death information, limiting the accuracy and relevance of mortality statistics for policy and planning.” “Data gaps severely limit the ability to monitor real-time health trends, compare outcomes across countries, and design effective public health responses,” Labrique said. Image Credits: John Cameron, Priscila Oliveira. WHO Declares DRC Ebola Outbreak a Public Health Emergency: ‘May Be ‘Much Larger’ Than Reported 17/05/2026 Kerry Cullinan The outbreak of Ebola in the Democratic Republic of Congo (DRC) may be “a much larger outbreak than what is currently being detected and reported, with significant local and regional risk of spread”, the World Health Organization (WHO) warned on Sunday. The WHO declared the outbreak a public health emergency of international concern (PHEIC) on Sunday, confirming that it involves the Ebola species, Bundibugyo virus disease (BVD). There is no vaccine or treatment for BVD, and a high case fatality rate of 30-50%. By Saturday, there were 336 suspected cases and 87 deaths, 13 of which had been confirmed as BVD, according to the Africa Centres for Disease Control and Prevention. Very high risk of spread in DRC Africa CDC warned that the risk of spread within the DRC was “very high” as a “four-week detection delay” had enabled “extensive uncontrolled community transmission”. It also said the risk for East Africa is “high”. The outbreak is likely to have originated in the Mongbwalu health zone of DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Two laboratory-confirmed cases (including one death) with no apparent link to each other were reported in Kampala in Uganda, late last week, involving two people travelling from the DRC. Meanwhile, insecurity and conflict in the DRC are “restricting surveillance and rapid response operations”, Africa CDC noted. While there are no approved vaccines or therapeutics, Africa CDC said its research team is studying the candidate vaccine, Ervebo, and potential treatments including “DP134, Remdesivir, Opaldesivir (oral form), and monoclonal antibodies”. It also warned that while national and regional stocks of personal protective equipment (PPE) are “sufficient to cover existing demand patterns”, if transmission increases, countries will need to import new PPE and the lead time for this is six to eight weeks. Why ‘public health emergency’? “Response measures include deployment of rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, the set-up of safe treatment centres, and community engagement,” the WHO said in a statement issued on Sunday. WHO Director-General Dr Tedros Adhanom Ghebreyesus said that the outbreak meets the criteria of the definition of PHEIC in terms of the International Health Regulations as it is “extraordinary”, constitutes a public health risk to other countries and “requires international coordination and cooperation to understand the extent of the outbreak, to coordinate surveillance, prevention and response efforts, to scale up and strengthen operations and ensure ability to implement control measures.” The “extraordinary” nature of the outbreak includes “unusual clusters of community deaths with symptoms compatible BVD”, and the high positivity rate of the initial samples collected (eight positive out of 13 samples). The WHO is in the process of convening an emergency committee under the provisions of the IHR, “as soon as possible” to advise affected countries on how to respond to the outbreak. WHO Member States Should Treat Fossil Fuels like Tobacco – as a Public Health Threat 15/05/2026 Jeni Miller Protests against fossil fuel lobbyists at COP30 in Bélem, Brazil, likening them to having the tobacco industry at a health conference. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. In the coming days, the annual World Health Assembly will convene in Geneva. Following the recent Santa Marta Conference on Transitioning Away from Fossil Fuels, national health ministers and global health leaders have both an opportunity and responsibility to address the root cause of the climate-induced health crisis: fossil fuels. The Santa Marta conference addressed the need to transition away from fossil fuels, the root cause of climate change. Fifty-seven countries, representing one-third of the global economy, committed to developing roadmaps to end fossil fuel use, marking an important step toward protecting public health and the climate. Santa Marta demonstrated growing momentum beyond traditional climate negotiations. While the UN climate COP process remains essential, countries increasingly recognize that progress has been too slow given the escalating impacts of climate change and health. The next Santa Marta conference, hosted by Tuvalu and Ireland in 2027, will provide a key opportunity to strengthen international cooperation on phasing out fossil fuels. Fossil fuel combustion constitutes the biggest public health emergency of our time Heavy-Duty trucks and buses spew out soot, including climate-changing black carbon and health harmful PM2.5 on a highway. Climate change is not only an environmental issue; it is a public health emergency. Fossil fuels are not just an energy source; they are harmful to health. Despite this, health was largely overlooked – the final Santa Marta conference text had no mention of health. The health community must raise a clamour to ensure that future climate negotiations take our health into consideration. Fossil fuels harm human health throughout their lifecycle, from extraction and refining to transport, combustion, and petrochemical production. They pollute air, water, and soil; drive extreme heat and food insecurity; worsen respiratory and cardiovascular diseases; and contribute to millions of premature deaths each year. Frontline communities near extraction sites, refineries, highways, ports, and petrochemical facilities face disproportionate risks of toxic exposure, cancer, displacement, and economic disruption. The world is already experiencing the consequences of the fossil-fuel-driven climate crisis. Last month, temperatures in parts of South and Southeast Asia reached 45 to 46°C, making outdoor work unsafe and pushing the limits of human survivability. Floods, wildfires, storms, crop failures, and infectious disease outbreaks are increasingly overwhelming health systems worldwide. Subsidizing the sale of products that harm human health Ending fossil fuel subsidies would be one of the most effective global public health interventions ever, also averting 1.2 deaths a year from air pollution. Yet governments continue to subsidize the very products causing this harm. In 2024 alone, fossil fuels received an estimated US$725 billion in public subsidies, even as air pollution, much of it from fossil fuels, costs the global economy about US$8.1 trillion annually in healthcare expenses, lost productivity, and premature deaths. From a public health perspective, this contradiction is stark: governments are using public funds to subsidize disease, death, climate disruption, and increased pressure on already overburdened health systems. The true cost of fossil fuels remains obscured because health harms are treated as “externalities.” But asthma, strokes, heat deaths, cancers, pregnancy complications, and polluted drinking water are not externalities; they are direct and devastating impacts. When these costs are fully accounted for, fossil fuels are no longer economically rational. They are a dangerous and outdated relic. Following the example of Tobacco Six out of ten smokers, or 750 million people globally want to quit tobacco use. For decades already, the health community has carried the weight of responding to the symptoms of the climate-induced health crisis while often avoiding its primary cause. This must change. And yet, the health community has both the moral authority and institutional capacity to speak to the impacts of fossil fuels directly. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. There is already a clear precedent: the World Health Organization Framework Convention on Tobacco Control (FCTC), the first global treaty negotiated under WHO leadership. The FCTC recognized that protecting health requires more than treating disease; it requires regulating the industry responsible for the harm. We can apply this same approach to fossil fuels. Tobacco control showed that effective public health action requires conflict-of-interest protections, restrictions on advertising and sponsorship, public education, fiscal measures, warning labels, litigation support, and international cooperation to reduce demand for harmful products. Fossil fuels require a similarly comprehensive response. Health ministries and the WHO have a critical role in advancing this agenda. The 78th session of the World Health Assembly in May 2025 – member states passed a Global Action Plan for climate and health. Ending fossil fuel subsidies would put teeth into that decision. The World Health Assembly is the world’s highest decision-making forum on health. Resolutions passed in Geneva shape national health priorities, influence financing, guide public health norms, and determine how governments respond to emerging threats. WHA can guide the WHO Secretariat in advocating for stronger conflict-of-interest protections to limit the influence of the fossil fuel industry in health policymaking and other multilateral processes. They can document the full lifecycle health harms of fossil fuels, plan protective health measures, promote health impact assessments for fossil fuel projects and infrastructure, and support air pollution standards based on current science. They can also champion subsidy reform as a public health intervention and help redirect public finance toward clean energy, resilient health systems, and social protection. The health community can also help revoke the social license of the fossil fuel industry by clearly communicating that these products are fundamentally incompatible with health protection. This is especially urgent as fossil fuel companies continue to use disinformation, greenwashing, and political influence to delay action, tactics long recognized by the public health community from efforts against other health-harming industries. At WHA78 last year, countries made progress through the WHO Global Action Plan on Climate Change and Health and commitments to reduce air pollution deaths. However, these efforts will remain incomplete unless governments address the primary driver of both climate change and air pollution: fossil fuels. WHA member states must recognise that fossil fuels are health-harming products, and their phase-out is a public health imperative. The science is clear, the health evidence is overwhelming, and solutions exist. The question now is whether the global health community is prepared to address the cause of the crisis, not just its consequences. On May 19th, the Global Climate and Health Alliance and the Office of the United Nations High Commissioner for Human Rights (OHCHR) will co-host Fossil Fuels, Health, and Human Rights – Centering Health and Human Rights in the Global Transition Away from Fossil Fuels where the issue will be discussed. It would be open to attend in person in Geneva and via Zoom. Dr Jeni Miller is Executive Director of the Global Climate and Health Alliance, a consortium of more than 250 health professional and health civil society organisations and networks from around the world addressing climate change. Image Credits: Mike Muzurakis IISD/ENB , UNEP, Galen Crout , Sarah Johnson. Posts navigation Older postsNewer posts
Zero for 52: WHO Warns World Set to Miss Every Global Health Target by 2030 18/05/2026 Stefan Anderson Annual report finds progress slowing, stalling or reversing across every global health set out in the SDG agenda. The world is on course to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the World Health Organization has warned, as ministers from its 194 member states gather in Geneva for an assembly tasked with reversing that trajectory. With malaria cases rising, maternal deaths still occurring at nearly three times the targeted rate and childhood vaccination coverage plateauing or falling in some regions, progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 edition of the WHO’s World Health Statistics report. “Progress is too slow, too uneven, and increasingly fragile,” Yukiko Nakatani, WHO assistant director-general for health systems, access and data, told a press briefing on Wednesday. “The report is an urgent reminder for member states and all health partners together: we must refocus efforts, safeguard hard-won gains and renew progress.” WHO Director-General Dr Tedros Adhanom Ghebreyesus said progress toward the health goals was “insufficient, uneven across regions and populations, and increasingly vulnerable to systemic shocks”, with a disproportionate burden falling on low- and middle-income countries, especially those in fragile and conflict-affected settings. “Progress has stalled on universal health coverage, maternal and child health and reduction in premature mortality due to noncommunicable diseases — which remain the leading causes of mortality globally,” Tedros said. “These data tell a story of both progress and persistent inequality,” the WHO chief added, “with many people – especially women, children and those in underserved communities – still denied the basic conditions for a healthy life.” Once achievable health targets out of reach The UN estimates that around 17% of SDG targets are on track globally. The SDG health targets are part of a wider agenda adopted by all UN member states in 2015, setting goals on poverty, hunger, education, gender equality, climate and health by 2030. The third goal — “ensure healthy lives and promote well-being for all at all ages” — sets the dozens of indicators tracked by the annual WHO report, ranging from maternal mortality and HIV incidence to tobacco use and air pollution deaths. These were once seen as among the most achievable of the SDGs, given significant progress made under the agenda’s predecessor, the Millennium Development Goals. That hope has not materialised — and the wider SDG agenda is faring no better, with the latest UN figures finding only about a sixth of all targets on course for the 2030 deadline. “Of the 52 health-related SDG indicators reviewed in this report, more than half have numeric SDG or other global targets,” WHO found. “And none is on track to meet the target at the global level.” Malaria reversing, TB barely moving Tuberculosis incidence rates, globally and by WHO region, 2015, 2024 and the 2030 target. The reversal of progress in eradicating malaria is perhaps the starkest failure on the SDG health agenda. While the world set a target to reduce cases by 90% by 2030, global incidence has instead risen by 8.5%. The African Region carries nearly the entire global burden, recording an estimated 282 million cases in 2024. Only the South-East Asia Region is on track to meet the 2025 milestone of a 75% reduction. Tuberculosis is another major failure: of the 80% reduction target set in the WHO End TB Strategy, just 12% has been achieved since 2015. The European Region cut its TB rate by 39% over the period, while the Region of the Americas went backwards, recording a 13% increase. The African Region, despite still bearing the highest burden, achieved a 28% reduction, more than double the global average. The HIV picture is brighter, with new infections falling 40% since 2010 to 1.3 million worldwide in 2024. The African Region has cut new infections by 70% — a major achievement — but still accounts for 65% of the 40.8 million people living with HIV worldwide. Yet HIV incidence cuts remain well short of the 90% SDG target. Hope circulated before 2015 that ending the AIDS epidemic by 2030 was within reach, has faded away. Maternal and child deaths: progress stalling Maternal mortality ratio, by WHO region, 2000–2023. The global maternal mortality ratio has fallen 40% since 2000, but at 197 deaths per 100,000 live births in 2023 it remains nearly three times the 2030 target of fewer than 70 deaths per 100,000 live births. The annual rate of reduction has slowed to 1.6% since 2015. The world needs that figure to climb to nearly 15% to hit the SDG, a pace more than nine times faster than the world has managed over the past quarter century. Doing so would mean preventing nearly 700,000 maternal deaths by 2030. Each day, 712 women still die from maternal causes — one every two minutes. A staggering 80% of those deaths occur in sub-Saharan Africa, where girls face a one-in-40 chance of dying of pregnancy-related complications by age 15. Central and Southern Asia come a distant second, accounting for 17% of the global death toll. Globally, nearly 95% of all maternal deaths occur in low- and lower middle-income countries. Meanwhile, 73 countries, mostly in Europe, Latin America and the Caribbean, recorded fewer than 20 maternal deaths in 2020. Vaccination coverage flatlines Global immunization rates against diphtheria, tetanus and pertussis, measles, pneumococcal infections, and human papillomavirus, 2000–2024. Routine childhood immunisation has largely flatlined, with global coverage stuck below the levels needed to prevent the outbreaks of vaccine-preventable diseases now resurging in several regions. Coverage with the third dose of the diphtheria-tetanus-pertussis vaccine has plateaued at around 85%, while second-dose measles vaccination sits at 76% — far below the roughly 95% the WHO says is needed to prevent outbreaks. The Region of the Americas, once a global leader on routine immunisation, now reports lower coverage for three of four core vaccines than in 2015. The WHO has linked persistent immunity gaps to the rising measles transmission reported across several regions over the past year, including major outbreaks in the United States, Europe and parts of the Eastern Mediterranean. Coverage of the human papillomavirus vaccine, which protects against cervical cancer, has grown faster than any other core vaccine since 2021 — but from a very low base, reaching just 28% of the target group of 9-14-year-old girls globally in 2024. A pandemic toll three times larger than officially recorded Excess death rates (crude and age-standardized), by World Bank income group, 2020–2023. A key finding buried deep in the report is a new estimate for excess deaths related to the COVID-19 pandemic. The WHO now estimates 22.1 million deaths above expectation occurred between 2020 and 2023, roughly three times the 7 million COVID-19 deaths officially reported worldwide. Excess mortality peaked at 10.4 million in 2021, with men experiencing age-standardised excess death rates around 50% higher than women, and people aged 85 and over recording rates ten times those of younger adults, the report found. The ratio of excess deaths to officially reported COVID-19 deaths rose from roughly 1:1 in 2020 to about 9:1 by 2023, which the WHO attributes increasingly to underreporting as many countries wound down testing and attempted to move past the crisis. The pandemic erased nearly a decade of gains in life expectancy and healthy life expectancy, the WHO chief said, with only female life expectancy returning to pre-pandemic levels globally by 2023. “The COVID-19 pandemic inflicted a setback of historic proportions,” Tedros said. “Recovery since 2022 has been uneven, with persistent disparities according to region, age and sex.” Where there has been progress Age-standardized prevalence of current tobacco use in people 15 years and older, by sex, globally and by WHO region, 2010 and 2024. Some indicators are moving in the right direction. Tobacco use has fallen 27% since 2010 — narrowly missing the 30% reduction target — and alcohol consumption is down 13%. Between 2015 and 2024, 961 million more people gained access to safely managed drinking water, 1.2 billion to safe sanitation, 1.6 billion to basic hygiene services, and 1.4 billion to clean cooking fuels. The number of people requiring interventions for neglected tropical diseases has fallen 36% since 2010. “These trends reflect too many deaths that could have been avoided,” Nakatani said. “With rising environmental risks, health emergencies, and a worsening health financing crisis, we must act urgently — strengthening primary health care, investing in prevention, and securing sustainable financing to build resilient health systems and get back on track.” A ‘global health financing emergency’ Density of health professionals, globally and by WHO region. The WHO warned that the limited gains were now under serious threat from a “global health financing emergency”, as billions of dollars cut by the United States and other wealthy donors, much of it destined to fund progress towards the SDGs, are now gone. “Official development assistance for health was estimated to be 30-40% less in 2025 than in 2023,” Tedros said. “Many countries face long-standing structural constraints including high debt burdens and insufficient domestic public financing. Sudden aid reductions risk significant disruption of essential health services, reduced access to life-saving essential medicines and vaccines.” A WHO rapid assessment of 108 low- and lower-middle-income countries earlier this year found that 63% reported job losses, salary suspensions or reductions among health and care workers as a result of the aid cuts. Nearly 70% anticipated future recruitment problems in the health sector. Alain Labrique, director of WHO’s Department of Data, Digital Health, Analytics and Artificial Intelligence, noted that because the report’s data run only through 2024, the full effect of recent cuts to US foreign aid and other donor retrenchment is not yet visible. “Should these trends continue, and we don’t see reinvigorated investment in global health, this will have an effect on global health indicators,” he said. “It may continue to cause a reversal in the patterns that we worked so hard to gain.” Missing data paints a darker picture Timeliness of WHO Member States in reporting cause-of-death data, 2025. Compounding the picture is the fact that the WHO’s own data is incomplete — and likely understates the scale of the problem. Of an estimated 61 million deaths globally in 2023, only around 21 million were reported to the agency with cause-of-death information. Just 12 million had meaningful coding under the International Classification of Diseases, the global standard used to record what people die from and the foundation of comparable mortality statistics worldwide. Only 18% of countries reported mortality data within a year. Nearly a third have never submitted cause-of-death data at all. The shortfalls are concentrated in low- and lower-middle-income countries, where civil registration systems are weakest and where the disease burden is heaviest. Funding cuts have also disrupted disease surveillance, Nakatani said. “Erosion of data, planning, and surveillance systems undermines reliable measurement, which is essential for progress,” Tedros said. “Too few deaths are recorded with timely, accurate, and meaningful cause-of-death information, limiting the accuracy and relevance of mortality statistics for policy and planning.” “Data gaps severely limit the ability to monitor real-time health trends, compare outcomes across countries, and design effective public health responses,” Labrique said. Image Credits: John Cameron, Priscila Oliveira. WHO Declares DRC Ebola Outbreak a Public Health Emergency: ‘May Be ‘Much Larger’ Than Reported 17/05/2026 Kerry Cullinan The outbreak of Ebola in the Democratic Republic of Congo (DRC) may be “a much larger outbreak than what is currently being detected and reported, with significant local and regional risk of spread”, the World Health Organization (WHO) warned on Sunday. The WHO declared the outbreak a public health emergency of international concern (PHEIC) on Sunday, confirming that it involves the Ebola species, Bundibugyo virus disease (BVD). There is no vaccine or treatment for BVD, and a high case fatality rate of 30-50%. By Saturday, there were 336 suspected cases and 87 deaths, 13 of which had been confirmed as BVD, according to the Africa Centres for Disease Control and Prevention. Very high risk of spread in DRC Africa CDC warned that the risk of spread within the DRC was “very high” as a “four-week detection delay” had enabled “extensive uncontrolled community transmission”. It also said the risk for East Africa is “high”. The outbreak is likely to have originated in the Mongbwalu health zone of DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Two laboratory-confirmed cases (including one death) with no apparent link to each other were reported in Kampala in Uganda, late last week, involving two people travelling from the DRC. Meanwhile, insecurity and conflict in the DRC are “restricting surveillance and rapid response operations”, Africa CDC noted. While there are no approved vaccines or therapeutics, Africa CDC said its research team is studying the candidate vaccine, Ervebo, and potential treatments including “DP134, Remdesivir, Opaldesivir (oral form), and monoclonal antibodies”. It also warned that while national and regional stocks of personal protective equipment (PPE) are “sufficient to cover existing demand patterns”, if transmission increases, countries will need to import new PPE and the lead time for this is six to eight weeks. Why ‘public health emergency’? “Response measures include deployment of rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, the set-up of safe treatment centres, and community engagement,” the WHO said in a statement issued on Sunday. WHO Director-General Dr Tedros Adhanom Ghebreyesus said that the outbreak meets the criteria of the definition of PHEIC in terms of the International Health Regulations as it is “extraordinary”, constitutes a public health risk to other countries and “requires international coordination and cooperation to understand the extent of the outbreak, to coordinate surveillance, prevention and response efforts, to scale up and strengthen operations and ensure ability to implement control measures.” The “extraordinary” nature of the outbreak includes “unusual clusters of community deaths with symptoms compatible BVD”, and the high positivity rate of the initial samples collected (eight positive out of 13 samples). The WHO is in the process of convening an emergency committee under the provisions of the IHR, “as soon as possible” to advise affected countries on how to respond to the outbreak. WHO Member States Should Treat Fossil Fuels like Tobacco – as a Public Health Threat 15/05/2026 Jeni Miller Protests against fossil fuel lobbyists at COP30 in Bélem, Brazil, likening them to having the tobacco industry at a health conference. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. In the coming days, the annual World Health Assembly will convene in Geneva. Following the recent Santa Marta Conference on Transitioning Away from Fossil Fuels, national health ministers and global health leaders have both an opportunity and responsibility to address the root cause of the climate-induced health crisis: fossil fuels. The Santa Marta conference addressed the need to transition away from fossil fuels, the root cause of climate change. Fifty-seven countries, representing one-third of the global economy, committed to developing roadmaps to end fossil fuel use, marking an important step toward protecting public health and the climate. Santa Marta demonstrated growing momentum beyond traditional climate negotiations. While the UN climate COP process remains essential, countries increasingly recognize that progress has been too slow given the escalating impacts of climate change and health. The next Santa Marta conference, hosted by Tuvalu and Ireland in 2027, will provide a key opportunity to strengthen international cooperation on phasing out fossil fuels. Fossil fuel combustion constitutes the biggest public health emergency of our time Heavy-Duty trucks and buses spew out soot, including climate-changing black carbon and health harmful PM2.5 on a highway. Climate change is not only an environmental issue; it is a public health emergency. Fossil fuels are not just an energy source; they are harmful to health. Despite this, health was largely overlooked – the final Santa Marta conference text had no mention of health. The health community must raise a clamour to ensure that future climate negotiations take our health into consideration. Fossil fuels harm human health throughout their lifecycle, from extraction and refining to transport, combustion, and petrochemical production. They pollute air, water, and soil; drive extreme heat and food insecurity; worsen respiratory and cardiovascular diseases; and contribute to millions of premature deaths each year. Frontline communities near extraction sites, refineries, highways, ports, and petrochemical facilities face disproportionate risks of toxic exposure, cancer, displacement, and economic disruption. The world is already experiencing the consequences of the fossil-fuel-driven climate crisis. Last month, temperatures in parts of South and Southeast Asia reached 45 to 46°C, making outdoor work unsafe and pushing the limits of human survivability. Floods, wildfires, storms, crop failures, and infectious disease outbreaks are increasingly overwhelming health systems worldwide. Subsidizing the sale of products that harm human health Ending fossil fuel subsidies would be one of the most effective global public health interventions ever, also averting 1.2 deaths a year from air pollution. Yet governments continue to subsidize the very products causing this harm. In 2024 alone, fossil fuels received an estimated US$725 billion in public subsidies, even as air pollution, much of it from fossil fuels, costs the global economy about US$8.1 trillion annually in healthcare expenses, lost productivity, and premature deaths. From a public health perspective, this contradiction is stark: governments are using public funds to subsidize disease, death, climate disruption, and increased pressure on already overburdened health systems. The true cost of fossil fuels remains obscured because health harms are treated as “externalities.” But asthma, strokes, heat deaths, cancers, pregnancy complications, and polluted drinking water are not externalities; they are direct and devastating impacts. When these costs are fully accounted for, fossil fuels are no longer economically rational. They are a dangerous and outdated relic. Following the example of Tobacco Six out of ten smokers, or 750 million people globally want to quit tobacco use. For decades already, the health community has carried the weight of responding to the symptoms of the climate-induced health crisis while often avoiding its primary cause. This must change. And yet, the health community has both the moral authority and institutional capacity to speak to the impacts of fossil fuels directly. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. There is already a clear precedent: the World Health Organization Framework Convention on Tobacco Control (FCTC), the first global treaty negotiated under WHO leadership. The FCTC recognized that protecting health requires more than treating disease; it requires regulating the industry responsible for the harm. We can apply this same approach to fossil fuels. Tobacco control showed that effective public health action requires conflict-of-interest protections, restrictions on advertising and sponsorship, public education, fiscal measures, warning labels, litigation support, and international cooperation to reduce demand for harmful products. Fossil fuels require a similarly comprehensive response. Health ministries and the WHO have a critical role in advancing this agenda. The 78th session of the World Health Assembly in May 2025 – member states passed a Global Action Plan for climate and health. Ending fossil fuel subsidies would put teeth into that decision. The World Health Assembly is the world’s highest decision-making forum on health. Resolutions passed in Geneva shape national health priorities, influence financing, guide public health norms, and determine how governments respond to emerging threats. WHA can guide the WHO Secretariat in advocating for stronger conflict-of-interest protections to limit the influence of the fossil fuel industry in health policymaking and other multilateral processes. They can document the full lifecycle health harms of fossil fuels, plan protective health measures, promote health impact assessments for fossil fuel projects and infrastructure, and support air pollution standards based on current science. They can also champion subsidy reform as a public health intervention and help redirect public finance toward clean energy, resilient health systems, and social protection. The health community can also help revoke the social license of the fossil fuel industry by clearly communicating that these products are fundamentally incompatible with health protection. This is especially urgent as fossil fuel companies continue to use disinformation, greenwashing, and political influence to delay action, tactics long recognized by the public health community from efforts against other health-harming industries. At WHA78 last year, countries made progress through the WHO Global Action Plan on Climate Change and Health and commitments to reduce air pollution deaths. However, these efforts will remain incomplete unless governments address the primary driver of both climate change and air pollution: fossil fuels. WHA member states must recognise that fossil fuels are health-harming products, and their phase-out is a public health imperative. The science is clear, the health evidence is overwhelming, and solutions exist. The question now is whether the global health community is prepared to address the cause of the crisis, not just its consequences. On May 19th, the Global Climate and Health Alliance and the Office of the United Nations High Commissioner for Human Rights (OHCHR) will co-host Fossil Fuels, Health, and Human Rights – Centering Health and Human Rights in the Global Transition Away from Fossil Fuels where the issue will be discussed. It would be open to attend in person in Geneva and via Zoom. Dr Jeni Miller is Executive Director of the Global Climate and Health Alliance, a consortium of more than 250 health professional and health civil society organisations and networks from around the world addressing climate change. Image Credits: Mike Muzurakis IISD/ENB , UNEP, Galen Crout , Sarah Johnson. Posts navigation Older postsNewer posts
WHO Declares DRC Ebola Outbreak a Public Health Emergency: ‘May Be ‘Much Larger’ Than Reported 17/05/2026 Kerry Cullinan The outbreak of Ebola in the Democratic Republic of Congo (DRC) may be “a much larger outbreak than what is currently being detected and reported, with significant local and regional risk of spread”, the World Health Organization (WHO) warned on Sunday. The WHO declared the outbreak a public health emergency of international concern (PHEIC) on Sunday, confirming that it involves the Ebola species, Bundibugyo virus disease (BVD). There is no vaccine or treatment for BVD, and a high case fatality rate of 30-50%. By Saturday, there were 336 suspected cases and 87 deaths, 13 of which had been confirmed as BVD, according to the Africa Centres for Disease Control and Prevention. Very high risk of spread in DRC Africa CDC warned that the risk of spread within the DRC was “very high” as a “four-week detection delay” had enabled “extensive uncontrolled community transmission”. It also said the risk for East Africa is “high”. The outbreak is likely to have originated in the Mongbwalu health zone of DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Two laboratory-confirmed cases (including one death) with no apparent link to each other were reported in Kampala in Uganda, late last week, involving two people travelling from the DRC. Meanwhile, insecurity and conflict in the DRC are “restricting surveillance and rapid response operations”, Africa CDC noted. While there are no approved vaccines or therapeutics, Africa CDC said its research team is studying the candidate vaccine, Ervebo, and potential treatments including “DP134, Remdesivir, Opaldesivir (oral form), and monoclonal antibodies”. It also warned that while national and regional stocks of personal protective equipment (PPE) are “sufficient to cover existing demand patterns”, if transmission increases, countries will need to import new PPE and the lead time for this is six to eight weeks. Why ‘public health emergency’? “Response measures include deployment of rapid response teams, delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control assessments, the set-up of safe treatment centres, and community engagement,” the WHO said in a statement issued on Sunday. WHO Director-General Dr Tedros Adhanom Ghebreyesus said that the outbreak meets the criteria of the definition of PHEIC in terms of the International Health Regulations as it is “extraordinary”, constitutes a public health risk to other countries and “requires international coordination and cooperation to understand the extent of the outbreak, to coordinate surveillance, prevention and response efforts, to scale up and strengthen operations and ensure ability to implement control measures.” The “extraordinary” nature of the outbreak includes “unusual clusters of community deaths with symptoms compatible BVD”, and the high positivity rate of the initial samples collected (eight positive out of 13 samples). The WHO is in the process of convening an emergency committee under the provisions of the IHR, “as soon as possible” to advise affected countries on how to respond to the outbreak. WHO Member States Should Treat Fossil Fuels like Tobacco – as a Public Health Threat 15/05/2026 Jeni Miller Protests against fossil fuel lobbyists at COP30 in Bélem, Brazil, likening them to having the tobacco industry at a health conference. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. In the coming days, the annual World Health Assembly will convene in Geneva. Following the recent Santa Marta Conference on Transitioning Away from Fossil Fuels, national health ministers and global health leaders have both an opportunity and responsibility to address the root cause of the climate-induced health crisis: fossil fuels. The Santa Marta conference addressed the need to transition away from fossil fuels, the root cause of climate change. Fifty-seven countries, representing one-third of the global economy, committed to developing roadmaps to end fossil fuel use, marking an important step toward protecting public health and the climate. Santa Marta demonstrated growing momentum beyond traditional climate negotiations. While the UN climate COP process remains essential, countries increasingly recognize that progress has been too slow given the escalating impacts of climate change and health. The next Santa Marta conference, hosted by Tuvalu and Ireland in 2027, will provide a key opportunity to strengthen international cooperation on phasing out fossil fuels. Fossil fuel combustion constitutes the biggest public health emergency of our time Heavy-Duty trucks and buses spew out soot, including climate-changing black carbon and health harmful PM2.5 on a highway. Climate change is not only an environmental issue; it is a public health emergency. Fossil fuels are not just an energy source; they are harmful to health. Despite this, health was largely overlooked – the final Santa Marta conference text had no mention of health. The health community must raise a clamour to ensure that future climate negotiations take our health into consideration. Fossil fuels harm human health throughout their lifecycle, from extraction and refining to transport, combustion, and petrochemical production. They pollute air, water, and soil; drive extreme heat and food insecurity; worsen respiratory and cardiovascular diseases; and contribute to millions of premature deaths each year. Frontline communities near extraction sites, refineries, highways, ports, and petrochemical facilities face disproportionate risks of toxic exposure, cancer, displacement, and economic disruption. The world is already experiencing the consequences of the fossil-fuel-driven climate crisis. Last month, temperatures in parts of South and Southeast Asia reached 45 to 46°C, making outdoor work unsafe and pushing the limits of human survivability. Floods, wildfires, storms, crop failures, and infectious disease outbreaks are increasingly overwhelming health systems worldwide. Subsidizing the sale of products that harm human health Ending fossil fuel subsidies would be one of the most effective global public health interventions ever, also averting 1.2 deaths a year from air pollution. Yet governments continue to subsidize the very products causing this harm. In 2024 alone, fossil fuels received an estimated US$725 billion in public subsidies, even as air pollution, much of it from fossil fuels, costs the global economy about US$8.1 trillion annually in healthcare expenses, lost productivity, and premature deaths. From a public health perspective, this contradiction is stark: governments are using public funds to subsidize disease, death, climate disruption, and increased pressure on already overburdened health systems. The true cost of fossil fuels remains obscured because health harms are treated as “externalities.” But asthma, strokes, heat deaths, cancers, pregnancy complications, and polluted drinking water are not externalities; they are direct and devastating impacts. When these costs are fully accounted for, fossil fuels are no longer economically rational. They are a dangerous and outdated relic. Following the example of Tobacco Six out of ten smokers, or 750 million people globally want to quit tobacco use. For decades already, the health community has carried the weight of responding to the symptoms of the climate-induced health crisis while often avoiding its primary cause. This must change. And yet, the health community has both the moral authority and institutional capacity to speak to the impacts of fossil fuels directly. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. There is already a clear precedent: the World Health Organization Framework Convention on Tobacco Control (FCTC), the first global treaty negotiated under WHO leadership. The FCTC recognized that protecting health requires more than treating disease; it requires regulating the industry responsible for the harm. We can apply this same approach to fossil fuels. Tobacco control showed that effective public health action requires conflict-of-interest protections, restrictions on advertising and sponsorship, public education, fiscal measures, warning labels, litigation support, and international cooperation to reduce demand for harmful products. Fossil fuels require a similarly comprehensive response. Health ministries and the WHO have a critical role in advancing this agenda. The 78th session of the World Health Assembly in May 2025 – member states passed a Global Action Plan for climate and health. Ending fossil fuel subsidies would put teeth into that decision. The World Health Assembly is the world’s highest decision-making forum on health. Resolutions passed in Geneva shape national health priorities, influence financing, guide public health norms, and determine how governments respond to emerging threats. WHA can guide the WHO Secretariat in advocating for stronger conflict-of-interest protections to limit the influence of the fossil fuel industry in health policymaking and other multilateral processes. They can document the full lifecycle health harms of fossil fuels, plan protective health measures, promote health impact assessments for fossil fuel projects and infrastructure, and support air pollution standards based on current science. They can also champion subsidy reform as a public health intervention and help redirect public finance toward clean energy, resilient health systems, and social protection. The health community can also help revoke the social license of the fossil fuel industry by clearly communicating that these products are fundamentally incompatible with health protection. This is especially urgent as fossil fuel companies continue to use disinformation, greenwashing, and political influence to delay action, tactics long recognized by the public health community from efforts against other health-harming industries. At WHA78 last year, countries made progress through the WHO Global Action Plan on Climate Change and Health and commitments to reduce air pollution deaths. However, these efforts will remain incomplete unless governments address the primary driver of both climate change and air pollution: fossil fuels. WHA member states must recognise that fossil fuels are health-harming products, and their phase-out is a public health imperative. The science is clear, the health evidence is overwhelming, and solutions exist. The question now is whether the global health community is prepared to address the cause of the crisis, not just its consequences. On May 19th, the Global Climate and Health Alliance and the Office of the United Nations High Commissioner for Human Rights (OHCHR) will co-host Fossil Fuels, Health, and Human Rights – Centering Health and Human Rights in the Global Transition Away from Fossil Fuels where the issue will be discussed. It would be open to attend in person in Geneva and via Zoom. Dr Jeni Miller is Executive Director of the Global Climate and Health Alliance, a consortium of more than 250 health professional and health civil society organisations and networks from around the world addressing climate change. Image Credits: Mike Muzurakis IISD/ENB , UNEP, Galen Crout , Sarah Johnson. Posts navigation Older postsNewer posts
WHO Member States Should Treat Fossil Fuels like Tobacco – as a Public Health Threat 15/05/2026 Jeni Miller Protests against fossil fuel lobbyists at COP30 in Bélem, Brazil, likening them to having the tobacco industry at a health conference. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. In the coming days, the annual World Health Assembly will convene in Geneva. Following the recent Santa Marta Conference on Transitioning Away from Fossil Fuels, national health ministers and global health leaders have both an opportunity and responsibility to address the root cause of the climate-induced health crisis: fossil fuels. The Santa Marta conference addressed the need to transition away from fossil fuels, the root cause of climate change. Fifty-seven countries, representing one-third of the global economy, committed to developing roadmaps to end fossil fuel use, marking an important step toward protecting public health and the climate. Santa Marta demonstrated growing momentum beyond traditional climate negotiations. While the UN climate COP process remains essential, countries increasingly recognize that progress has been too slow given the escalating impacts of climate change and health. The next Santa Marta conference, hosted by Tuvalu and Ireland in 2027, will provide a key opportunity to strengthen international cooperation on phasing out fossil fuels. Fossil fuel combustion constitutes the biggest public health emergency of our time Heavy-Duty trucks and buses spew out soot, including climate-changing black carbon and health harmful PM2.5 on a highway. Climate change is not only an environmental issue; it is a public health emergency. Fossil fuels are not just an energy source; they are harmful to health. Despite this, health was largely overlooked – the final Santa Marta conference text had no mention of health. The health community must raise a clamour to ensure that future climate negotiations take our health into consideration. Fossil fuels harm human health throughout their lifecycle, from extraction and refining to transport, combustion, and petrochemical production. They pollute air, water, and soil; drive extreme heat and food insecurity; worsen respiratory and cardiovascular diseases; and contribute to millions of premature deaths each year. Frontline communities near extraction sites, refineries, highways, ports, and petrochemical facilities face disproportionate risks of toxic exposure, cancer, displacement, and economic disruption. The world is already experiencing the consequences of the fossil-fuel-driven climate crisis. Last month, temperatures in parts of South and Southeast Asia reached 45 to 46°C, making outdoor work unsafe and pushing the limits of human survivability. Floods, wildfires, storms, crop failures, and infectious disease outbreaks are increasingly overwhelming health systems worldwide. Subsidizing the sale of products that harm human health Ending fossil fuel subsidies would be one of the most effective global public health interventions ever, also averting 1.2 deaths a year from air pollution. Yet governments continue to subsidize the very products causing this harm. In 2024 alone, fossil fuels received an estimated US$725 billion in public subsidies, even as air pollution, much of it from fossil fuels, costs the global economy about US$8.1 trillion annually in healthcare expenses, lost productivity, and premature deaths. From a public health perspective, this contradiction is stark: governments are using public funds to subsidize disease, death, climate disruption, and increased pressure on already overburdened health systems. The true cost of fossil fuels remains obscured because health harms are treated as “externalities.” But asthma, strokes, heat deaths, cancers, pregnancy complications, and polluted drinking water are not externalities; they are direct and devastating impacts. When these costs are fully accounted for, fossil fuels are no longer economically rational. They are a dangerous and outdated relic. Following the example of Tobacco Six out of ten smokers, or 750 million people globally want to quit tobacco use. For decades already, the health community has carried the weight of responding to the symptoms of the climate-induced health crisis while often avoiding its primary cause. This must change. And yet, the health community has both the moral authority and institutional capacity to speak to the impacts of fossil fuels directly. Just as health leaders reframed tobacco from a consumer product to a public health threat, they can now help shift the narrative on fossil fuels. There is already a clear precedent: the World Health Organization Framework Convention on Tobacco Control (FCTC), the first global treaty negotiated under WHO leadership. The FCTC recognized that protecting health requires more than treating disease; it requires regulating the industry responsible for the harm. We can apply this same approach to fossil fuels. Tobacco control showed that effective public health action requires conflict-of-interest protections, restrictions on advertising and sponsorship, public education, fiscal measures, warning labels, litigation support, and international cooperation to reduce demand for harmful products. Fossil fuels require a similarly comprehensive response. Health ministries and the WHO have a critical role in advancing this agenda. The 78th session of the World Health Assembly in May 2025 – member states passed a Global Action Plan for climate and health. Ending fossil fuel subsidies would put teeth into that decision. The World Health Assembly is the world’s highest decision-making forum on health. Resolutions passed in Geneva shape national health priorities, influence financing, guide public health norms, and determine how governments respond to emerging threats. WHA can guide the WHO Secretariat in advocating for stronger conflict-of-interest protections to limit the influence of the fossil fuel industry in health policymaking and other multilateral processes. They can document the full lifecycle health harms of fossil fuels, plan protective health measures, promote health impact assessments for fossil fuel projects and infrastructure, and support air pollution standards based on current science. They can also champion subsidy reform as a public health intervention and help redirect public finance toward clean energy, resilient health systems, and social protection. The health community can also help revoke the social license of the fossil fuel industry by clearly communicating that these products are fundamentally incompatible with health protection. This is especially urgent as fossil fuel companies continue to use disinformation, greenwashing, and political influence to delay action, tactics long recognized by the public health community from efforts against other health-harming industries. At WHA78 last year, countries made progress through the WHO Global Action Plan on Climate Change and Health and commitments to reduce air pollution deaths. However, these efforts will remain incomplete unless governments address the primary driver of both climate change and air pollution: fossil fuels. WHA member states must recognise that fossil fuels are health-harming products, and their phase-out is a public health imperative. The science is clear, the health evidence is overwhelming, and solutions exist. The question now is whether the global health community is prepared to address the cause of the crisis, not just its consequences. On May 19th, the Global Climate and Health Alliance and the Office of the United Nations High Commissioner for Human Rights (OHCHR) will co-host Fossil Fuels, Health, and Human Rights – Centering Health and Human Rights in the Global Transition Away from Fossil Fuels where the issue will be discussed. It would be open to attend in person in Geneva and via Zoom. Dr Jeni Miller is Executive Director of the Global Climate and Health Alliance, a consortium of more than 250 health professional and health civil society organisations and networks from around the world addressing climate change. Image Credits: Mike Muzurakis IISD/ENB , UNEP, Galen Crout , Sarah Johnson. Posts navigation Older postsNewer posts